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Summary 
1  Summary 
 
Cell division entails the segregation of replicated chromosomes during mitosis and the 
separation of the cytoplasm and its organellar content in cytokinesis to yield two daughter 
cells. During cytokinesis a circumferential furrow is established on the surface of a dividing cell 
that deepens perpendicular to the axis of the mitotic spindle. The furrow differentiates into the 
intercellular bridge, which contains a specialized organelle, the midbody, lying in its centre. At 
the midbody, membrane insertion allows sealing of the cytoplasmic channel that interconnects 
the daughter cells and results in their separation. High fidelity in cytokinesis regulation is an 
essential mechanism to prevent aberrant divisions and, in consequence, multinucleation and 
accumulation of centrioles that can lead to unwanted cell transformation. 
This study demonstrates that BRUCE (baculovirus inhibitor of apoptosis repeat 
containing ubiquitin-conjugating enzyme), a huge 528 kDa anti-apoptotic protein with ubiquitin-
conjugating activity, is a regulator of cytokinesis. Depletion of BRUCE from cultured 
mammalian cells leads to the formation of elongated syncytia and to cytokinesis-associated 
apoptosis. Furthermore, BRUCE is required for proper midbody structure and formation of its 
central part, the midbody ring. 
It is shown that BRUCE can serve as a multifunctional scaffold by interacting with the 
vesicle targeting machinery and mitotic regulators. Upon mitotic exit, BRUCE is targeted to the 
midbody ring via its C-terminus binding to MKLP1 (mitotic kinesin-like protein 1), which is a 
core component of the midbody ring. Additionally, this study identifies BRUCE as a component 
of tubular endosomes in interphase cells and it is demonstrated that this compartment is 
utilized as a pool for membrane insertion in late cytokinesis. Hence, the molecular basis of the 
phenotypes seen after BRUCE depletion are a failure of membrane delivery and defective 
recruitment of mitotic regulators to the midbody ring. Notably, these phenotypes resemble 
those seen in cells depleted of centriolin, a protein necessary for the localization of membrane 
tethering factors to the midbody ring. 
Additionally, it is demonstrated that ubiquitin itself shows a dynamic pattern of 
localization first highly concentrated on midbody microtubules and later on the midbody ring 
after constriction of the intercellular connection. Upon BRUCE depletion, this localization 
pattern of ubiquitin is lost and midbody rings are lost concomitantly. Both BRUCE and MKLP1 
are ubiquitylated and UBPY (ubiquitin-specific protease Y) is shown to serve as their de-
ubiquitylating enzyme. Preventing de-ubiquitylation by a dominant negative mutant of UBPY  
leads to the accumulation of binucleate cells and mislocalization of MKLP1.  
BRUCE can therefore serve as a factor linking the ubiquitin-proteasome system to 
membrane traffic thereby ensuring proper abscission during cytokinesis. 
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2  Introduction 
 
2.1  Cytokinesis as the final process in cell division 
Animal cell division is usually divided in five discernible phases, the first four of which 
(prophase, metaphase, anaphase and telophase) ensure segregation of the genetic material 
into the two daughter cells. The fifth phase – cytokinesis – representing the final and 
irreversible step of division, separates the cytoplasmic volumes of the daughter cells by 
sealing the intercellular bridge, which connects them (Figure 1).  
 
 
 
As early as in 1891, Flemming described specialized structures in lung epithelial cells 
of salamander larva that were only visible late during cell division (Flemming, 1891). He 
speculated that these might represent the vertebrate equivalent of the plant cell plate. Notably, 
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he discovered a densely stained body at the site of abscission, 1-1.5 µm in size, naming it 
!Zwischenkörper" (midbody) which he could also trace in cells that had finally separated. 
According to his perception the !Zwischenkörper" then vanished at the cell boundary. 
Furthermore, he perceived that the !Verbindungsfäden" (connecting threads) are constricted at 
the site of abscission coming from both daughter cells and ending in the !Zwischenkörper" on 
either side. He also recognized an !eigenthümliche Differenzirung" (strange differentiation) of 
stainable bodies earlier when the site of furrowing is first discernible and concluded that this 
might represent the structures that transform into the !Zwischenkörper". Flemming"s 
observations and other early reports on cell division lead to the widely accepted concept that 
the mitotic apparatus is important for both transport of chromosomes to opposite poles and for 
the division of the cytoplasmic mass (Belar, 1929a; Belar 1929b; Inoue 1953). 
Cytokinesis is usually described by four timely and morphologically distinct sub- 
processes. Already overlapping with anaphase, signals derived from the mitotic spindle specify 
the cleavage plane and thereby cortical sites for furrowing. This is preceded by furrow 
ingression mediated by a plasma membrane anchored ring consisting of actin and myosin II. 
Beneath this ring, microtubule remodeling and protein relocalization from spindle poles and 
centromeres leads to the formation of the midzone holding the half-spindles apart. Constriction 
of the cell cortex subsequently leads to the formation of a narrow intercellular channel that 
contains the midbody consisting of tightly bundled anti-parallel microtubules originating from 
the midzone that embrace a phase-dense structure called midbody ring. Finally, during 
abscission, vesicular material is delivered along midbody microtubules to the midbody ring. 
Homo- and probably heterotypic fusion events of vesicles seal the intercellular connection, 
thereby separating the two daughter cells (Glotzer, 2001; Eggert et al., 2006). 
In this study, BRUCE is introduced as a novel factor acting during late stages of 
cytokinesis. The following outline will describe the molecular mechanisms of cytokinesis, its 
links to the cell cycle machinery, membrane traffic and ubiquitin-dependent regulation to allow 
a classification of BRUCE in the context of late stages of cell division. The outline will focus on 
animal cells and the mammalian nomenclature for genes and proteins unless noted otherwise.  
 
2.2  The timing of cytokinesis 
The existence of a time window during the cell cycle in which cytokinesis can occur was first 
demonstrated in experiments by Rappaport (Rappaport, 1975; Rappaport and Rappaport, 
1993) and this phase was later termed C-phase (Canman et al., 2000). C-phase timing, like 
any other cell cycle stage, relies on cyclin-dependent kinases (Cdks), which drive cells through 
mitosis in cooperation with several other protein kinases such as those of the Polo and Aurora 
Introduction 
4
 
families (Nigg, 2001). Cdks are only active when bound to their cognate cyclin cofactor. 
Fluctuations in cyclin levels due to synthesis and regulated destruction therefore allow Cdk 
activity to be restricted to certain phases of the cell cycle. Evidence from several experimental 
systems suggests that Cdk1 activity has to drop to allow cytokinesis and that the spindle must 
be assembled properly (Wheatley et al., 1997; Canman et al., 2000). These two prerequisites 
must also be met in order to allow anaphase onset and mitotic exit (Peters, 2006). The cell 
cycle oscillator therefore dictates the timing of cytokinesis by ensuring the coordination of 
chromosome segregation with separation of the cytoplasm. Interestingly, the inhibition of Cdk1 
after anaphase onset alone is sufficient to induce cytokinesis without chromosome segregation 
(Niiya et al., 2005). Apart from Cdk1, another cell cycle-regulated kinase, Polo-like kinase 1 
(Plk1), represents a key component of mitotic and cytokinetic events (Barr et al., 2004). Its 
activity rises during mitosis and Plk1 subsequently phosphorylates several components 
needed for midzone and midbody formation (see below). Moreover, Plk1 can dock to pre-
phosphorylated proteins and thereby reach subcellular sites where its activity is needed e.g. 
centrosomes, the midzone, and the midbody. These pre-phosphorylated sites are often 
created by Cdk1 (Elia et al., 2003). Cdk1 and Plk1 action can hence be considered a hand-
over mechanism. 
Furthermore, cytokinesis timing is connected to the phosphorylation of myosin II which 
is elementary for the proper formation and function of the contractile actomyosin ring, although 
the kinase necessary for this process is not yet unambiguously identified (Komatsu et al., 
1997a; Komatsu et al., 1997b; Kosako et al., 2000; Komaba et al., 2001; Murata-Hori et al., 
2000; Murata-Hori et al., 2001; Suizu et al., 2002; Yamashiro et al., 2003; Batchelder et al., 
2007). Nonetheless, several of the kinases implicated are also found to be regulated by 
upstream kinases, which are in turn cell cycle-dependent. Additionally, inhibiting ubiquitin-
dependent protein degradation prevents or slows down cytokinesis (Shuster and Burgess, 
2002; Straight et al., 2003; and see below). This could be explained by a stabilization of cyclin 
B, the activating cofactor for Cdk1, thereby keeping its activity high. Altogether, kinase 
signaling governed by the cell cycle starting from the point of anaphase onset represents the 
up-most layer of temporal regulation in cytokinesis. 
 
2.3  Cleavage site specification 
Establishing the cleavage site represents the first step in cytokinesis, which is subject to both 
temporal regulation – coupling it to the cell cycle –  and spatial regulation –  coupling it to 
spindle position (Glotzer, 2001; Eggert et al., 2006). Since the classical experiments performed 
by Rappoport in the 1960ies (Rappaport, 1996), it has become clear that cues originating from 
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the spindle apparatus can induce furrowing, the first morphologically distinct event in 
cytokinesis, by modulation of cortical actin (Bray and White, 1988; see Figure 1). Nonetheless, 
until recently, the contributions from astral microtubules (the radial non-spindle microtubules 
originating from centrosomes) vs. spindle midzone microtubules (anti-parallel microtubules 
from the spindle remaining after chromosome separation) were unclear. Spatial separation of 
asters and midzones using laser-dissection showed that the furrow is first positioned by an 
astral signal and subsequently by a second midzone-derived signal (Bringmann and Hyman, 
2005). Several factors were identified that are either needed for both furrowing activities 
(components of the contractile ring), or are needed primarily for the midzone-induced furrowing 
(kinases, microtubule bundling factors, kinesin transport protein, see below). The astral 
pathway seems to negatively regulate cortical myosin II recruitment, thereby inducing a break 
in symmetry that allows equatorial furrowing by coalescence of cortical contractile elements 
(Werner et al., 2007). Strikingly, there is an additional layer of asymmetry in many cell types in 
that unilateral furrowing can be observed: Cells first initiate a symmetric circumferential furrow, 
but then one of its edges stops furrowing while the furrow associated with the opposing edge 
continues (Savoian et al., 1999). This suggests that individual furrowing units can work 
independently and that the contractile ring does not function like a 'purse string' as previously 
envisioned. Recent data supports these ideas and shows that asymmetry might originate from 
anillin (an actin filament cross linker) and septins (filamentous components of the contractile 
ring). These proteins allow unilateral instead of circumferential symmetry of furrowing, thereby 
ensuring robustness of cytokinesis and adaptability to developmentally demanded asymmetric 
ingression (Maddox et al., 2007). 
The molecular requirements that specify the site of furrowing are mainly attributed to 
signaling via Rho GTPases (Piekny et al., 2005). Rho cooperates with its guanine nucleotide 
exchange factor (GEF) Ect2 and its GTPase activating protein (GAP) MgcRacGAP to 
coordinate contractile ring assembly. Downstream targets for Rho are kinases implicated in 
myosin II phosphorylation (citron kinase, Rho kinase ROCK), myosin phosphatase, and formin 
family proteins that promote actin polymerization. Recently, the initial event for Rho activation 
has been elucidated (Burkard et al., 2007; Petronczki et al., 2007; Brennan et al., 2007). The 
key mitotic kinase Plk1 phosphorylates Ect2, which only then can bind to MgcRacGAP at the 
spindle midzone from where it reaches cortical sites. Here, this protein complex can act on 
Rho to induce contractile ring formation. Surprisingly, the Plk1-dependent mechanism for Rho 
localization seems to be conserved in yeast where cytokinesis apparently utilizes different 
mechanisms (Yoshida et al., 2006). In contrast to the current notion, it was also recently 
shown that Ect2 serves mainly to restrict activated Rho to the midzone/furrow and that a newly 
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discovered GEF, GEF-H1, is needed for persistent Rho activation, probably superseding Ect2 
as the major GEF for Rho (Birkenfeld et al., 2007).  
 
2.4  The spindle midzone and the formation of the midbody 
Concomitant with the formation of the cortical actomyosin ring, large rearrangements take 
place in the spindle midzone. Elongated overlapping microtubules underneath the contractile 
ring that were formerly attached to the spindle become gradually self-organized and bundled. 
They also lose contact with centromeres and their organizing centers, lying in the cytoplasm, 
at this point also contain !-tubulin (Julian et al., 1993; Shu et al., 1995). The micotubules of the 
midzone keep the two genomes separate and deliver proteins that trigger the second signal for 
furrow formation. Bundling of midzone microtubules is achieved by the joint action of 
microtubule associated proteins (MAP) and kinesin motor proteins. The function of the spindle 
midzone was already outlined in the stembody hypothesis by Belar (Belar, 1929a; Belar, 
1929b), who described !Stemmfasern" (pushing threads, microtubules) that help to further push 
spindle poles apart in order to support chromosome segregation and cell elongation,  
PRC1 (protein required for cytokinesis 1) represents a major microtubule-bundling 
factor in the midzone as demonstrated in vivo and in vitro (Mollinari et al., 2002). It is tightly 
regulated by cell cycle-dependent kinases (Jiang et al., 1998; Zhu and Jiang, 2005). PRC1 can 
only interact with kinesin motor proteins like KIF4, which travel on midzone microtubules, if its 
Cdk1-dependent phosphorylation is lost. Furthermore, Cdk1 phosphorylation of PRC1 in 
metaphase is thought to prevent Plk1 binding. After anaphase onset, Cdk1 activity drops and 
Plk1 can phosphorylate PRC1, thereby creating its own docking site. PRC1 then in turn 
delivers Plk1 to the midzone/midbody (Neef et al., 2007). In addition, there seems to be an 
interdependency of localization: on the one hand, PRC1 interacts with several kinesins needed 
for cytokinesis (KIF4, KIF14, MKLP1/2) and is needed for their proper localization as well as 
for the localization of their cargo e.g. citron kinase (Gruneberg et al., 2006). On the other hand, 
depletion of mitotic kinesins MKLP1/2 also leads to a block in midzone assembly and a loss of 
PRC1 at that site (Matuliene and Kuriyama, 2002; Gruneberg et al., 2004). Recently it has 
been shown that at least 15 kinesins are involved in mitosis/cytokinesis regulation (Zhu et al., 
2005). Among these are Eg5, KIF2A and KIFC1 which are needed for spindle formation, 
MCAK, CENP-E, KIF14, KIF18 and KID required for chromosome alignment, and KIF3A, 
KIF4A/B, KIF12, MPP1 and MKLP1/2 essential for cytokinesis (Abaza et al., 2003; Zhu et al., 
2005; D"Avino et al., 2007; Chen et al., 2007).  
A core component at the midzone besides PRC1 is the plus-end-directed motor protein 
mitotic kinesin-like protein 1 (MKLP1 or KIF23) (Nislow et al., 1992). In interphase cells, 
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MKLP1 localizes exclusively to the nucleus. In cytokinesis, MKLP1 is first associated with the 
midzone and then with the midbody ring (Adams et al., 1998). MKLP1 persistently associates 
with the midbody ring also when it is taken up as a division remnant (Nislow et al., 1990; 
Powers et al., 1998; Raich et al., 1998). In all animal systems tested, MKLP1 is essential for 
the persistence of the contractile ring, midzone assembly and completion of cytokinesis. 
MKLP1 co-purifies on the one hand with Plk1 and on the other hand with MgcRacGAP in a 
complex called centralspindlin from C. elegans embryos and human cells, most likely in a 2:2 
stoichiometry (Liu et al., 2004; Mishima et al., 2002; Yuce et al., 2005). This configuration 
might allow bridging of anti-parallel microtubules. Additionally, this complex binds the Rho GEF 
Ect2. Hence, the centralspindlin complex represents an integrating element allowing midzone-
derived furrowing activity by mediating a crosstalk of actomysosin ring regulators and activities 
that support midbody formation. 
In order to function in cytokinesis, MKLP1 needs to be de-phosphorylated at sites that 
were phosphorylated by Cdk1 in metaphase and has in turn to be phosphorylated by Aurora B, 
the kinase component of the chromosomal passenger complex (Guse et al., 2005; Neef et al., 
2006; see below). Aurora B phosphorylation thereby inactivates a bipartite nuclear localization 
signal preventing premature nuclear re-import of MKLP1. Interestingly, transfer of Aurora B 
from centromeres to the midzone requires a functionally related kinesin, MKLP2 (Hill et al., 
2000; Neef et al., 2006). Moreover, both MKLP1 and MKLP2 bind to and are phosphorylated 
by Plk1 (Lee et al., 1995; Adams et al., 1998; Neef et al., 2003) and the modifications are 
probably also important for proper cytokinesis. MKLP1 possesses an alternatively spliced 
isoform, called CHO1, that includes exon 18 (Kuriyama et al., 2002). The domain encoded by 
exon 18 allows CHO1 to additionally bind actin, arguing for a direct link of the midzone to the 
cortical actomyosin ring and divergent functions of the two isoforms at the midzone. Notably, 
MKLP1 also plays a role in postmitotic cells. It has been found in dendritic processes where it 
establishes the pattern of non-uniform microtubule polarity (Sharp et al., 1997). 
Another factor that can interact both with mitotic kinesins and bundle microtubules, is 
Cep55 (Fabbro et al., 2005; Zhao et al., 2006). Cep55 binds to the centralspindlin complex and 
also to Tsg101, a component of the !endosomal sorting complex required for transport" 
(ESCRT) (Zhao et al., 2006; Carlton and Martin-Serrano, 2007). The role of ESCRT in 
cytokinesis will be described below. Notably, Cep55 was identified as a centrosomal protein 
where it interacts with !-tubulin ring complex anchoring proteins (Fabbro et al., 2005). To 
participate in cytokinesis, Cep55 is first phosphorylated by Erk2/Cdk1, which creates a docking 
site for Plk1, which in turn adds another phosphorylation allowing Cep55 to travel to the 
midzone. Here, it is needed for proper formation of the midbody by localizing PRC1 and 
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MKLP2, as well as for membrane-mediated abscission by controlling the SNARE proteins 
endobrevin and syntaxin-2 (Zhao et al., 2006). Hence, Cep55 represents a direct link of 
centrosomes and the midbody (Doxsey, 2005). There are also several other proteins, like 
Cdc14A, Lats1/2 and centriolin that localize to centrosomes and translocate to the midbody in 
cytokinesis (see below; Doxsey, 2005; Doxsey et al., 2005). 
The idea of molecular contacts mediated by proteins translocating from centrosomes to 
midbodies is supported by findings in HeLa cells, demonstrating a post-anaphase 
repositioning of centrosomes towards the midbody (Piel et al., 2001). Piel et al. concluded that 
only when the mother centriole moved to the midbody and then back to the cell center, cells 
finally separate. They also provide evidence that the function of the centrosome is to release 
midbody microtubules to proceed with abscission. 
A central element that serves to connect the above mentioned events of midzone and 
midbody formation to the dynamics of the mitotic spindle is a protein complex known as the 
chromosomal passenger complex (CPC). It consists of the kinase Aurora B, the inner 
centromere protein INCENP, the small baculovirus inhibitor of apoptosis repeat (BIR)-
containing protein survivin, and borealin (Ruchaud et al., 2007). In metaphase, CPC is 
concentrated on inner centromeres by the interdependent binding of INCENP and survivin to a 
not yet unambiguously identified centromere-receptor. A contribution of centromeric histones 
CENP-A and H2A.Z to CPC recruitment is suggested (Zeitlin et al., 2001; Kunitoku et al., 
2003; Rangasamy et al., 2003). At this stage, Aurora B phosphorylates histone H3 and 
condensin subunits, probably leading to altered chromosome structures (Giet and Glover, 
2001). Subsequently, CPC is crucial for the release of arm cohesion, kinetochore maturation 
and proper spindle assembly. After anaphase onset, CPC transfers from centromeres to the 
midzone and the midbody. This transfer is at least in part dependent on MKLP2 (Gruneberg et 
al., 2004; see above). Besides this, Aurora B phosphorylates multiple other proteins 
(MgcRacGAP, MKLP1, myosin II) whose modification positively affects cytokinesis. 
Similar to mitotic kinesins and their respective cargo, there seems to be a great extend 
of interdependencies as far as localization of CPC components and substrates is concerned. A 
putative CPC-function at the interface of chromosome segregation and cytokinesis is 
suggested by the so-called NoCut pathway in S. cerevisiae, where the Aurora B-homolog Ipl1 
regulates the localization of two anillin-like proteins, Boi1/2, negative regulators of cytokinesis 
(Norden et al., 2006). Boi1/2 are removed from the bud neck only when chromosome 
separation is completed and Ipl1 is inactive. A similar process is not yet described for higher 
eukaryotes.  
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Figure 2 summarizes the molecular inventory of cytokinesis described so far by 
grouping proteins in three main classes: Regulators, structural components of the actomyosin 
ring, and components of the central spindle necessary for midbody formation. 
 
 
 
2.5  Links between mitotic exit and cytokinesis 
As detailed above, there are multiple lines of evidence that suggest first a coupling of mitotic 
exit to the licensing of cytokinesis and second an involvement of centrosomes or centrosomal 
proteins in cytokinesis. This demands a comparison to the elaborate networks that govern 
mitotic exit in yeast, the mitotic exit network (MEN) in S. cerevisiae and the septation initiation 
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network (SIN) in S. pombe. (Krapp et al., 2004; Bosl and Li, 2005; Doxsey et al., 2005). The 
yeast equivalents of centrosomes, the spindle pole bodies (SPBs), constitute the organizing 
platforms of both networks. Like in animal cell cytokinesis, these networks ensure cell division 
after completion of chromosome separation with an interphase-like state of Cdk1/Cdc2 activity. 
The core of both networks is a GTPase system that monitors the position of the anaphase 
spindle. Interestingly, SIN and MEN are organized asymmetrically. In fission yeast SIN, 
inhibitory components are localized to the old SPB. In budding yeast, the old SPB translocates 
into the bud and activators bind on this SPB.  
This asymmetry in SIN and MEN might be needed to prevent premature activation 
before anaphase. Notably, similar asymmetries are also found in animal cell cytokinesis, e.g. 
asymmetric centrosome movement (Piel et al., 2001) and asymmetric delivery of membranes 
to the midbody (Gromley et al., 2005; see below). If the spindle is positioned improperly, 
SIN/MEN can delay anaphase onset. Additionally, in budding yeast, MEN is coupled to mitotic 
exit by the Cdc14 early anaphase release (FEAR). Cdc14, a phosphoprotein phosphatase, 
drives mitotic exit by dephosphorylating and thereby activating anaphase promoting complex 
(APC) activators and Cdk inhibitors. Cdc14 is only transiently released in early anaphase and 
MEN activation later allows sustained release leading to a second wave of cyclin degradation, 
mitotic exit and cytokinesis. Notably, Cdc14 localization is affected by the yeast Plk1 homolog 
Cdc5 (Visintin et al., 2003).  
Due to the general differences between yeast and animal cells – e.g. closed vs. open 
mitosis, budding before spindle alignment, etc. – a similar regulation like FEAR/MEN in higher 
eukaryotes is not directly extrapolatable. Nevertheless, several components that could either 
act as the scaffold homologs (yeast Nud1 vs. mammalian centriolin), activating kinases (yeast 
Dbf2 vs. mammalian Lats1/2) or phosphatases (yeast Cdc14 vs. mammalian Cdc14A/B) are 
also found in mammals. However, there is no evidence yet for a centrosome-organized mitotic 
exit or a checkpoint-like delay in cytokinesis in animal cells.  
Data from higher eukaryotes provide evidence that there is not a unique decisive 
substrate that, when phosphorylated by Cdk1, prevents mitotic exit or cytokinesis on its own 
(Pines, 2006). It seems more likely that multiple targets need to be dephosphorylated in order 
to drive different sub-processes, leading to mitotic exit and cytokinesis. Several lines of 
evidence also disfavor the existence of a positive-feedback loop that would accelerate exit 
from mitosis once Cdk activity is low, limiting the similarities of mammalian mitotic exit to the 
networks in budding and fission yeast (Straight et al., 2003; Potapova et al., 2006). 
The plethora of regulatory principles and interdependencies that can be found during 
cytokinesis allow to conclude that a multitude of events, like degradation of cell cycle 
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regulators, cytoskeletal rearrangements and membrane traffic converge on the midbody. 
Therefore, the following chapters will describe the contributions of membrane traffic and of 
processes regulated by the ubiquitin-proteasome system to cytokinesis. 
 
2.6  Membrane traffic and its role in cell division 
In animal cells, it has become clear that plasma membrane remodeling is an integral element 
of abscission, the final event that takes place on the midbody (Straight and Field, 2000; Finger 
and White, 2002; Otegui et al., 2005; Albertson et al., 2005; Matheson et al., 2005; Baluska et 
al., 2006). It requires coordination by several regulators of vesicle trafficking that will be 
discussed below. 
Observing X. laevis eggs during cleavage, it has been found more than 30 years ago 
that new membrane is formed prior to cleavage (Bluemink and de Laat, 1973). Concerning the 
timing of this membrane delivery, the authors concluded that membrane insertion in 
cytokinesis is a late event, which is separable from furrow ingression. Furthermore, it has been 
shown during the process of cellularization in D. melanogaster that new membrane is inserted 
from intracellular pools (Lecuit and Wieschaus, 2000). During the first 13 divisions in 
Drosophila development, cells divide in a syncytium with only partially ingressing furrows in 
divisions 10-13. During the 14th division, for the first time in the process of cellularization, full 
cytokinesis occurs for all cells (Mazumdar and Mazumdar, 2002). 
Concerning the origin of membranes that are inserted in the cleavage furrow, several 
lines of evidence suggest that Golgi-derived exocytic membranes contribute to cytokinesis. 
Drosophila cellularization, in contrast to cleavages in C. elegans and sea urchins, is sensitive 
to inhibition of GTPases regulating protein secretion by Brefeldin A (BFA) (Shuster and 
Burgess, 2002; Sisson et al., 2000) and the Golgi membrane proteins strabismus (Lee et al., 
2003) and lava lamp (Sisson et al., 2000; Papoulas et al., 2005) are both required for 
cellularization. Lava lamp has also been shown to regulate targeted membrane insertion by 
dynein-based Golgi-movements (Papoulas et al., 2005). Besides exocytosis, endocytosis is 
also needed for membrane remodeling at the furrow. Both processes depend on small 
GTPases of the Rab and Arf/Arl families. Rab proteins are general regulators of organelle 
identity that specify the targeting of incoming membranes to the right acceptor membrane 
(Chavrier et al., 1990; Huber et al., 1993; Lombardi et al., 1993; Casanova et al., 1999; 
Sönnichsen et al., 2000; Zerial and McBride, 2001; Grigoriev et al., 2007). In the initial step of 
membrane fusion, the specific pairing of membrane zipping SNARE proteins (soluble NSF 
attachment protein receptors) between the two bilayers ensures selection of the right donor 
and acceptor membrane (Chen and Scheller, 2001). During this process Rabs define a second 
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layer of control preventing erroneous SNARE-mediated fusions. SNARE proteins syntaxin 2 
and endobrevin/VAMP8 themselves were found to be essential for cytokinesis (Low et al., 
2003). Rab proteins, like the related Arf/Arl proteins (Gillingham and Munro, 2007), are small 
GTPases. They switch between a GDP- and a GTP-bound state and this change is 
interconnected to a cycle of reversible attachment to membranes. After delivery to their target 
membranes, Rabs are activated by exchange of GDP to GTP, allowing interaction with an 
effector molecule. After completion of downstream events and GTP hydrolysis, Rabs are 
retrieved by GDI (GDP dissociation inhibitor) and delivered to their starting compartment 
(Goody et al., 2005). Besides SNARE proteins a multitude of Rab effector proteins are known 
to transduce information to downstream targets on their respective organelle.  
D. melanogaster mutants in endocytosis (Rab5 and dynamin GTPases) show impaired 
cellularization and, in the case of a dynamin mutant, accumulation of secretory cargo in 
recycling endosomes that contain Rab11 (Pelissier et al., 2003). This is explained by the fact 
that the large GTPase dynamin is not only important for endocytosis but also for vesiculation at 
intracellular organelles like the trans-Golgi network (TGN) and also Rab11 recycling 
endosomes. D. melanogaster expressing a dominant-negative version of Rab11 cannot 
perform cellularization. This phenotype resembles that of the nuclear-fallout (Nuf) mutant 
(Strickland and Burgess, 2004). In the Nuf mutant, actin and membrane remodeling at the 
furrow are impaired. Notably, the human Nuf homolog arfophilin-2/FIP4 binds to both Rab11 
and the small GTPase Arf5 in a GTP-dependent manner (Hickson et al., 2003). Recent data 
suggest that Nuf/FIP4 regulates the timing of Rab11 recycling endosome delivery to the 
cleavage furrow. FIP4 is concentrated around centrosomes only while Rab11 translocates to 
the furrow (Riggs et al., 2007). This mechanism of traffic regulation may constitute another 
example of centrosome-organized events in cytokinesis (see above). 
Further reports identified a whole family of Rab11/25-interacting proteins (FIPs), which 
all possess a C-terminal Rab-binding domain (Prekeris et al., 2000; Prekeris et al., 2001; 
Lindsay and McCaffrey, 2002; Hales et al., 2002). As mentioned above for FIP4, FIP3 can also 
bind to Arf GTPases. This dual Rab/Arf interaction plays a major role in the regulation of 
cytokinesis. It has been demonstrated that a dominant-negative form of Rab11 (Rab11-S25N) 
can induce multinucleation and that FIP3, FIP4 and Rab11 all localize to the midbody (Wilson 
et al., 2005). Disruption of the interaction of FIP3 with Rab11 led to cytokinesis failure and 
induced multinucleation. The recruitment of FIP3/4 to the midbody in turn depends on their 
interaction with Arf6 (Fielding et al., 2005). On the midbody, FIP3/4 serve as connectors 
between Arf6/Exo70 and Rab11 to allow vesicle tethering prior to fusion (Fielding et al., 2005). 
Introduction 
13
 
In addition to Arf6, there are probably contributions from other Arf-family members like Arf1 
and Arl1 to cytokinesis (Altan-Bonnet et al., 2003; Skop et al., 2004). 
Systematic approaches to elucidate the role of other Rab proteins in cytokinesis 
yielded partially contradictory data. Yu and colleagues (Yu et al., 2007) claim that only Rab11 
is involved in cytokinesis. In contrast, Kouranti and coworkers (Kouranti et al., 2006) show that 
interfering with Rab35 induced substantial binucleation. HeLa cells expressing dominant 
negative Rab35 S22N mislocalize the septin SEPT2/Nedd5 and the membrane lipid PI(4,5)P2 
(Kouranti et al., 2006). For PI(4,5)P2 the function at the cleavage furrow is mainly to recruit 
lipid-binding proteins containing PH-domains like PLC! (Naito et al., 2006) and to tether the 
contractile ring to the plasma membrane (Field et al., 2005).  
An additional example highlighting the importance of regulators of targeted membrane 
insertion for cytokinesis is represented by the recently demonstrated cooperation of the 
exocyst complex with the large coiled-coil centrosomal protein centriolin. In a screen for 
scleroderma pigmentosa autoantigens, Gromley and colleagues identified centriolin, which is 
found on the maternal centriole and, interestingly, also on the midbody (Gromley et al., 2003). 
They could show that centriolin depletion induces a rather unique failure in cytokinesis. Cells 
form regular furrows but never separate and form long intercellular bridges. Apart from 
extensive coiled-coils, centriolin also harbors a Nud1/Cdc11 domain. Cdc11 represents the 
scaffold of the above mentioned S. cerevisiae mitotic exit network. Overexpression of this 
isolated domain also elicits a failure in cytokinesis. Surprisingly, interconnected cells generated 
by centriolin depletion can undergo mitosis with a seemingly normal progeny. Centriolin has 
been found to interact with membrane targeting factors Snapin, a SNARE-associated protein 
and components of the exocyst complex namely Sec5, 8 and 15 (Gromley et al., 2005, see 
below). Cytokinetic centriolin localization has been pinned down further to the midbody ring. In 
addition, it was shown that Snapin and every single subunit of the exocyst localize to the 
midbody ring and that their localization to this site depends on centriolin. As a consequence, 
cells fail to undergo abscission and secretory vesicles accumulate adjacent to the midbody 
ring when cells are depleted of centriolin. Notably, Gromley et al. present evidence that some 
part of membrane material is delivered to the midbody only from one side.  
The exocyst, an evolutionarily conserved vesicle tethering complex, was originally 
identified in yeast (Novick et al., 1980; Novick et al., 1981; TerBush et al., 1996; Hsu et al., 
2004). Mutants in exocyst genes accumulate post-Golgi vesicles and it has been 
demonstrated that exocyst subunits localize to sites of polarized exocytosis. The mammalian 
complex has a size of 600-700 kDa and consists of Sec3, Sec5, Sec8, Sec10, Sec15, Exo70 
and Exo84. Interestingly, in mammals, the exocyst complex co-purifies with a septin-complex 
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(Hsu et al., 1998). The exocyst is implicated in various processes mediating constitutive 
secretion from the TGN to the plasma membrane. It also plays a central role in targeting 
vesicles to the midbody ring (Gromley et al., 2005). During cytokinesis, the exocyst relocalizes 
from a pericentrosomal site to the midbody. During this relocalization it also transfers another 
GTPase, RalA, to the midbody (Chen et al., 2006). Disruption of the RalA-exocyst functions on 
either side causes late stage cytokinesis failure like binucleation but also formation of two- to 
four-cell syncytia interconnected by elongated bridges filled with microtubule bundles. This 
phenotype in turn resembles the one of centriolin depletion arguing that this reflects an 
epistatic relationship. 
 
 
 
Several reports (Nislow et al., 1990; Powers et al., 1998; Raich et al., 1998; Gromley et 
al., 2005) demonstrated that part of the midbody – the midbody ring and adhering microtubules 
– are in fact taken up by one of the daughter cells after abscission. Consequently, this uptake 
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generates asymmetry, probably the only inherent asymmetric feature in cell division besides 
unilateral membrane delivery. However, there are also cases where asymmetry needs to be 
avoided (see also discussion). To maintain an initially undifferentiated state, progenitor cells 
have to divide symmetrically. A scenario that meets these requirements has been found in 
neuroepithelial cells. In these cells a transmembrane protein and somatic stem cell marker 
CD133/prominin-1 is clustered on midbodies that form at the apical side of the epithelium 
facing the neural tube (Dubreuil et al., 2007). To avoid asymmetric inheritance of the stem cell 
marker, cells release prominin-1-containing midbodies into the neural tube fluid.  
Figure 3 summarizes the molecular inventory of membrane traffic in cytokinesis as 
described above by grouping individual factors in six categories: Golgi proteins, lipids and lipid 
modifiers, recycling endosomal proteins, vesicular and plasma membrane proteins, ESCRT 
components, and centrosomal proteins. Several of these factors are regulated by ubiquitin, 
which will be discussed in the following paragraph. 
 
2.7  Post-translational modification of proteins with ubiquitin 
The covalent attachment of ubiquitin to target proteins constitutes a post-translational 
modification, which serves multiple purposes like protein degradation by the ubiquitin-
proteasome system (UPS) or modulation of protein function and/or localization (Figure 4). 
Protein modification with ubiquitin involves an enzymatic cascade of at least three steps 
(Jentsch, 1992; Kerscher et al., 2006). Ubiquitin is first synthesized as a poly-ubiquitin protein 
(3-5 ubiquitin units from the UbB gene and 9-10 ubiquitin units from the UbC gene) or as a 
fusion protein to the N-termini of ribosomal proteins (ribosomal protein L40 in the case of the 
UbA52 gene and ribosomal protein S27a in the case of the UbA80 gene) (Finley et al., 1989; 
Chan et al., 1995). These fusion proteins are then cleaved into their monomeric components 
by ubiquitin C-terminal hydrolases (UCHs) (Rose and Warms, 1983; Pickart and Rose, 1985). 
Hereafter, ubiquitin is activated by an E1 ubiquitin-activating enzyme that uses ATP to 
adenylate ubiquitin at its C-terminus. This ubiquitin-AMP is rapidly attacked by an internal 
sulfhydryl group in the E1 leading to an ubiquitin-E1 thioester (Ciechanover et al., 1982; Haas 
et al., 1982, Haas et al., 1983). The thioester is then transferred to an E2 ubiquitin-conjugating 
enzyme and transferred to the target protein by the help of an E3 ubiquitin ligase forming an 
isopeptide bond between the C-terminal carboxyl group in ubiquitin and the !-amino group of 
an internal lysine in the target (Hershko et al., 1986). E3 ligases of the RING-type (really 
interesting new gene) bring the E2 and the substrate into close proximity to allow ubiquitylation 
from the E2-thioester. In the case of HECT-type (homologous to E6-AP carboxy terminus) E3 
ligases, the E2-ubiquitin thioester is transferred onto a cystein in the E3 HECT domain and 
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then transfered to the substrate which is bound by the HECT E3 (Pickart, 2001). Selection in 
substrate modification is conferred by this final step at the level of the E3 ubiquitin ligase. This 
is also illustrated by the number of proteins known for each class of enzymes. So far only two 
E1 enzymes are known, while there are 33 E2 enzymes and 500-1000 E3 enzymes in 
mammalian cells (Kaiser and Fon, 2007; Jin et al., 2007; Pelzer et al., 2007). The 
computational analysis for the human genome is predicting even higher numbers (Semple et 
al., 2003). 
Attachment of ubiquitin to an internal lysine onto an already covalently coupled 
ubiquitin leads to the formation of ubiquitin chains. During chain elongation another class of 
proteins, called E4, can act as auxiliary factors to allow efficient extension of the chain (Koegl 
et al., 1999). Mass spectrometry has shown that any of the seven internal lysines in ubiquitin 
can be used for chain formation with a relative abundance order of K48, K11, K63, K6, K27, 
K29 and K33 based on semi-quantitative estimation from spectral counts (Xu and Peng, 
2006). Furthermore, different linkages can occur in one chain resulting in so-called barbed or 
forked chains (Peng et al., 2003; Tagwerker et al., 2006). The type of ubiquitin modification, 
e.g. mono-ubiquitylation, multiple mono-ubiquitylation or poly-ubiquitylation with different chain 
topologies, results in different fates for the substrate: Ubiquitin modifications are recognized by 
specific receptors harboring ubiquitin-binding domains that can differentiate between chain 
length and/or chain linkage (Pickart and Fushman, 2004; Figure 4). At least 14 different 
ubiquitin binding domains (UBDs) are known until now (Hurley et al., 2006). These domains 
are structurally divergent but most of them interact with a hydrophobic patch around I44 of 
ubiquitin (Hicke et al., 2005). They show low affinities to monomeric ubiquitin but increased 
binding to polymeric ubiquitin. 
Proteins modified with ubiquitin are subsequently transferred to the proteasome, if 
chains are linked via internal lysine 48 of ubiquitin. For certain substrates transfer to the 
proteasome also depends on the sequential action of ubiquitin-binding factors that work in a 
hand-over mechanism (Richly et al., 2005). Furthermore, the length of the K48-linked chain 
critically influences the affinity for the proteasome (Thrower et al., 2000). At the proteasome, a 
multi-subunit assembly with an inner cavity lined with proteolytic sites, ubiquitin chains are 
trimmed off. Hereafter, the target protein is dragged into the cavity and degraded into small 
peptides in an ATP-dependent manner.  
In contrast, mono-ubiquitylation or modification with chains through internal lysine 63 of 
ubiquitin are considered modifications that normally do not lead to proteasomal degradation 
but serve a wide range of other processes, like endocytosis, protein sorting, membrane traffic, 
transcription, DNA repair, ribosomal protein synthesis or cell cycle regulation (Pickart and 
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Fushman, 2004). These modifications on the one hand can signal via interaction with proteins 
containing UBDs. An obvious model in this case is that the linkage of a poly-ubiquitin chain 
determines its function either by presenting a specific pattern of hydrophobic sites or by 
restricting the chain's ability to adopt certain conformations. The specificity of a given ligand's 
interaction would then be dictated by its ability to select one chain conformation over another 
or to discriminate between different conformations. On the other hand, ubiquitylation might 
mask a binding site and therefore prevent interaction with ligands. A third possibility besides 
the modulation of binary protein-protein contacts is the formation or dissolution of protein 
complexes by ubiquitylation, which seems especially relevant for patho-physiological 
processes like neurodegenerative diseases. 
 
 
 
Introduction 
18
 
Furthermore, numerous de-ubiquitylating enzymes (DUBs) allow rapid de-modification 
and regulation/timing of the post-translational modification. DUBs can be grouped in five 
subfamilies. Four of these subfamilies comprise cysteine proteases: Ubiquitin-specific 
proteases (UBP), ubiquitin C-terminal hydrolases (UCH), Josephine domain proteins and 
ovarian tumor-related proteases (OUT). The fifth subfamily are metalloproteases containing a 
JAMM/MPN+ domain (Amerik and Hochstrasser, 2004). DUBs can proofread ubiquitin-protein 
conjugates, remove ubiquitin from cellular adducts and keep the proteasome free of inhibitory 
ubiquitin chains thereby coupling de-ubiquitylation to degradation (Amerik and Hochstrasser, 
2004). Additionally, DUBs are required for the regulation of gene silencing, inflammatory 
signaling and the maturation of late endosomes into multivesicular bodies (MVB) (see below).  
Ubiquitylation besides its !canonical" role in protein degradation through its reversibility 
represents a versatile post-translational modification to regulate protein activity, location and 
conformation. Interestingly, there is increasing evidence demonstrating a crosstalk between 
ubiquitylation and other post-translational modifications like phosphorylation or modification by 
ubiquitin-like proteins such as SUMO (small ubiquitin-like modifier) (Hunter, 2007). 
 
2.8    Ubiquitin-dependent  cell  cycle  transitions  and  the  regulation  of  
         cytokinesis  
A central role for ubiquitin lies in the turnover of cyclin proteins, which are the key elements 
driving the cell cycle by activating cell cycle dependent kinases (Cdks) (Glotzer et al., 1991; 
see above). Besides cyclins a great number of other proteins need to be degraded during the 
cell cycle by the UPS (Pines, 2006). Modification of cyclins and other cell-cycle regulated 
proteins is carried out mostly by two classes of multi-subunit ubiquitin ligases. The most 
prominent is the anaphase-promoting complex/cyclosome (APC/C), which consists of at least 
11 subunits that assemble on a scaffold (Apc2), a RING-finger protein (Apc11) and a subunit 
that is important for substrate recognition and extension of the poly-ubiquitin chain 
(Doc1/Apc10) (Peters, 2006). Substrate selection during the cell cycle requires the binding to 
one of two activating WD40-domain proteins known as Cdc20 and Cdh1 (Figure 5). Cdc20 
exclusively binds to APC/C if phosphorylated by Cdk1, and the assembled APCCdc20 primarily 
recognizes proteins that harbor destruction boxes (a R/KXXL/I/M/V sequence). APCCdc20 is 
therefore active only until anaphase onset: At this point Cdk1 activity drops because its cyclin 
B activator is degraded and thus also phosphorylation of Cdc20 stops. Substrates for APCCdc20 
are proteins that need to be degraded in prometa- and metaphase (e.g. cyclin A, Nek2 kinase). 
In early M-phase and probably already in interphase (Di Fiore and Pines, 2007) APCCdc20 is 
kept inactive by binding to the inhibitor Emi1 (Machida and Dutta, 2007). Emi1 needs to be 
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phosphorylated by Plk1 to be ubiquitylated by another E3 ligase complex, SCFßTrCP (see 
below). However, the main inhibition of APCCdc20 takes place on the level of spindle assembly. 
APCCdc20 is active only if all kinetochores are attached to spindle microtubules. This scenario is 
also called spindle assembly checkpoint (Peters, 2006). At unattached kinetochores, the 
checkpoint proteins Mad2 and BubR1 build complexes with Cdc20 or APCCdc20 as long as 
unattached kinetochores are present. It has been suggested that the Mad2/Cdc20 and 
BubR1/Cdc20 complexes might sequester Cdc20 away from the APC/C and thereby keep it 
inactive (Peters, 2006). A similar mechanism involving the inhibitor Emi1 has recently been 
described (Ban et al., 2007). Emi1 binds the spindle-organizing NuMA/dynein-dynactin 
complex to anchor and inhibit the APC/C at spindle poles, probably limiting destruction of 
spindle-associated cyclin B.  
When all kinetochores are finally attached, APCCdc20 can drive cell cycle progression by 
ubiquitylation of cyclin B leading to inactivation of Cdk1. Furthermore, APCCdc20 also promotes 
degradation of  securin which in turn activates separase, a protease that mediates sister 
chromatid separation. Due to the decrease in Cdk1 activity, the affinity of Cdc20 for the APC/C 
decreases and Cdh1, at anaphase onset, can bind to the APC/C as it is now hypo-
phosphorylated, and Emi1, which also sequesters Cdh1 away from the APC/C, is now 
phosphorylated by Plk1 and degraded (Moshe et al., 2004; Hansen et al., 2004). The APCCdh1 
modifies targets different from those recognized by APCCdc20, which include functional 
components of mitosis- and cytokinesis structures (kinetochores, spindle, contractile ring, 
midbody) to convert cells back into an interphase state. These comprise the spindle midzone 
protein PRC1 and the contractile ring regulators anillin (Zhao and Fang, 2005) and Ect2 (see 
above) (Pines, 2006). Furthermore, APCCdh1 drives degradation of mitotic regulators survivin, 
Aurora A and Plk1 (Castro et al., 2002; Lindon and Pines, 2004). Preventing Plk1 degradation 
at the end of mitosis interferes with the coordination of spindle relative to cleavage furrow 
position and, in consequence, results in cytokinesis failure (Lindon and Pines, 2004).  
Another class of multi-subunit ubiquitin ligases with roles in mitosis are Skp1-Cullin-F-
box (SCF) ligases. They are composed of a scaffolding cullin, a RING-finger protein (Rbx1), an 
adaptor protein (Skp1), and a substrate-interacting F-box protein. Approximately 70 F-box 
proteins are identified in humans so far allowing to accommodate for a wide range of 
substrates. In contrast to the APC/C, SCF-ligases recognize phospho-degrons in target 
proteins and therefore the recognition of SCF-substrates does not depend on the modification 
of the ligase itself but on the modification of the substrate. As described above, the SCFßTrCP is 
crucial for cell cycle progression by degrading APC/C inhibitors like Emi1 (Moshe et al., 2004; 
Hansen et al., 2004). An SCF complex with the F-box protein Skp1 (SCFSkp1) has been found 
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to localize on the midbody where it mediates ubiquitylation of a kinesin important for 
chromosome movement and midzone establishment, CENP-E (Liu et al., 2006).   
 
 
 
Besides F-box proteins there are also proteins of the BTB-family (Bric-a-
brac/Tramtrack/Broad complex) that can act as substrate recruiting factors in complex with 
cullin 3. Complexes of Cul3 with the BTB proteins KLHL9 and KLHL13 are required for 
chromosome alignment and midzone/midbody formation (Sumara et al., 2007). These 
complexes remove the CPC component Aurora B from chromosomes and allow transport to 
the midzone by mediating Aurora B ubiquitylation. 
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As outlined above, exit from mitosis requires the degradation of cell cycle regulators by 
the ubiquitin proteasome system. Several observations allow to conclude that ubiquitin-
dependent processes are also spatially linked to cytokinesis: Components of the UPS like the 
ubiquitin activating enzyme E1 and the proteasome itself are both concentrated on midbodies 
(Grenfell et al., 1994; Wojcik et al., 1995). Furthermore, the chromosomal passenger proteins 
survivin and Aurora B (Zhao et al., 2000; Sumara et al., 2007) as well as Plk1 (Lindon and 
Pines, 2004) are degraded most likely on midbody microtubules. Also the core APC/C subunit 
Doc1/Apc10 was found on the midbody (Kurasawa and Todokoro, 1999). In addition, 
proteasomal inhibition after anaphase onset revealed that cells fail to complete cytokinesis 
when ubiquitin-dependent degradation is shut down (Straight et al., 2003). Recent findings 
extend this view showing that a combination of Cdk1 and proteasomal inhibition can revert late 
cytokinetic stages to a pre-anaphase state (Potapova et al., 2006).  
 
2.9  A role for components of multivesicular body formation in cytokinesis 
Apart from ubiquitin-mediated degradation by the proteasome there is a second type of 
ubiquitin-dependent degradation by targeting proteins to proteolytic organelles like the vacuole 
or lysosomes. Most substrates of this pathway are either cell surface transmembrane proteins 
that are endocytosed or biosynthetic cargo originating from the trans Golgi network. Both types 
of substrates are often mono-ubiquitylated at their cytoplasmic domains. The best 
characterized ubiquitin-dependent step in this pathway is the maturation of endosomes into 
multivesicular bodies. These MVBs form through invagination of the limiting membrane of 
endosomes. 
The !endosomal sorting complex required for transport" (ESCRT), which consists of 
four multi-subunit protein complexes ESCRT-0 to –III, drives ubiquitin-dependent sorting and 
the formation of multi-vesicular bodies (MVB). ESCRT components are known to recognize 
specific membrane lipids on the one hand and ubiquitylated transmembrane proteins on the 
other hand (Hurley and Emr, 2006). Dual recognition allows sequential recruitment of ESCRT 
subcomplexes and leads to the clustering and sorting of proteins but can also lead to inward 
budding of membrane domains into the lumen of endosomes. Lysosomal hydrolases can then 
digest the luminal content.  
Recently, this well-established pathway for sorting of ubiquitylated membrane proteins 
at endosomes has been found to be involved in cytokinesis regulation as well (Spitzer et al., 
2006; Carlton and Martin-Serrano, 2007; Morita et al., 2007). Several members of ESCRT 
were described to be essential for cytokinesis. During the abscission step in cytokinesis a 
problem similar to the one in enveloped virus egress is encountered. Thin membrane tubules 
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have to be resolved from within a cell to yield separate membranes. This led to the speculation 
that cytokinesis and viral budding might make use of a similar molecular machinery. 
Intriguingly, the recruitment of ESCRT components to the midbody seems to be brought about 
by the centrosomal protein Cep55 (see above). Cep55 binds to the ESCRT-I component 
Tsg101 and to another protein Alix, both found to be needed for viral budding (Garrus et al., 
2001; Strack et al., 2003). Additionally, Tsg101 can bind the Rho-associated kinase ROCK 
(see above) and IQGAP1, a factor probably involved in actin remodeling during cytokinesis 
(Machesky, 1998).  
Furthermore, late ESCRT components like ESCRT-III CHMPs and Vps4, an AAA-
ATPase that is implicated in ESCRT disassembly and membrane modulation, localize to the 
midbody and overexpression of CHMPs and expression of dominant negative Vps4(K173Q) 
give rise to cytokinesis failure (Carlton and Martin-Serrano, 2007; Morita et al., 2007).  
The involvement of ESCRT components in the regulation of cytokinesis additionally 
represents an emerging link between membrane traffic and the ubiquitin-proteasome system in 
cytokinesis. The ESCRT machinery contains several ubiquitin-binding modules: In ESCRT-0 
the multidomain protein Vps27/Hrs can bind to ubiquitylated proteins via an ubiquitin 
interaction motif (UIM), in ESCRT-I Vps23/Tsg101 can bind via an ubiquitin E2-variant domain 
(UEV) and in ESCRT-II Vps36 can bind via the GRAM-like ubiquitin-binding in EAP45 domain 
(GLUE) (Hurley and Emr, 2006; Williams and Urbé, 2007). Whether in cytokinesis ESCRT 
complexes function in a conveyor belt-like mechanism that involves a stepwise hand-over of 
ubiquitylated proteins from one ESCRT subcomplex to the other or rather in the fashion of a 
gradually assembling concentric ring, is still unknown (Nickerson et al., 2007). 
 This outline so far described cytokinesis regulation and the specific contributions from 
different cellular pathways. The data presented in this study focuses on the role of BRUCE in 
membrane transport and ubiquitylation during cytokinesis. The following chapter will thus give 
information on the current knowledge about BRUCE.  
 
2.10  BRUCE represents an unusual BIRP 
Programmed cell death or apoptosis is driven by caspases, the proteases executing proteolytic 
cleavage of the cell inventory (Salvesen and Duckett, 2002). Proteolytic activity of caspases 
can be inhibited by so-called BIRPs, proteins that harbor a baculovirus inhibitor of apoptosis 
repeat (BIR). BIRPs also protect cells from apoptosis by ubiquitylation and degradation of pro-
apoptotic factors (Verhagen et al., 2001). The BIR domain represents a zinc-binding fold of 
approximately 70 amino acids harboring a CX2CX6WX3DX5HX6C consensus sequence (Hinds 
et al., 1999). Notably, linker sequences at the boundaries of BIR domains have been shown to 
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bind to activated caspases thereby sterically preventing access to substrates (Riedl et al., 
2001; Huang et al., 2001; Chai et al., 2001).  
In mammalian cells, after loss of mitochondrial integrity, apoptosis-inducing factors like 
Smac and the serine protease HtrA2 are released through permeability transition pores. These 
factors can bind to BIRPs via a short N-terminal sequence on the same surfaces where 
caspases bind. This results in a competition of Smac/HtrA2 and caspases for BIRP binding. 
Therefore, as soon as the cytoplasmic concentration of Smac/HtrA2 rises above a critical level, 
caspases are relieved from repression by BIRPs and can initiate apoptosis (Ditzel and Meier, 
2002).  
BRUCE is an unusual BIRP, firstly due to its size of 528 kDa and secondly due to the 
fact that it contains a single BIR-domain and an ubiquitin-conjugating enzyme (UBC) E2-
domain, whereas most other BIRPs contain several BIR-domains and a C-terminal RING 
finger domain. BRUCE was discovered in a screen using degenerate primers for ubiquitin-
conjugating (UBC) enzymes (the E2 enzymes of the ubiquitin conjugation pathway, see above) 
(Hauser, 1992). In vitro BRUCE can form a thioester with ubiquitin and can transfer ubiquitin to 
substrate proteins demonstrating that it possesses a functional UBC domain (Hauser et al., 
1998; Bartke et al., 2004; Hao et al., 2004). Cell fractionation and membrane flotation 
experiments revealed that BRUCE is a peripherally membrane associated protein (Bardroff, 
1997). Furthermore, BRUCE was found to localize mainly to the TGN and perinuclear vesicles. 
It was also demonstrated that cancer cells expressing high levels of BRUCE are resistant to 
apoptosis-inducing agents and that conversely downregulating BRUCE results in sensitivity to 
these agents (Chen et al., 1999).  
Notably, analysis of the ortholog of BRUCE in Drosophila, dBRUCE, showed that it is in 
fact involved in apoptosis regulation. dBRUCE could inhibit apoptosis executed via the 
Smac/HtrA2-related pro-apoptotic factors Reaper and Grim but not apoptosis induced via a 
third related factor, Hid (Vernooy et al., 2002). This argued for a role of dBRUCE in specialized 
pathways leading to cell death. Indeed, during the final step of spermatogenesis in Drosophila, 
spermatids remove their bulk cytoplasm in the process of spermatid individualization. This 
process is accompanied by an apoptosis-like caspase activation which has to be restricted 
locally and temporally (Arama et al., 2003). Strikingly, in dbruce -/- flies, which are male sterile, 
spermatids acquire hyper-condensed nuclei and finally degenerate, indicating uncontrolled or 
excessive apoptosis. There is also evidence that spermatogenesis in mammals involves 
transient caspase activation and, in consequence, there might be a need for the anti-apoptotic 
potential of BRUCE (Arama et al., 2003).  
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In addition, BRUCE functions as an inhibitor of apoptosis protein in mammalian cells 
(Bartke et al., 2004; Hao et al., 2004). It can bind and inhibit activated initiator caspases-8 and 
-9 and executioner caspases-3, -6 and -7. Furthermore, both Smac and HtrA2 are able to 
compete for BRUCE-bound caspases. Interestingly, BRUCE is also a substrate of caspases 
and the serine protease HtrA2, pointing to a role in regulating apoptosis at early stages when 
proteolytic activity mediated by these enzymes is still low. Furthermore, BRUCE can 
ubiquitylate both Smac and HtrA2 and probably also caspase-9, a caspase initiating apoptosis 
after mitochondrial permeabilization (Bartke et al., 2004; Hao et al., 2004). Although only a 
mono-ubiquitylationon the substrate Smac was observed in vitro, BRUCE might collaborate 
with other E3 ligases for poly-ubiquitylation and proteasomal degradation. This is likely also 
the case for the other BRUCE substrates HtrA2 or caspases. The anti-apoptotic function is 
probably further restricted to certain subcellular structures, e.g. the TGN and endosomes, 
where BRUCE localizes (Hauser et al., 1998). Besides the regulation of caspases/pro-
apoptotic factors, BRUCE itself seems to be regulated via ubiquitin-dependent degradation. 
Nrdp1/FLRF (neuregulin degrading protein 1/fetal liver ring finger), a RING finger containing 
ubiquitin ligase initially found to be involved in the degradation of the receptor tyrosine kinase 
ErbB3/4 (Diamonti et al., 2002; Qiu and Goldberg, 2002), can act as an ubiquitin ligase for 
BRUCE leading to its proteasome-dependent degradation (Qiu et al., 2004). Overexpression 
of Nrdp1 was shown to decrease cellular levels of BRUCE and to induce apoptosis by an 
uncharacterized mechanism. Notably, Nrdp1 also interacts with a de-ubiquitlyating enzyme 
USP8/UBPY (ubiquitin-specific protease 8 or Y) (Wu et al., 2004). UBPY is a cysteine 
protease with highest similarity to yeast Doa4. It is implicated in cell cycle regulation, efficient 
downregulation of the EGF receptor and stability regulation of ESCRT-0 components Hrs and 
STAM2 (Clague and Urbé, 2006). Depletion of UBPY leads to an increase in size and number 
of MVBs and accumulation of ubiquitin on their surface (Row et al., 2006). UBPY knockout in 
mice results in embryonic lethality and knockout in adult animals leads to a severe liver failure 
(Niendorf et al., 2007). Apart from the UBPY-Nrdp1-BRUCE complex there is a UBPY-OTU1-
GRAIL complex described with OTU1 (ovarian tumor 1), representing a member of the ovarian 
tumor gene DUBs, and GRAIL, an ubiquitin E3 ligase crucial for the induction of anergy in CD4 
T-cells (Soares et al., 2004).  
Depletion of BRUCE in cultured cells results in sensitization to apoptotic stimuli and 
finally cell death (Qiu et al., 2004; Hao et al., 2004; Ren et al., 2005). Additionally, depletion in 
the lung cancer cell line H460 seemingly led to a stabilization of the p53 tumor suppressor, 
which might be specifically accompanied by mitochondrial-triggered apoptosis (Ren et al., 
2005). BRUCE-deficient mice die perinatally due to impaired placental development that can 
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be attributed to insufficient differentiation (Lotz et al., 2004). However, in contrast to data 
obtained in cultured cells and to gene-trap mice where N-terminal truncated forms of BRUCE 
are fused to a ß-galactosidase-neomycin cassette, no signs for elevated apoptosis in the 
knockout embryos could be observed (Lotz et al., 2004; Hitz et al., 2005, Ren et al., 2005). In 
the case of gene-trap mice, where insertion of the trap occurred in intron 45 (Hitz et al., 2005) 
or in intron 30 (Ren et al., 2005), the apoptotic phenotype might be explained by the fact that 
the artificially created fusion proteins behave more like dominant negative versions. The 
reason might be that out of the two functional domains characterized so far only the UBC 
domain is inactivated. Figure 6 depicts BRUCE in a schematic network of protein-protein 
interactions as described above.  
 
 
 
Besides apoptosis regulation, BIRPs like survivin (Li et al., 1999) and cIAP1 (Samuel et 
al., 2005) are also known to participate in cell cycle events and cytokinesis. Notably, with 
respect to its BIR-domain, BRUCE is most closely related to survivin. Survivin represents a 17 
kDa protein which harbors an N-terminal BIR domain and a C-terminal coiled-coil domain. It 
constitutes a core component of the chromosomal passenger complex and is therefore also 
essential for cytokinesis (see above). Survivin was described to bind to p34cdc2 which 
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phosphorylates Thr34 in survivin, thus enabling it to inhibit caspase-9 specifically when cells 
pass trough cytokinesis (O!Connor et al., 2000). Similar to BRUCE, survivin can firmly bind to 
Smac but shows only limited potential in inhibiting caspases in vivo (Song et al., 2003; Banks 
et al., 2000). The C-terminal coiled-coil domain was shown to bind microtubules (Reed and 
Bischoff, 2000). Furthermore, overexpression of survivin led to reduced centrosomal 
microtubule nucleation and reduced microtubule dynamics in spindles and midbodies (Rosa et 
al., 2006).  
cIAP1, a predominantly nuclear protein in interphase, has recently been described to 
participate in cell cycle regulation (Samuel et al., 2005). After nuclear re-accumulation in 
telophase, a small pool of cIAP1 associates with the midbody in a complex with survivin. Cells 
overexpressing cIAP1 exhibit an accumulation in G2/M, grow slower and show cytokinesis 
defects. 
Intriguingly, the single BIR proteins of C. elegans BIR-1 and S. cerevisiae Bir1p do not 
inhibit apoptosis but instead are involved in cell cycle regulation (Fraser et al., 1999; Uren et 
al., 1999). Taken together, this suggests that the ancestral funtion of BIRPs may be to control 
cell cycle events and that regulation of apoptosis as a specific pathway that emerged in 
multicellular organisms was accompanied by BIR gene duplication. 
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3  Aim of this study 
 
Several recent reports demonstrated that, besides their roles in apoptosis regulation, BIRP 
proteins are also utilized by other cellular pathways. The subject of this study, the giant multi-
functional ubiquitin-conjugating enzyme BRUCE, is classified as an anti-apoptotic BIRP 
(Bartke et al., 2004; Hao et al., 2004). However, previous work suggested that BRUCE, 
besides directly affecting apoptosis, can also act as a general survival factor (Bartke, 2004; 
Lotz, 2004).  
The aim of this study is to investigate the functions of BRUCE in mammalian tissue 
culture cells and to discover functions that link BRUCE!s anti-apoptotic activity to specific 
cellular processes. To this objective, depletion of BRUCE from cells by RNA interference was 
established and truncation constructs were generated that are able to mimic the effect of 
BRUCE depletion. The resulting phenotypes were analyzed biochemically and by microcopy 
techniques such as life-cell imaging to delineate the underlying molecular basis. Additionally, 
this study describes novel interactors of BRUCE to allow a better understanding of the various 
pathways this multi-functional protein is implicated in. 
Beyond this initial scope, a general involvement of the ubiquitin-proteasome system in 
cytokinesis regulation is described with a focus on BRUCE and UBPY, an enzyme with de-
ubiquitylating activity. Additionally, a search for proteins that might become ubiquitylated 
during cytokinesis revealed that the mitotic kinesin MKLP1 is a target for this modification. 
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4  Results 
 
4.1  BRUCE localizes to the midbody ring and associates with mitotic regulators 
Previous reports demonstrated that BRUCE is a cytosolic protein, which is peripherally 
associated with endomembranes (Hauser et al., 1998). In search for a physiological role of 
BRUCE in unchallenged cells, the subcellular distribution of BRUCE was re-examined using 
antibodies that detect the endogenous protein. By using three different polyclonal antibodies 
directed against N- or C-terminal regions of BRUCE (Bartke et al., 2004; Hauser et al., 1998) 
(Figure 7A), a comparable staining pattern is detected (Figure 7B) and cells depleted of 
BRUCE show virtually no staining (Figure 7C).  
 
 
 
In both HeLa and U2OS cells BRUCE relocalizes considerably during the cell cycle 
(Figure 8 and 9). It concentrates in a pericentriolar compartment in interphase, moves partially 
to spindle poles in metaphase, and finally localizes to the spindle midzone and the midbody in 
telophase and during cytokinesis (Figure 8A and Figure 9A). On the midbody, BRUCE 
localizes in a characteristic ring-like arrangement that is embraced by Aurora B and 
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microtubules (Figure 8B and 8C), indicating that BRUCE is associated with the midbody ring 
(Gromley et al., 2005). 
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By using siRNAs targeting MKLP1, a mitotic kinesin essential for the formation of the 
midbody matrix (Matuliene and Kuriyama, 2002), complete loss of BRUCE at the midbody ring 
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can be observed in midbody-forming cells (Figure 8C). In untreated cells, BRUCE localizes to 
the midbody ring as soon as this structure first appears in telophase, and BRUCE persists on 
the ring even after its uptake by one of the daughter cells after completion of abscission 
(Figure 8D and 8E).  
Notably, midbody ring remnants taken up by one of the daughter cells following 
cytokinesis are almost exclusively found in the plane of the plasma membrane (Figure 8D). 
Following the concept that the midbody ring might serve as the site for membrane-mediated 
abscission, a HeLa cell line expressing HA-epitope tagged albumin was constructed, which 
allows to investigate membrane traffic and to trace vesicles containing constitutively secreted 
cargo. Localization of secretory vesicles on the midbody ring is visible only in late cytokinesis 
when the intercellular bridge has constricted to about 1 µm in diameter, whereas BRUCE, as 
an apparent firm resident of the midbody ring, localizes to the midbody ring much earlier, 
concurrent with its formation (Figure 8E). 
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Given its highly dynamic localization pattern during cell division, a search for binding 
partners was performed also investigating whether BRUCE might be a target for mitotic 
phosphorylation. Indeed, BRUCE is particularly phosphorylated in S-phase extracts (data not 
shown) and immunopurified BRUCE is also phosphorylated by co-purified factors whereas a 
control protein purified by the same method is not (Figure 10A). By immunopurification (IP) of 
FLAG-tagged BRUCE, or immunoprecipitation of the endogenous protein, BRUCE associates 
with the mitotic kinases Cdk1, MEK1, and Plk1 (Figures 10B-10G). In order to characterize the 
binding site in BRUCE for kinases, FLAG-tagged BRUCE, the BIR-domain mutant 
(FLAGBRUCEbir), an N-terminal fragment that is normally created by caspase cleavage 
(FLAGBRUCE 1-648) and a control protein (FLAGluciferase) were immunopurified (Figure 10B). 
Whereas the control protein shows no binding to either MEK1 or Plk1, all BRUCE constructs 
bind to both kinases. This indicates that the N-terminus of BRUCE is required for kinase 
interaction and that a functional BIR-domain is dispensable.  
Recently, a mixed IAP-IAP complex of survivin and XIAP was identified (Dohi et al., 
2004). The midzone and midbody localization of BRUCE might allow an interaction with 
survivin, which is also enriched there. Hence, complex formation between BRUCE and survivin 
was investigated. When overexpressed, survivin can indeed co-precipitate BRUCE and vice 
versa (Figure 11A and 11B). In addition, BRUCE is able to mono-ubiquitylate survivin in vitro 
(Figure 11C), arguing for a regulatory modification or a priming ubiquitylation for the 
degradation of survivin later on in cytokinesis. These data indicate that the two BIRPs may 
indeed cooperate at the midzone or the midbody, where both proteins are found (Figure 8A) 
(Ruchaud et al., 2007). 
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Interestingly, when performing in vitro ubiquitylation reactions, it was frequently 
observed that reactions containing BRUCE, however not supplemented with ubiquitin 
activating enzyme E1, can support ubiquitylation (data not shown). Immunopurified BRUCE 
was therefore analyzed for co-purifying E1 activity (Figure 12A). Strikingly, peptides 
corresponding to a protein called UBE1L2/Uba6/E1-L2 were recovered in mass spectrometric 
analysis (Figure 12B). This protein has only recently been found to be a functional E1 for 
ubiquitin and probably also for the ubiquitin-like modifier FAT10 (Jin et al., 2007; Chiu et al., 
2007; Pelzer et al., 2007). UBE1L2 shows an identical domain composition to Uba1 with 
varying identities of 30-60% in each domain (Figure 12C). UBE1L2 is probably a specialized 
E1 that can only transfer ubiquitin to a small number of E2s like e.g. UBE2Z/Use1 and 
probably BRUCE. The putative association of UBE1L2 with BRUCE might argue for an Uba1-
independent loading of BRUCE with ubiquitin by this newly identified ortholog. Further testing 
will be needed to conclude whether BRUCE is an E2 that specifically functions together with 
UBE1L2. 
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4.2  BRUCE is a component of tubular and recycling endosomes and associates  
       with the exocyst 
In order to further characterize the vesicular system where BRUCE resides, cells were stained 
with anti-!-tubulin and anti-BRUCE antibodies. Indirect immunofluorescence revealed that 
endomembranes containing BRUCE cluster around centrosomes (Figure 13A). Furthermore, 
peripheral vesicles decorated with BRUCE are collinear with microtubules, suggesting the 
presence of a vesicular system that utilizes the microtubule network for transport processes 
(Figure 13C). When testing an association of BRUCE with additional factors on endogenous 
levels, !-tubulin can be specifically co-precipitated with an anti-BRUCE serum (Figure 13C). 
BRUCE can therefore be characterized as a resident of membranous organelles that travel on 
microtubules and BRUCE might mediate or modulate contacts with tubulin. Additionally, 
BRUCE localization along microtubules seems to depend on functional centrosomes. In a 
setting of artificially amplified centrosomes by treating U2OS cells with hydroxyurea (Meraldi et 
al., 1999), BRUCE-stained structures accumulate in strange cellular protrusions (Figure 9C). 
This indicates that when microtubule organization is disrupted BRUCE localization is also 
affected.  
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To elucidate whether the peripheral carriers that contain BRUCE are responsible for 
endocytosis or exocytosis, a transferrin uptake experiment was performed (Figure 14A). Co-
localization of BRUCE with transferrin can be observed after a chase of 15 min when most of 
the transferrin is either already re-exocytosed via a quick recycling route (Hopkins, 1983) or 
reaches the pericentrosomal recycling compartment. At this point, the highest degree of co-
localization can be detected, arguing for an association of BRUCE with recycling endosomes. 
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Additionally, exocytosis was examined by the use of a temperature-sensitive folding 
mutant of the vesicular stomatitis virus glycoprotein (VSVGtsO45) (Flamand, 1970; Gallione and 
Rose, 1985).  
 
 
Results 
37 
VSVG is first inserted into the ER membrane, glycosylated and further trimmed at the 
Golgi where it is packaged into transport containers that travel to the plasma membrane. The 
Orsay strain revertant ts45 (tsO45) is characterized by three amino acid exchanges that trap 
the protein in the ER at the non-permissive temperature of 39°C due to a folding problem. 
Secretion can be triggered by shifting cells to the permissive temperature of 32°C. Following 
the transport route of VSVGtsO45 after release of the temperature block, co-localization with 
BRUCE at the point when most of the VSVG reaches the Golgi/TGN interface can be observed 
(Figure 14B). Strikingly, BRUCE is still found on VSVG-containing carriers right before they 
reach the plasma membrane (Figure 14C, carrier marked by an arrow). The pericentrosomal 
localization, the co-localization with recycled cargo at sites of late recycling and the association 
of BRUCE with traffic containers for exocytic cargo allows to conclude that BRUCE is 
associated with recycling and secretory endosomes. To characterize BRUCE localization 
further, co-localization with markers of the vesicular system was tested. Only partial co-
localization with the TGN markers golgin p230 and TGN38 can be found (Figure 9B) (Hauser 
et al., 1998).  
However, for a more detailed analysis, U2OS cells were generated that stably express 
GFP-Rab8 and GFP-Rab11, respectively. In these cells, a substantial co-localization with both 
endosomal GTPases Rab8 and Rab11 can be observed, even with Rab8-positive, peripheral 
tubular endosomes (Figure 15A, 15B and 15E). Besides Rab GTPases that define the 
recycling compartment, other factors for membrane tethering like the exocyst complex are also 
found here. This is also reflected by the co-localization of BRUCE with the exocyst subunit 
Sec8 (Figure 15C).  
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Importantly, Rab8 and Rab11, as well as the exocyst subunits Sec6 and Sec8, 
physically associate with BRUCE, as demonstrated by immunoprecipitations (Figure 15D and 
15G). Similar to the mitotic kinases (Figure 10B), the binding site for the exocyst seems to lie 
within the N-terminal region of BRUCE (Figure 15D, upper right panel) and thus involves a 
different region in BRUCE than the one used for midbody ring interaction (see below). Notably, 
similar to exocyst subunit Exo70 (Vega and Hsu, 2001), BRUCE also relocalizes to growth 
cones in neuronally differentiated cells (Figure 16), strongly indicating that BRUCE is firmly 
connected to the exocyst and plays a more general role in targeted membrane delivery. 
 
 
 
 
 
4.3  Rab11- and Rab8-endosomes are sources of membrane material in  
       cytokinesis and the midbody ring acts as a barrier 
Due to the finding that BRUCE associates with the midbody ring (Figure 8) and is also found 
on recycling and secretory vesicles (Figure 8, Figure 14 and Figure 15) the question emerged 
whether vesicles containing BRUCE participate in cytokinesis. Experiments shown here could 
confirm previous observations (Fielding et al., 2005) that suggested a role for recycling Rab11-
endosomes in cytokinesis. Two pools of Rab11-endosomes are found on both sides of the 
intercellular bridge during cytokinesis, and a small fraction also seems to reach the midbody 
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ring (Figure 15E). However, in contrast to a recent report on HeLa cells (Yu et al., 2007), in 
engineered U2OS cells GFP-Rab8 staining at the midbody can be found (Figure 15F and 15H) 
and also at the newly formed plasma membrane at the contact site of dividing cells (Figure 
15I). Indeed, live cell imaging suggests that Rab8-endosomes are delivered to the midbody 
ring and that this supplied material then diffuses at the plasma membrane laterally (Figure 
17A). Remarkably, by using photobleaching experiments, it can be shown that Rab8-
endosomes are unable to move freely from one perspective daughter cell to the other once the 
midbody ring has been assembled in telophase (Figure 17B), which differs from the otherwise 
mobile behavior of these vesicles during interphase.  
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This finding considerably substantiates the idea that midbody rings, in addition to 
acting as the site for membrane delivery, may play a role as a diffusion barrier in-between the 
two prospective daughter cells (Schmidt and Nichols, 2004). Apparently, this barrier does not 
only prevent intercellular exchange of plasma membrane-associated material as shown before 
(Schmidt and Nichols, 2004), but also of endosomal vesicles. 
It should be emphasized that cytokinesis in U2OS cells probably demands for more 
plasma membrane remodeling than cytokinesis in HeLa cells because of the intercellular 
bridge in U2OS being rather short and often appearing to lie on top of the cells instead of 
being continuous with the cell protrusion generated by the cleavage furrow as can be seen for 
HeLa cells.  
 
4.4  BRUCE harbors a midbody ring-targeting domain 
The distinctive and dynamic localization of BRUCE suggested the presence of dedicated 
targeting domains. The use of BRUCE truncation constructs that comprise N-terminal portions 
of the protein reveals that the typical localization of BRUCE at sorting compartments requires 
its C-terminal region (Figure 18A). Hence, a fusion of GFP to the C-terminal 145 amino acids 
containing also the last 20 amino acids of the UBC domain was constructed (referred to as 
BRUCE-C). Surprisingly, this construct does not localize to pericentriolar endosomes but 
localizes to the phase-dense midbody ring that also contains MKLP1 (Figure 18B, 18C, 20B 
and 20C). Time-lapse video microscopy demonstrates that the BRUCE-C-labeled ring-like 
structure shows a degree of mobility and tilting characteristic for the midbody ring, and that it is 
taken up by one of the daughter cells following abscission (Figure 18B and Figure 19A). Prior 
to the uptake, the midbody ring moves along the intercellular bridge and contacts the plasma 
membrane of one cell (Figure 20A). As the localization of endogenous BRUCE to the midbody 
ring depends on MKLP1 (Figure 8C), one can speculate that BRUCE-C might contain a 
specific interaction domain with midbody ring components. 
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Indeed, MKLP1 co-precipitates with full-length, endogenous BRUCE (Figure 18D, 
upper panel) and also with BRUCE-C (Figure 18D, lower panel). Interestingly, BRUCE-C 
selectively binds the faster migrating variant, MKLP1, but not CHO1, a larger variant caused 
by alternative splicing that additionally possesses an actin-interacting tail (Figure 18E). As both 
isoforms are present at the midbody (Kuriyama et al., 2002), this finding argues for different 
functions of these two variants during late stages of cytokinesis.  
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Notably, the C-terminal tail of BRUCE (BRUCE-C) is highly conserved from flies to 
vertebrates (Figure 19B), suggesting that the midbody targeting domain (MTD) and the 
interaction with MKLP1 are features of all BRUCE family members. As BRUCE-C at moderate 
expression levels binds exclusively to the midbody ring, it is feasible to speculate whether this 
construct could probably act as a dominant-negative tool specifically to monitor the function of 
BRUCE at this location. Indeed, overexpression of BRUCE-C can displace endogenous 
BRUCE from MKLP1 and the midbody ring (Figure 18F). Moderate overexpression of BRUCE-
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C leads to aberrant cytokinesis and binucleation (Figure 20F). Notably, prolonged expression 
of BRUCE-C for three days, finally leads to apoptosis (Figure 20D), indicating that the 
apoptotic signal is probably triggered by the absence of BRUCE from the midbody ring. FACS 
analysis of cells overexpressing BRUCE-C supports the notion that cells most likely convert 
into binucleate structures first and then undergo apoptosis (Figure 20E). 
 
 
 
4.5  BRUCE depletion causes defective abscission and cytokinesis-associated 
       apoptosis 
Depleting cultured cells of BRUCE was previously shown to reduce cell viability (Ren et al., 
2005). To delineate the underlying mechanism, different siRNAs targeting BRUCE were 
designed (see Materials and Methods and Figure 21A). siRNA delivery by electroporation in 
U2OS cells leads to undetectable protein levels of BRUCE three days after transfection (Figure 
22A). 
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Monitoring of cells depleted of BRUCE shows strikingly elongated structures with 
interconnected cells as revealed by flow cytometry (Figure 22B and 22C). In contrast to 
survivin depletion, no cells with giant nuclei can be observed, arguing for a different mode of 
failure in cell division. Higher concentrations of siRNA and prolonged incubation show a loss of 
the normal diploid 2N population (Figure 22C) and an increased sub-G1 population, indicative 
of syncytia-like cells finally undergoing apoptosis. Moreover, reminiscent of centriolin depletion 
(Gromley et al., 2003), some apparently not completely detached cells fuse again or undergo 
mitosis while still interconnected (Figure 21B and see below). However, in contrast to the 
results obtained by Ren and coworkers (Ren et al., 2005), in the experiments shown here 
(Figure 22A), no increase in p53 levels was detected. Furthermore, p53 downstream targets 
like p21 also show no up-regulation, suggesting that apoptosis in these cells is not an 
immediate response to BRUCE depletion but a later corollary. 
Live cell video microscopy reveals that BRUCE-depleted cells form a normal cleavage 
furrow, but do not complete cytokinesis even after hours. Some cells do not even regain their 
normal flattened appearance (Figure 22D). As mentioned above, cytokinesis structures are 
slightly different in HeLa cells that develop long intercellular connections. When HeLa cells are 
depleted of BRUCE, they undergo apoptosis, but, intriguingly, only during attempted 
cytokinesis (Figure 22E-G). After the formation of the midbody ring, almost 60% of the cells 
are apoptotic (Figure 22F). Note that cells in interphase are not undergoing apoptosis while the 
dividing cell shows membrane blebbing as early as 30 minutes after furrowing (Figure 22G). 
This suggests a mechanism by which apoptosis is triggered via cues that originate at the 
midbody in the absence of BRUCE. 
 
4.6  BRUCE is required for membrane delivery to the midbody ring 
As the experiments shown above demonstrated that BRUCE-C binding to the midbody ring 
acts in a dominant-negative fashion, membrane trafficking during cytokinesis was investigated 
making use of this tool. 
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In order to delineate the possible cause for aberrant cytokinesis in cells expressing BRUCE-C, 
HeLa cells stably expressing tagged albumin – as introduced above (see Figure 8) – were 
used. Secretory vesicles can only be found in the intercellular bridge in the case of 
untransfected cells but not in cells transfected with BRUCE-C. Cells expressing BRUCE-C 
show ball-like accumulations of vesicles in proximity to the intercellular bridge, interestingly, 
only on one side, speaking for failed membrane delivery as the cause of aberrant cytokinesis 
(Figure 23A).  
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To draw a generalized conclusion whether complete loss of BRUCE also leads to 
problems in membrane targeting, U2OS cells stably expressing GFP-Rab11 were treated with 
control siRNA or siRNA targeting BRUCE, respectively. In control cells that just completed 
cytokinesis (Figure 23B, upper panel), Rab11 readily adopts an interphase localization pattern 
and phospho-tyrosine staining is found on the midbody as it has recently been described 
(Kasahara et al., 2007). In contrast, BRUCE-depleted cells show an accumulation of Rab11- 
as well as phospho-tyrosine-positive material in close proximity to one side of the midbody 
(Figure 23B, lower panel), indicative of a failure in not only targeting membranes but also 
kinases recently found to be essential for the completion of cytokinesis. Notably, appearance 
of Src and ERK on the midbody have been described to be dependent on Rab11 (Kasahara et 
al., 2007), therefore, an indirect effect on these factors as a consequence of the defects in 
Rab11-endosomes cannot be ruled out. 
 
4.7  Midbodies and midbody rings are platforms for ubiquitylation 
Since it has already been demonstrated that BRUCE possesses ubiquitin ligase activity 
(Bartke et al., 2004; Hauser et al., 1998), it could be asked whether the midbody ring might be 
a site of ubiquitylation. Contrary to the current belief (Pines and Lindon, 2005), a distinct 
pattern of localization for ubiquitin can be observed during cytokinesis using a cell line that 
stably expresses a GFP-ubiquitin fusion protein (Figure 24A). Concomitant with the formation 
of the midbody ring in late telophase, ubiquitin is concentrated symmetrically on the distal tips 
of midzone microtubules omitting the midbody ring and persists until these microtubules 
constrict to form the midbody. Hereafter, ubiquitin is undetectable on the midbody but, 
surprisingly, reappears after 10-15 min on the midbody ring. Notably, inhibition of proteasomes 
with the inhibitor MG132 reveals that the dynamic relocalization of ubiquitin to the midbody ring 
depends on active protein degradation (Figure 24B).  
This behavior of ubiquitin during cytokinesis unappreciated so far demanded closer 
investigation by fluorescent recovery after photobleaching (FRAP) experiments in order to 
better understand ubiquitin dynamics at this site. FRAP reveals that ubiquitin on the midbody 
ring during cytokinesis shows vastly reduced recovery as compared to e.g. cytosolic ubiquitin 
in the same cell or on midbody microtubules (Figure 25A, left panel and data not shown). To 
demonstrate that this is not simply due to the longer distance of the midbody ring from the 
general ubiquitin pool in the cell, midbody rings already taken up by one daughter cell were 
analyzed (Figure 25A, right panel). Ubiquitin on these rings shows essentially no recovery, 
concluding that ubiquitin on the midbody ring is of a substantially different dynamic nature than 
any other cellular pool of ubiquitin. 
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This suggests that ubiquitin has a high turnover at the midbody through active ubiquitylation 
and de-ubiquitylation of proteins near the midbody microtubules. In striking contrast, ubiquitin 
on midbody ring components, can barely be replaced, once this modification has occurred. 
The local ubiquitylation activity is thus probably turned off at this stage. 
 
 
 
Relocalization of ubiquitin during cytokinesis is similar in HeLa cells (Figure 25B, top 
panel). Cells of both cell lines often harbor, besides the midbody ring engaged in cytokinesis, 
one or rarely two additional rings, which most likely represent remnants from previous 
divisions. Intriguingly, only the putative active midbody ring in the intercellular bridge is 
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decorated with ubiquitin whereas the midbody ring remnants apparently gradually loose the 
modification (Figure 25B, lower panel). This finding is in agreement with the FRAP data 
(Figure 25A), showing that ubiquitylation of the midbody ring occurs only once during 
cytokinesis, before the onset of abscission. 
Notably, BRUCE and ubiquitin are closely associated during cell division and colocalize 
at the midbody ring during late cytokinesis (Figure 25C), suggesting that at least some of the 
detected ubiquitylation may be mediated by BRUCE (see Discussion). This allows to reason 
that BRUCE is most likely not implicated in degradative ubiquitylation due to the stability of 
midbody ring localized ubiquitin and its extremely low exchange rate. 
 
4.8  Evidence for the de-ubiquitylating enzyme UBPY/USP8 being implicated in  
       cytokinesis 
Recent data (Wu et al., 2004) describe a complex containing BRUCE and the de-ubiquitylating 
enzyme USP8/UBPY, probably bridged by the RING-finger ubiquitin ligase Nrdp1/FLRF. 
BRUCE itself might be present as an oligomer in this complex (Bartke et al., 2004). It was 
therefore tested whether de-ubiquitylating activity might influence midbody-localized ubiquitin. 
Using a catalytically inactive form of UBPY (UBPYC>A) that serves as a substrate trap (Alwan 
and van Leeuwen, 2007), an interaction with both BRUCE and MKLP1 can be detected 
(Figure 26A). Furthermore, UBPYC>A is localized on the midbody ring (Figure 27B), suggesting 
that ubiquitylation and de-ubiquitylation activities may work as a switchboard at this site. 
Hence, one can also ask whether BRUCE and MKLP1 are targets for UBPY-mediated de-
ubiquitylation and whether interference with this process leads to problems in cytokinesis. 
Intriguingly, BRUCE itself is ubiquitylated at its C-terminal domain (data not shown) and 
its ubiquitylation is enhanced when Nrdp1 is overexpressed, and lost when UBPY is 
overexpressed (Figure 26B). Using a denaturing purification protocol, it is also possible to 
demonstrate that MKLP1 is modified by mono-/oligo- but not multi-ubiquitylation and that this 
modification is strongly reduced when UBPY is overexpressed (Figure 26C). An increase of 
modified forms of MKLP1 by overexpression of UBPYC>A further argues for it acting as a de-
ubiquitylating enzyme on the midbody ring and probably also argues that de-ubiquitylation 
rather than ubiquitylation activity might be limiting and important for regulation. In fact, HeLa 
cells transfected with UBPYC>A show more than 30% binucleated cells and, additionally, a 
mislocalization of MKLP1 to the cytoplasm in interphase whereas MKLP1 normally localizes to 
the nucleus at this cell cycle state (Figure 26D). This phenotype is reminiscent of an MKLP1 
knockdown, suggesting that UBPY-mediated de-ubiquitylation of MKLP1 may trigger nuclear 
import, which appears to be needed for normal cytokinesis (Liu and Erikson, 2007). 
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Furthermore, in cells overexpressing UBPYC>A it is frequently observed that the tubular 
endosomal compartment where BRUCE localizes is highly compacted in the pericentrosomal 
area and that peripheral tubules that are still found in cells overexpressing wild type UBPY are 
almost completely lost in the case of the substrate trap mutant (Figure 27A). This indicates 
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that, besides functions in cytokinesis, UBPY also serves to regulate the appearance and 
probably also the mobility of tubular recycling endosomes. Preventing de-ubiquitylation of 
proteins on their surface therefore seems to inhibit the budding of carriers into the cell 
periphery. 
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4.9  BRUCE is required for midbody integrity, midbody ring formation, and  
       midbody-localized ubiquitin 
Prompted by the striking physical and functional connection of BRUCE with the midbody and 
the midbody ring, it seemed likely that BRUCE itself is crucial for the organization of these 
Results 
55 
structures. Indeed, significantly reduced MKLP1-positive midbody material can be found in 
BRUCE-depleted cells (Figure 28A and 28C and see also Figure 23B).  
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Additionally, a gradual effect on the midbody structure upon continued BRUCE depletion is 
detectable. Depletion for no more than three days leads to moderately misorganized 
midbodies with unfocused Aurora B staining (Figure 28B, top panel) and unconstricted 
microtubules (Figure 28C, top panel). However, BRUCE depletion for five days results in 
syncytia-like cells, which contain severely malformed midbodies, as visualized by Aurora B or 
MKLP1 staining (Figure 28B and 28C lower panels). Finally, most cells fail to form their 
midbody rings altogether and remnants do not persist, and those few cells that retain their 
midbody rings (less than 10%), have hitherto not adopted a syncytia-like appearance (Figure 
28D). 
Furthermore, it was investigated if localization of ubiquitin to midbody microtubules and 
the midbody ring is affected when cells are depleted of BRUCE. Cells treated with control 
siRNA showed the ubiquitin localization pattern described above (Figure 29, upper panels). In 
contrast, cells depleted for BRUCE neither showed a distinct staining of ubiquitin at midbody 
microtubules nor a detectable staining at the midbody ring (Figure 29, lower panels). These 
results suggest that BRUCE is not only required for normal vesicle targeting to the site of 
abscission, but also for the integrity of the midbody and the midbody ring, as well as for their 
striking ubiquitin modification. 
Surprisingly, cells were found that fused with an adjacent cell and undergo a joint 
mitosis, a scenario not reported so far, but resembling divisions in syncytial networks 
described for centriolin depletion (Gromley et al., 2003). This clearly indicates that syncitia-like 
cells that are seemingly separate are in fact still interconnected.  
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4.10  BRUCE appears also to be important for cytokinesis regulation in mice 
Remarkably, aberrant mitotic and cytokinetic structures, like multipolar spindles and tripolar 
cytokinesis, were also observed in spontaneously immortalized BRUCE-/- MEFs (Figure 30). 
This argues for a loss of fidelity in cell division after loss of BRUCE expression on the one 
hand and for an accommodation to the genetic instability caused by these erroneous divisions 
on the other hand. Interestingly, the loss of BRUCE seems to be overcome by the loss of 
expression of other factors like e.g. p53 or p21 leading to a transformation-like state of the 
immortalized cells (see Discussion). 
To prove that BRUCE is also involved in cytokinetic structures in tissues from live 
animals, mouse testis sections were stained for BRUCE (Figure 31). Spermatogenesis takes 
place in mouse testicular seminipherous tubules. This process involves the differentiation of 
the otherwise transient intercellular bridge of somatic cells or cells in culture and its midbody 
ring into a stable specialized structure, the ring canal. These ring canals provide a permanent 
connection of sperm precursor cells to allow communication of the syncytium and exchange of 
cytoplasmic contents. Notably, BRUCE is found to be a constituent of this developmentally 
regulated organelle (Figure 31). This argues for a broader involvement of BRUCE in processes 
in which cytokinetic structures fulfill specialized functions. 
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5  Discussion 
Ever since the early pioneering years of cell cycle research, cytokinesis remained a fascinating 
process because of its startling mechanical behavior. The two most perceptible processes of 
cytokinesis in animal cells, the contraction of the cleavage furrow and the physical separation 
of the daughter cells by abscission, are now recognized as two functionally and 
mechanistically different steps (Shuster and Burgess, 2002). The organizing principle for 
abscission is represented by the midbody, which is the target site for membrane delivery and 
membrane fusion, the driving forces of abscission. In particular the unique midbody ring, 
located at the midpoint of the intercellular bridge that connects the two prospective daughter 
cells, has emerged as the crucial structural element that guides the final steps of cytokinesis. 
This rigid and unvaryingly sized structure, originally described by Flemming as !Zentralkörper" 
(thus sometimes called !Flemming body"; Flemming, 1891), emerges in telophase and survives 
in one daughter cell in most cases often until the next division. 
This study demonstrates that BRUCE, an unconventional baculovirus inhibitor of 
apoptosis repeat protein (BIRP) and multifunctional peripheral membrane protein with ubiquitin 
ligase activity, is an important regulator in cytokinesis. BRUCE coordinates processes at the 
midbody ring that are elementary for proper abscission. The functional integrity of the midbody, 
its formation, and membrane delivery to the site of abscission depend on the presence of 
BRUCE. Moreover, the discovery of a unique and highly dynamic localization pattern of 
ubiquitin conjugates at the midbody during cytokinesis reveals a so far unrecognized role of 
the ubiquitin proteasome system in regulating final stages of cell division. Additionally, this 
study demonstrates that BRUCE depletion disrupts ubiquitin localization at the midbody. 
 
5.1  BRUCE, a BIRP with a highly dynamic behavior during the cell cycle 
Recent studies have emphasized that animal cell cytokinesis is driven primarily by 
homotypically and heterotypically fusing endosomes and that a general requirement for 
exocytosis exists in any cytokinesis-related process (Finger and White, 2002; Albertson et al., 
2005; Baluska et al., 2006). This study has shown that BRUCE follows the flow of vesicular 
traffic during cytokinesis. In interphase cells, BRUCE localizes to the TGN and 
tubular/recycling endosomes, but during cytokinesis, a fraction travels to the midzone where it 
arrives specifically at the midbody. Notably, BRUCE associates with the midbody ring 
concomitant with its appearance in telophase, travels into one daughter cell with the midbody 
ring after completed abscission, and remains bound to the discarded midbody ring all along 
until a new ring is formed during the next cell division.  
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It is conjectured that the dynamic relocalization of BRUCE is almost exclusively driven 
by the movement of organelle-bound BRUCE along microtubules. The majority of these 
organelles where BRUCE localizes are essentially large pleiomorphic traffic intermediates 
linked to Rab8 and Rab11 and probably Rab13 GTPases (Figures 13 to 15) (Peränen et al., 
1996; Urbé et al., 1993; Yamamoto et al., 2003). Besides small round vesicles that are also 
essential for protein traffic in cells, large pleiomorphic traffic carriers seem to move the bulk of 
secretory cargo by en bloc extrusion and cleavage of large membranes (Polishchuk et al., 
2003; Luini et al., 2005). These carriers emerge from the TGN, the penultimate compartment 
along the pathway for most secreted proteins. Formation and movement of these carriers 
depend on protein kinase D, dynamin, microtubules, kinesin motor proteins and the exocyst 
complex (Ghanekar and Lowe, 2005; Kreitzer et al., 2000; Polishchuk et al., 2003; 
Ponnambalam and Baldwin, 2003). Interestingly, interactions of BRUCE with several 
components of TGN to plasma membrane carriers were observed, like subunits of the exocyst 
membrane targeting complex, microtubules, and Rab8 and Rab11 GTPases (Figures 13 and 
15). Additionally, transport carriers containing albumin or VSVG also stained positively for 
BRUCE and pleiomorphic traffic intermediates containing BRUCE were found exclusively 
collinear with microtubules (Figures 13 and 14). This allows the conclusion that in interphase 
cells BRUCE is a component of TGN to plasma membrane transport units moving on 
microtubules. During exocytic transport, BRUCE might act in different steps of trafficking, e.g. 
by affecting the ubiquitylation status of transport factors. However, it seems unlikely that 
BRUCE is implicated in fusion steps at the plasma membrane because it is found on 
peripheral carriers but never reaches the plasma membrane itself (Figure 8E). 
For BRUCE partially localizes to both centrosomes and the TGN (Figure 9), it is 
tempting to speculate that cues originating from microtubule organizing centers (MTOCs) 
regulate trafficking of BRUCE-containing carriers. Two types of MTOCs are described so far. 
The well-characterized centrosomes which tether microtubule minus ends via !-tubulin ring 
complexes and, only recently discovered, the TGN with tethering occuring via the peripheral 
membrane protein GCC185 and the microtubule binding protein CLASP (Bornens, 2002; 
Efimov et al., 2007). Strikingly, under conditions of artificially amplified centrosomes by 
treatment of U2OS cells with hydroxyurea, this study shows that BRUCE localizes around one 
centrosome even if this centrosome moves into the cell periphery or in cellular protrusions 
(Figure 9C). This clearly demonstrates that centrosomes act as key regulators for the tubular 
endosomes BRUCE is localized to. 
During the relocalization events from endosomes to midbodies, BRUCE associates 
with numerous trafficking components and also mitotic regulators. An association of BRUCE 
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with kinases regulating mitotic events (Cdk1, Plk1, and Mek1) is shown in this study (Figure 
10). Notably, both Plk1 and the active form of Cdk1 in complex with cyclin B are localized to 
centrosomes (Tsvetkov et al., 2003; Jackman et al., 2003) and both kinases are additionally 
involved in phosphorylating proteins on the Golgi apparatus to allow unlinking of Golgi stacks 
in early prophase (Colanzi and Corda, 2007). Phosphorylation of BRUCE by Cdk1 should 
occur early during mitosis as Cdk1 represents the kinase that drives cells through mitosis. As 
a general mechanism, Plk1 can localize to specific sites within cells where Cdk-mediated 
phosphorylation provides a structural mechanism for targeting the Plk1 kinase domain to its 
substrates (Elia et al., 2003). Co-localization of BRUCE and Plk1 can be observed on spindle 
poles and on the midbody arguing for an interaction at later stages of mitosis. 
 Considering the sequential Cdk1-Plk1 action, one can speculate that the mobile 
behavior of BRUCE is most likely regulated by a stepwise phosphorylation as was recently 
shown for two proteins required for cytokinesis. Both the peripheral Golgi lipid transfer protein 
Nir2 (Litvak et al., 2004) and the centrosomal protein Cep55 (Fabbro et al., 2005) undergo a 
priming phosphorylation by Cdk1 which in turn creates a docking site for Plk1. Preventing 
phosphorylation in either protein caused cytokinesis defects. It is therefore likely that a similar 
mechanism of phosphorylation-mediated relocalization might also apply for BRUCE as it 
contains a (S/T)PX(K/R) Cdk1 phosphorylation consensus site (VASTPPR at amino acids 
3914-3920), several putative (D/E)XST(I/L/F/W/M/V/A) Plk1 sites (e.g. at amino acids 3967-
3970 and 3990-3993 and therefore close to the Cdk1 site), and physically interacts with both 
Cdk1 and Plk1. 
Additionally, BRUCE interacts with a third kinase, Mek1 (mitogen-activated protein 
kinase and Erk kinase 1) (Figure 10). Mitogens induce the sequential activation of the mitogen-
activated protein kinase (MAPK) network kinases Raf1, Mek1, Erk2 and Rsk via the small 
GTPase Ras (Chang et al., 2003). Besides this conventional MAPK signaling, Mek1 is also 
involved in regulating membrane traffic and Golgi morphology. Organelle bound Mek1/Erk was 
shown to be required for bidirectional transport of melanosomes (Deacon et al., 2005). This 
finding was substantiated by a recent report that showed that a complex of Mek1, MP1 (Mek1 
partner 1) and a scaffolding protein related to MP1, p14, regulates endosomal traffic during 
tissue homeostasis (Teis et al., 2006). In addition, Raf1-dependent activation of Mek1 and its 
presence on the Golgi apparatus at the G2/M transition is required for Golgi complex 
fragmentation (Colanzi et al., 2003; Feinstein and Linstedt, 2007). This might argue for a role 
of Mek1 in detaching BRUCE from sites of interphase localization or in a general regulation of 
BRUCE in endosomal traffic. The identification of phosphorylation sites in BRUCE and the 
delineation of contributions of individual kinases to BRUCE!s modifications should therefore be 
Discussion 
61 
 
a future objective. Hence, it should be determined which phosphorylation events are needed 
for a constitutive contribution of BRUCE to vesicular trafficking, and which are specific to cell-
cycle transitions enabling BRUCE to translocate to the midbody ring.  
 It should be pointed out that there is evidence for a second link of BRUCE to MAPK 
signaling. Recently, it was demonstrated that signaling from non-receptor tyrosine kinases of 
the Src family is needed for completion of cytokinesis (Kasahara et al., 2007). In this case, the 
signal is transduced from Src via Mek1 and Erk to the midbody where high levels of tyrosine 
phosphorylation were detected. Furthermore, Kasahara et al. found that Erk translocation to 
the midbody in turn was dependent on proper Rab11 function. In addition to these findings, 
data presented in Figure 23 show that phospho-tyrosine modification does not reach the 
midbody ring if cells are depleted of BRUCE. An explanation for the loss of phospho-tyrosine 
signals at the midbody after BRUCE depletion might be that also Rab11 endosomes do not 
reach the midbody and associated MAPKs do not reach this site, either (Figure 23). It could be 
envisioned that BRUCE might act as an organellar scaffolding factor to guide the Mek/Erk 
module to the midbody ring on tubular endosomes. Scaffold proteins in general contribute to 
the specificity of Mek/Erk pathways in mammalian cells (Sacks, 2006). These include KSR 
(kinase suppressor of Ras), !-arrestin, MEK partner-1 (MP1, see above), Sef and IQGAP1 
(which is most likely also involved in cytokinesis). By organizing signaling complexes these 
scaffolds target Mek/Erk to specific substrates and facilitate communication with other 
pathways, thereby mediating diverse functions. BRUCE could generate a midbody ring based 
platform that allows crosstalk between MAPK signaling and vesicular traffic or ubiquitylation to 
drive completion of cytokinesis. 
 
5.2  BRUCE is needed for proper cell division 
This study demonstrates that BRUCE-depletion in cultured mammalian cells resulted in 
cytokinesis failure (Figures 21 and 22). The appearance of syncytial cells after BRUCE 
depletion in U2OS cells was partially reminiscent of the phenotype described for centriolin 
depletion (Gromley et al., 2003). In fact, besides syncytial cells that could still undergo mitosis, 
!innocent-bystander" mitosis can be observed as well meaning that a cell that undergoes 
mitosis drags a neighboring cell into this process (Figure 29). This clearly demonstrates that 
the structures observed after transfection of cells with BRUCE siRNA are interconnected 
syncytia and not just simply cells in tight contact. To allow dragging of neighboring cells into a 
joint mitosis it has to be assumed that cells can communicate most likely via connections 
bridging the cytoplasms that allow diffusion of a soluble signal, most likely emerging only from 
one cell. Additionally, this signal has to diffuse into the other cell in order to signal mitosis. The 
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fact that mitosis does not spread over the whole syncytium might be explained by a 
concentration gradient of the mitosis-inducing agent that only affects neighboring cells. Proper 
sealing of the intercellular bridge in cytokinesis therefore assures that mitotic and probably 
other soluble signals (e.g. apoptotic) cannot spread into other cells. It is not clear yet whether 
the cell that is dragged into a joint mitosis also replicates DNA prior to the fusion with the 
neighboring cell. In normal cells, probably right after constriction of the midbody, diffusion 
between daughter cells is no longer possible as demonstrated in this study by the fact that 
endosomes from one cell cannot traverse the midbody into the other daughter cell (Figure 17). 
Furthermore, cells with aneuploid DNA content are the outcome of divisions of a hexa- 
or octoploid cell-fusion, as could be seen by FACS analysis (Figure 22). After prolonged 
BRUCE depletion the syncytia and aneuploid cells they contain finally undergo apoptosis. 
Remarkably, aberrant mitotic and cytokinetic structures like multipolar spindles and 
tripolar cytokinesis are also found in spontaneously immortalized BRUCE-/- MEFs (Figure 30), 
arguing for problems in cytokinesis in the knockout animals as well as for an adaptation to the 
instability caused by these erroneous divisions. Adaptation in the knockout embryos probably 
takes place e.g. by switching to complementary factors like centriolin that can also mediate 
membrane targeting at the midbody ring. The involvement of BRUCE in cytokinesis and 
membrane traffic would explain the embryonic lethality without obvious signs of apoptosis 
observed for BRUCE-/- mice (see below). Taking into account that knockout animals for other 
inhibitor of apoptosis proteins like XIAP-/- mice (Harlin et al., 2001) and NAIP-/- mice (Holcik et 
al., 2000) are perfectly viable, favors the idea that inhibition of unwanted apoptosis during 
development is probably not the main function of IAP proteins or that functions of IAPs are 
overlapping. 
Additionally, the signs of apoptosis that were found in BRUCE gene trap mice (Ren et 
al., 2005; Hitz et al., 2005; see Introduction) can be explained by a dominant-negative effect of 
the BRUCE fragments still expressed in these mice. Due to the lack of the C-terminal part of 
BRUCE, which in the study presented here was shown to mediate targeting of BRUCE to the 
midbody ring (Figures 18 to 20), BRUCE truncations can still bind to factors needed for 
cytokinesis but might sequester them away from the site where they are needed. In this case 
complementary factors, would not be sufficient to protect cells from detrimental consequences 
as BRUCE truncations can function as competitors for other proteins needed during 
cytokinesis that would else bind to compensating factors. 
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5.3  Involvement of BRUCE and survivin in cytokinesis-coupled apoptosis 
The unique pattern of cell cycle specific localization in the midzone and on the midbody 
suggests a resemblance of BRUCE with the chromosomal passenger protein survivin which 
harbors a BIR domain that is more similar to that of BRUCE than to BIR domains in any other 
inhibitor of apoptosis protein. In addition to their physical interaction, BRUCE is able to mono-
ubiquitylate survivin in vitro arguing for a regulatory or priming ubiquitylation for the 
degradation of survivin later on in cytokinesis (Figure 11). Alternatively, ubiquitylation of 
survivin might allow for a dynamic association/dissociation from the midzone/midbody similar 
to the dynamic behavior of survivin on centromeres that is also regulated by cycles of 
ubiquitylation and de-ubiquitylation (Vong et al., 2005)  
It seems likely that mixed IAP-IAP complexes play a broader role in apoptosis 
regulation than previously thought. Besides the complex of BRUCE and survivin a mixed IAP-
IAP complex of survivin and XIAP can promote increased XIAP stability against ubiquitylation 
and allows synergistic inhibition of apoptosis (Dohi et al., 2004). The cytokinesis-associated 
apoptosis phenotype described in the study presented here for HeLa cells (Figure 22) can 
probably be connected to an observation that showed activation of caspase-9 on the midbody 
and subsequent apoptosis in HeLa cells that expressed a mutant form of survivin which is not 
phosphorylatable by Cdk1 and in consequence fails to stably bind caspase-9 (O!Connor et al., 
2000). Therefore, a mixed BRUCE-survivin complex is probably required for regulation of 
apoptosis on the midbody. Crystal structures of XIAP – an IAP protein with three BIR domains 
in tandem – with caspase-3 and -7 revealed that not the BIR domains themselves bind to the 
caspase!s active site but linker sequences in-between BIR domains (Chai et al., 2001; Huang 
et al., 2001; Riedl et al., 2001). It might thus be argued that a complex of BRUCE with survivin 
could represent a variation on the BRUCE oligomeric complexes needed for caspase inhibition 
(Bartke et al., 2004). In these complexes, BIR domains might arrange in a way that would 
generate similar linkers needed for firm inhibition of caspases. Furthermore, it would be 
interesting to investigate whether IAPs like BRUCE or XIAP can compete for other 
components of the chromosomal passenger complex for survivin binding. This would allow a 
switch in the function of survivin, e.g. at sites of high IAP concentrations, from a role in 
centromere/microtubule dynamics to apoptosis regulation (Jeyaprakash et al., 2007). 
The cytokinesis-coupled apoptosis found in HeLa cells after BRUCE depletion (Figure 
22) and the resemblance to the phenotype shown for the non-phosphorylatable survivin raise 
the question whether a cytokinesis checkpoint might exist. Such a checkpoint would either 
arrest cells in the state of failed cytokinesis or would trigger apoptosis when cells sense an 
erroneous cytokinesis. Making use of different manipulations that allow either a spindle 
Discussion 
64 
 
checkpoint override or block in cytokinesis completion, several reports demonstrated that cells 
containing active p53 arrested in the following G1 phase of the cell cycle with a tetraploid 
genome (Hirano and Kurimura, 1974; Cross et al., 1995; Minn et al., 1996; Lanni and Jacks, 
1998; Andreassen et al., 2001; Meraldi et al., 2002). The notion was therefore that mammalian 
somatic cells inherit a !tetraploidy checkpoint" that arrests cells after failed cytokinesis, which 
would thereby prevent aneuploidy and carcinogenesis (Margolis et al., 2003; Stukenberg, 
2004). However, this idea became less likely as it was demonstrated that multinucleate 
hepatocytes can proliferate and are not arrested finally (Fausto and Campbell, 2003). 
Furthermore, it was shown that cells harboring functional p53 can still undergo further rounds 
of mitosis and cytokinesis even if they start replicating from a tetraploid state (Uetake and 
Sluder, 2004). It was thus suggested that cleavage failure in living organisms alone is either 
not happening or not sufficient to cause problems by itself. There are also several reports on 
tetraploid humans that can survive up to 26 months after birth (Lafer and Neu, 1988; Lopez 
Pajares et al., 1990; Guc-Scekic et al., 2002). 
Other cases of apoptosis during cell division are unlikely to be important for a 
cytokinesis checkpoint because they are triggered much earlier in mitosis. DNA damage 
checkpoints (Castedo et al., 2004) and the spindle assembly checkpoint (Vogel et al., 2007) 
that signal via the checkpoint kinase Chk1/2 or via Polo-like kinases, respectively, can trigger 
apoptosis during metaphase or at anaphase onset, a process known as mitotic catastrophe 
(Castedo et al., 2002). Mitotic catastrophe is a p53 independent mechanism but involves the 
activation of caspase-2 and subsequent activation of the executioner caspase-3 (Castedo et 
al., 2004). Under certain conditions the spindle assembly checkpoint can also trigger a p73-
dependent and caspase-independent mitotic cell death (Niikura et al., 2007).  
Nonetheless, cells that harbor functional p53 can arrest after a failed cytokinesis in the 
following G1 phase (Uetake and Sluder, 2004; Wong and Stearns, 2005) and these binucleate 
cells developed hallmarks of senescence (Wong and Stearns, 2005). Strikingly, mouse 
embryonic fibroblasts isolated from BRUCE-/- embryos showed largely increased signs of 
senescence already after the second passage in culture indicative of an arrest after failed 
mitosis (Lotz, 2004). The function of BRUCE in cytokinesis in cell divisions of living organisms 
in particular might therefore be reflected by a G1 arrest and concomitant senescence which 
could lead to impaired differentiation and reduced growth rather than apoptosis. This was in 
fact observed for BRUCE-/- embryos where trophoblast cells of the placenta showed hallmarks 
of senescence but not of apoptosis (Lotz, 2004). Taken together, phenotypes found in tissue 
culture cells described in this study and in BRUCE-/- mice fit to a more global role of BRUCE in 
the regulation of cell division in cells that are not challenged by pro-apoptotic stimuli. It is not 
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excluded that developmental scenarios exist in which transient caspase-activation is needed 
for cell fate determination, which could also involve BRUCE. However, the general existence of 
a cytokinesis checkpoint is unlikely for several of the above mentioned reasons. Nota bene 
that BRUCE depletion in other cell types than HeLa did not induce cytokinesis-associated 
apoptosis but variable failures in cytokinesis. Nonetheless, it is likely that a specifically 
cytokinesis-associated apoptosis might be restricted to certain cell types that require 
specialized IAPs or a balanced ratio of different IAPs during cytokinesis like e.g. HeLa cells 
(Crnkovic-Mertens et al., 2006).  
 
5.4  Cell type specific mechanisms of cytokinesis and stable intercellular  
       connections during development 
As shown in this study, depletion of BRUCE in U2OS cells results in the loss of midbody rings 
after approximately 4-5 days as visualized by MKLP1-staining (Figure 28). It is therefore likely 
that BRUCE plays a role in the formation or integrity of the midbody ring. After three days of 
BRUCE siRNA treatment, cells furrowed normally but contained largely reduced midbody rings 
with midbody microtubules also lying outside of the midbody ring. Hence, BRUCE does not 
seem to play a role in furrow formation, actomyosin ring constriction, or midzone 
establishment. Instead, it seems likely that BRUCE itself might act as a scaffold to recruit other 
proteins to the midbody ring or to allow their firm association with the midbody ring. Thus, the 
loss of midbody rings could indicate either a faster turnover of their constituents or an 
inefficient formation. From the data presented here the latter seems more likely – taking into 
account the fact that midbody microtubule bundling is also reduced. 
When depleting BRUCE from hTERT-RPE1 cells, in addition to HeLa and U2OS cells, 
cells that complete cytokinesis but still harbor midbodies in cellular protrusions can be 
observed. Hence, the problem in abscission is apparently overcome by stretching the 
intercellular bridge until rupture. In consequence, the midbody is retracted in one cell and is 
found in a protrusion formerly constituting part of the intercellular channel. hTERT-RPE1 cells 
are very motile on standard cell culture ware and daughter cells are often found interconnected 
by extremely elongated intercellular channels, which would allow a rupture-like mechanism. In 
this scenario, the resulting hole in the plasma membrane would be minimal and could probably 
be sealed by constitutive secretion to the plasma membrane. Several other reports also 
described cells that apparently separated by rupture of the midbody (Mullins and Biesele, 
1977; Golsteyn et al., 1994) or where midbodies could be discarded even after cytokinesis was 
already completed (Dubreuil et al., 2007).  
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The differences in phenotypes observed in U2OS, hTERT-RPE1 and HeLa cells 
indicate that different cell types try to overcome problems in abscission using different 
mechanisms like elongation of the intercellular bridge and syncytia-like growth, midbody 
rupture, or cytokinesis-coupled apoptosis, respectively.  
Notably, cells in which myosin II is inhibited can still undergo cytokinesis, which is 
contractile ring independent but depends on strong adhesion (e.g. growth on fibronectin 
coated cell culture dishes) and on polar traction forces (Kanada et al., 2005). Additionally, in 
Dictyostelium so-called midwife cells can help in cytokinesis by severing the myosin II 
knockout daughter cells that would otherwise fail to undergo cytokinesis (Uyeda end Nagasaki, 
2004). These findings clearly demonstrate that cells even without a contractile ring can 
undergo normal cell division when the physical or cellular environment is appropriate. Several 
genes in fact relevant for cytokinesis might therefore not score in genome wide screens due to 
weak phenotypes or due to suppression of phenotypes by rescuing pathways or inappropriate 
experimental conditions (Somma et al., 2002; Echard et a., 2004). When testing the phenotype 
of BRUCE depletion in U2OS cells on different substrates (fibronectin, collagen) no rescue 
was observed. Elongated syncytia still formed, which indicates that cells try to separate by 
polar traction forces but, in contrast to furrowing problems, a failure in abscission cannot be 
overcome by simply pulling daughter cells to opposite directions. 
Although tissue culture cells studied here should, in general, divide in a symmetric 
fashion, the inheritance of the midbody remnant by only one of the daughter cells would 
generate asymmetry. Non-polarized transformed cells in culture are thus probably not ideally 
suited to investigate the consequences of asymmetric midbody remnant inheritance. 
Investigation of these cells did not reveal any evidence for differences in cell fate post 
cytokinesis completion. Furthermore, there were no hints suchlike observed in this study. 
However, a recent study demonstrated that dividing stem cells have developed mechanisms to 
avoid the generation of asymmetry by extrusion of the midbody remnant (Dubreuil et al., 
2007). These cells need to preserve their naïve state in order to allow the maintenance of an 
undifferentiated cellular reservoir during development or tissue regeneration. It would hence be 
interesting to study the fate of the midbody remnant during stem cell or developmentally 
demanded asymmetric divisions to delineate whether loss or inheritance of midbody remnants 
is accompanied by a switch in cell fate. 
Interestingly, the midbody is also used to allow a symmetric partitioning of cell fate 
determinants. Anchoring of vesicles associated with the spindle machinery at the midbody was 
recently found to allow equal segregation of a cell fate determinant into daughter cells (Bökel 
et al., 2006). A similar mechanism must take place on midbody microtubules as these 
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constitute the symmetric part and release of bound vesicles likely precedes membrane 
transport to the midbody that drives abscission. 
The symmetric features of the midbody are also utilized in developmental scenarios 
where midbodies are differentiated into stable intercellular bridges. These are found mostly in 
germ line cells (Robinson and Cooley, 1996). In mammalian and avian oogonia, stable 
connections allow coordinated entry into mitosis and/or atresia. In spermatocytes and 
spermatids they enable genetically segregated haploid spermatids to share diploid gene 
products after meiosis and to mediate rapid transfer of signals or nutrients. 
Spermatocytes/spermatids might be especially sensitive to stochastic gene expression. Stable 
bridges in-between cells apparently eliminate heterogeneity so that relatively uniform gametes 
can develop (Guo and Zheng, 2004). Strikingly, during the generation of BRUCE knockout 
mice, difficulties in mating of a male chimeric animal with wild type females were observed 
(Pyrowolakis, 2000). It was concluded that the animal was most likely sterile and therefore 
progeny was generated by in vitro fertilization. Following up on this finding, this study shows 
that BRUCE is a component of the stable intercellular bridges during spermatogenesis (Figure 
31). It can therefore be speculated that a loss of BRUCE might lead to problems in 
spermatogenesis, which would explain the male sterility.  
 A recent report described factors required for the formation and maturation of testis 
ring canals (Greenbaum et al., 2007). The authors identify a novel component, Tex14 – a 
putative testis-specific kinase – that is needed to allow transition from midbodies to ring canals 
(Greenbaum et al., 2006). Midbody maturation involves the removal of the actomyosin ring and 
microtubules after arrested cytokinesis. Subsequently, an outer ring of septins assembles on 
the primary inner midbody ring consisting of MKLP1 and MgcRacGAP. During later stages the 
inner ring expands from 1.5 to about 3 µm and the outer septin ring is gradually lost 
(Greenbaum et al., 2007). This study describes that BRUCE localizes to stable intercellular 
bridges in mouse testis. BRUCE might therefore be a good candidate for maintaining the 
differentiated state of the bridge as it is still found on expanded mature intercellular bridges 
and is a constituent of the inner midbody ring that is not lost during this differentiation process.  
 
5.5  Membrane delivery during cytokinesis 
This study demonstrates that tubular endosomal membranes transform into vesicular pools 
that are concentrated on the fanning out ends of midbody microtubules in cytokinesis. Along 
with these vesicles BRUCE travels to the midbody ring where part of it is already localized 
constitutively (Figures 8 and 15). Similar to recycling endosomes, it seems likely that tubular 
endosomes, normally needed for protrusion formation, might acquire specialized functions in 
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cytokinesis which are possibly mediated through BRUCE (Figure 15 and 17). Interaction of 
BRUCE with integral midbody components via its C-terminus and with the vesicle targeting 
machinery via its N-terminus allow to classify BRUCE as a linking factor (see model in Figure 
32C). The giant middle part of BRUCE, which seems devoid of any recognizable domains, 
might function to accommodate interactions especially in the crowded environment of the 
midbody. In unperturbed cells, no obvious asymmetry is detectable during membrane delivery 
to the intercellular bridge. But strikingly, interfering with BRUCE function by either depletion or 
expressing the isolated midbody targeting domain, that is not able to bind to the exocyst or 
Rab8/11 GTPases, reveales an intrinsic asymmetric feature of abscission. Under these 
conditions, secretory cargo as well as recycling endosomes accumulate in close proximity to 
the midbody ring. Furthermore, it seems that MAPK signaling modules do not reach the 
midbody ring, either, highlighting the role of vesicular transport for kinase signaling. The 
asymmetric aspect of membrane transport is thus probably masked by a second bulk pathway 
of secretion towards the midbody ring, which does not serve to seal the intercellular channel 
but rather provides new material for the extending plasma membrane. Additionally, this 
suggests that the midbody does not only serve as the structure for delivery of vesicles needed 
for sealing the intercellular channel but might mediate targeted membrane insertion in cells 
that require more extensive plasma membrane remodeling than e.g. HeLa cells. In this 
respect, the finding that Rab8 endosomes are also transported along midbody microtubules in 
U2OS cells points to a role of this compartment in regaining the flattened appearance of cells 
after mitosis (Figure 15, 17 and 32) in addition to other pathways of membrane addition from 
intracellular pools, like blebbing (Byers and Abramson, 1968; Boucrot and Kirchhausen, 2007). 
The movement of vesicles in the intercellular bridge could explain the drastic rapid 
movements of the midbody ring, especially as observed in HeLa cells (Figures 18 and 19). 
These movements could represent the consequences of the migration of thickenings or waves 
through the intercellular channel described almost 40 years ago (Byers and Abramson, 1968). 
The authors of this report observed asymmetry in the way that during later stages of 
cytokinesis waves emerged only on one side of the midbody. Rupture of the bridge took place 
just adjacent to the cell receiving these latter waves. Following the movements of the midbody 
ring in HeLa and U2OS cells it is also shown in the study presented here that prior to 
abscission the midbody ring contacts the cell that would later on take it up (Figure 19 and 20). 
It might therefore be concluded that vesicle movements fuel the translocation of the midbody 
ring inside the intercellular bridge and that directionality of these movements determines the 
fate of the midbody ring. Directionality of transport in turn might be governed by cues 
originating from centrosomes that are the only polarized organelles at this stage of cell 
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division. Besides its role in cytokinesis, targeted membrane insertion is required for a large 
number of other cellular processes. This study demonstrates that BRUCE also translocates to 
sites of membrane insertion during neuronal differentiation (Figure 16). Interestingly, this 
process involves another component that is a core component of the midbody ring, MKLP1 
(Kobayashi, 2002). MKLP1 is needed to form both podocyte processes and neuronal 
dendrites. Strikingly, their elongation is supported by Rab8-regulated basolateral-type 
membrane transport. This represents strong evidence for a general involvement of 
Rab8/BRUCE-positive endosomes in membrane transport to sites that require extensive 
plasma membrane remodeling. 
In summary, BRUCE represents a multifunctional scaffold that allows integration of 
signals from several regulators of vesicular trafficking to enable it to participate in numerous 
processes of targeted membrane insertion like neuronal differentiation, migration, and 
cytokinesis. 
 
5.6  Ubiquitin dynamics during cytokinesis 
At the time the actomyosin ring has constricted most, ubiquitin is found heavily concentrated 
on the plus-end tips of midbody microtubules (Figure 24 and 25). It is therefore tempting to 
speculate that, at this point, most cell cycle regulators that remained after mitotic exit (e.g. 
Aurora B, survivin, Plk1 etc.) are in fact degraded at that site thus creating compartmentalized 
protein degradation. Membrane traffic to the midbody ring possibly starts first after the 
actomyosin ring has dissolved and most degradation ceased. This could speak for a 
mechanism in which regulatory proteins that translocate to the midbody and need to be 
degraded there might impose a physical barrier that does not allow vesicular traffic. Bulk 
degradation of proteins on midbody microtubules during early cytokinesis would later on allow 
membrane flow to the midbody ring and could therefore act both as a timer and as an 
irreversible element that generates directionality of the transition. Interestingly, ubiquitylation 
on midbody microtubules and on the midbody ring are separate events as proteasome 
inhibition of cells in early cytokinesis prevents both cytokinesis and localization of ubiquitin to 
the midbody ring (Figure 24). 
In the 15-30 min time-window following ubiquitylation on microtubule plus-end tips 
virtually no ubiquitin is detectable on the midbody. With a gradual increase, ubiquitin is then 
exclusively found on the midbody ring. Surprisingly, this pool of ubiquitin is completely different 
in nature, as it virtually shows no exchange with the cytoplasmic ubiquitin pool (Figure 25). At 
least part of it might be brought there e.g. by BRUCE which possesses ubiquitin ligase activity. 
As ubiquitin on the midbody ring seems very static, modification at this site does apparently 
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not lead to proteolysis but rather triggers downstream processes by recruitment of ubiquitin-
binding proteins. Ubiquitin on the midbody ring could of course also represent auto-
ubiquitylated E2/E3 enzymes. This auto-ubiquitylation might be a consequence of the loss of 
substrates at that site and due to the high local concentration of E2s/E3s. Auto-ubiquitylation 
could then be accompanied by inactivation of E2s/E3s to result in a negative feedback. This 
negative feedback would support a current model claiming that irreversible cell cycle 
transitions cannot be attributed to a single molecule or reaction but that they originate from 
reaction networks (Novak et al., 2007). Systems-level interaction in this model creates a switch 
in the rates of two states that are coupled via an irreversible transition and a feedback 
mechanism that allows bi-stability. It is thus conjectured that modification of the midbody ring 
triggers a process that leads to irreversibility of the final step in cytokinesis.  
Such a secondary effect after midbody ring ubiquitylation might be mediated by 
ubiquitin binding proteins. Recent reports (Carlton and Martin-Serrano, 2007; Morita et al., 
2007) clearly demonstrated a role for the ESCRT machinery in cytokinesis. Recruitment of 
ESCRT components has been shown to be mediated by interaction with Cep55, ROCK and 
probably IQGAP1 (see Introduction). In addition, the localization of ubiquitin to the midbody 
ring could allow direct binding e.g. of Tsg101 in ESCRT-I and other ubiquitin-binding ESCRT 
components (Hrs in ESCRT-0, Vps36 in ESCRT-II) thereby extending the Cep55-dependent 
mechanism by which ESCRT components are recruited to the midbody ring (Carlton and 
Martin-Serrano, 2007; Morita et al., 2007). Moreover, ubiquitin might also contribute to the 
regulation of the activity of the ESCRT proteins. It therefore seems possible to speculate on a 
requirement for ubiquitin during ESCRT-mediated resolution of membrane tubules also in 
cytokinesis. 
Data presented here pointing to a direct function of the de-ubiquitylating enzyme UBPY 
in cytokinesis can be considered a direct link of ubiquitin-modification, vesicle transport, and 
ESCRT machineries (Figures 26 and 27). One reason to assume this is that UBPY also 
harbors a MIT-domain enabling it to bind to several ESCRT-III CHMP-proteins (Row et al., 
2007) thereby placing it at a late stage of MVB biogenesis. The involvement of UBPY in the 
regulation of cytokinesis could also explain previous data that implicated UBPY in cell cycle 
regulation (Naviglio et al., 1998). Interestingly, UBPY function seems to be restricted to certain 
cell cycle stages. UBPY was found to be phosphorylated at serine 680 thereby recruiting the 
phospho-binding proteins 14-3-3!, ", and # which, in turn, inhibit the de-ubiquitylating activity of 
UBPY (Mizuno et al., 2007). After M-phase, the phosphorylation on serine 680 decreases and 
inhibition by 14-3-3 is diminished concomitantly. Subsequently, during mitosis, UBPY activity 
increases allowing it to act on ubiquitylated proteins later on in mitosis, e.g. MKLP1, as is 
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shown in this study (Figure 26). The failure in MKLP1 de-ubiquitylation in the case of over-
expression of a catalytically inactive form of UBPY might therefore directly reflect the failure in 
cytokinesis observed.  Furthermore, mislocalization of MKLP1 to the cytoplasm in interphase 
cells would allow to speculate on problems in re-import of MKLP1 into the nucleus as cause for 
the cytokinesis failure. Ubiquitylation of MKLP1 might mask a nuclear localization signal (NLS) 
from recognition similar to the Aurora B mediated phosphorylation inside the NLS (Neef et al., 
2006). The constitutive ubiquitylation in fact phenocopied the deletion mutant of MKLP1 that 
lacked the NLS (Liu and Erikson, 2007). 
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Surprisingly, although UBPY and therefore de-ubiquitylating activity associated with the 
midbody ring, ubiquitin on the ring was not removed (Figure 25). The protection of midbody 
remnant bound ubiquitin from de-ubiquitylation might be achieved by enclosure of the midbody 
ring during abscission in a membrane-caged structure. Degradation of the remnant could 
therefore be similar to the one, which occurs inside multivesicular bodies. Hence, remnant 
clearance would be a cell cycle independent event, which resembles more to lysosomal 
degradation. This might explain why ubiquitin is found stably associating with the remnant and 
only slowly vanishing as it is gradually degraded inside a lysosome-like structure. This notion 
is also supported by the fact that interfering with the AAA-ATPase Vps4 leads to an arrest-like 
state in late cytokinesis (Morita et al., 2007). Furthermore, ubiquitylation of the midbody ring in 
addition to a possible impact on the ESCRT machinery might induce a switch in Rab proteins 
that are recruited to it. Notably, Rab7, a marker of lysosomes and autophagosomes (Feng et 
al., 1995; Eskelinen, 2005), was found in a proteomic study of the midbody inventory (Skop et 
al., 2004). Interestingly, there is a putative link to the ESCRT machinery via a protein called 
RILP that can interact with the Vps22 and Vps36 components of the ESCRT-II complex and 
Rab7 (Wang and Hong, 2006; Progida et al., 2007). Furthermore, subunits of ESCRT-I, -II and 
-III, as well as their regulatory ATPase Vps4 and the endosomal PI3P 5-kinase Fab1, all are 
required for autophagy (Rusten et al., 2007). A cell cycle independent compartmentalized 
lysosomal pathway for midbody remnant degradation would explain why in slowly proliferating 
cells only few midbody remnants could be observed, while fast replicating cells can harbor 
more than one such remnant. Additionally, a pathway suchlike could ensure that signaling from 
the remnant is prevented and thus the asymmetric inheritance, too, would not cause any 
cellular alterations. 
Taken together, the data presented here show that the midbody ring represents a 
structure on which processes leading to the final separation of daughter cells converge. 
BRUCE as an integrative molecular platform is implicated in formation and proper function of 
the midbody ring in respect to the maintenance of its architecture, ubiquitin modification of its 
constituents, and vesicle targeting (Figure 32). Ubiquitin dynamics at the midbody reveal a 
spatially and temporally highly regulated process of posttranslational modifications that ensure 
proper cytokinesis. Studying its inventory and regulation might lead to the understanding of 
inherent asymmetric features during cytokinesis like inheritance of the midbody ring by only 
one cell or unidirectional membrane flow. Future objectives are thus to understand the 
movements of the midbody ring and whether these originate from vesicular trafficking, as well 
as to investigate whether ubiquitylation of the midbody ring itself can trigger abscission, and, 
finally, to find out what might be the crucial substrates for ubiquitylation on the midbody ring. 
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6  Materials and Experimental Methods
6.1  Cloning and protein expression in E. coli
E. coli strains used for cloning and protein expression
BL21 (DE3) E. coli B F- dcm ompT hsdS(rB- mB-) gal !(DE3)
BL21 Codon Plus (DE3) – RIL E. coli B F- ompT hsdS(rB- mB-) dcm+ Tet
r gal !(DE3) endA
Hte [argU ileY leuW Camr]
XL1-Blue MR "(mcrA)183 "(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-
1 recA1 gyrA96 relA1 lac
E. coli cells were grown in LB or on LB plates (1% bacto-tryptone, 0.5% yeast extract, 1%
NaCl, 1.5% agarose) supplemented with 50 µg/ml Ampicillin or 30 µg/ml Kanamycin at 37°C.
Density of liquid cultures was determined by measuring the absorption at 600 nm wavelength
with a standard spectrophotometer (Eppendorf).
Plasmids for protein expression in E. Coli
Plasmids of the pET (pET21b(+), pET24b(+) and pET28a/b/c(+), Novagen) and of the pGEX
(pGEX2TK, pGEX4T1/2/3 and pGEX5X1, Amersham) vector series were used.
Preparation of chemically competent bacteria
To obtain highly competent cells a method from Inoue et al. (1990) was used. This protocol
differs from other procedures in that the bacterial culture is grown at 18°C rather than the
conventional 37°C.
Bacteria from frozen stock or single colonies from plates were used to inoculate a starter
culture of 25 ml of SOB (2% bacto-tryptone, 0.5% yeast extract, 0.05% NaCl and after solutes
have dissolved addition of 1% 250 mM KCl and 5 N NaOH ad pH 7.0) that was shaken at
37°C for 4-6 h. In the evening three flasks with 500 ml of SOB were inoculated with 1, 2 and 5
ml of the starter culture, respectively, and shaken at 18°C. When the OD600nm reached 0.55 the
next morning the culture vessel was transferred to an ice-water bath for 10 min. Cells were
harvested by centrifugation at 2500 g for 10 min at 4°C. The supernatant was discarded and
any remaining drops of medium removed using a vacuum aspirator. Cells were resuspended
in 100 ml of pre-chilled Inoue transformation buffer (55 mM MnCl2, 15 mM CaCl2, 250 mM
KCl, 10 mM PIPES [pH 6.7]) and again harvested by centrifugation. Thereafter cells were
resuspended in 40 ml of Inoue buffer and 3 ml of DMSO were added by swirling the
resuspension. The mixture was incubated on ice for 10 min. Aliquots of 100 µl were
dispensed into pre-chilled thin-wall PCR tubes, frozen in liquid nitrogen and afterwards stored
at –80°C until needed.
Plasmid DNA transformation in E. coli
Competent cells (in thin-wall or round-bottom tubes) were thawn on ice and 1.7 µl 10% #-
mercaptoethanol was added to 100 µl of bacterial cell suspension and incubated on ice for 10
min. After addition of 1-4 µl of dissolved DNA the suspension was again incubated on ice for
another 10-30 min. Cells were then heat-pulsed for 1 min at 42°C in a water bath and
transferred back on ice for 1 min. 1 ml of SOB medium supplemented with 20 mM glucose
was added and the suspension shaken for 30-60 min at 37°C. Hereafter cells were streaked
on LB plates with the appropriate antibiotic.
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Isolation of plasmid DNA
Plasmid DNA was isolated by alkaline lysis and binding to anion-exchange matrices using kits
from Qiagen, Macherey&Nagel and Bioneer. For plasmid mini preparations (yielding 5-20 µg
DNA), 4 ml of overnight cultures were used. For preparative purposes and to obtain DNA for
transfection of mammalian cells overnight cultures of 250 ml and 1.5 l (in case of BRUCE
constructs) were used. Manufacturers! protocols were slightly modified by centrifuging
potassium-SDS complexes at 2500 g for 15 min at room temperature and by precipitating
DNA after elution in a 10:7:1 ratio of elution buffer : isopropanol : 3 M Na-acetate [pH 5.2] at
3500 g for 30 min at 4°C. This 10:7:1 ratio mixture was also applied for general precipitation
of DNA from aqueous solutions.
Alternatively DNA was purified using a PEG precipitation protocol. After alkaline lysis (0.2 M
NaOH, 1% SDS) and precipitation of SDS-protein complexes (3 M KOAc, 1.18 M formic acid),
DNA was precipitated and resuspended in 50 mM glucose, 25 mM Tris [pH 8.0], 10 mM
EDTA and RNase was added ad 20 µg/ml and incubated 20 min at RT. After another round of
alkaline lysis and precipitation the supernatant was extracted using phenol/chloroform.
Hereafter, DNA was precipitated by addition of 1/4 volume 10 M NH4OAc and 2 volumes
ethanol and centrifugation at 10000 g (4°C). The pellet was resuspended in 2 ml TE and 0.8
ml of PEG solution were added (30% PEG 8000, 1.6 M NaCl). The suspension was incubated
overnight at 4°C, pelleted the other day, the pellet resuspended, dissolved and precipitated
with isopropanol and then finally resuspended in an appropriate volume of TE or dH2O. DNA
was quantified with a Nanodrop device (peqlab) with 1 OD260 nm = 50 µg DNA.
Phenol/chloroform extraction of DNA
Extraction was performed using a 25:24:1 mixture of phenol : chloroform : isoamyl-alcohol
(Roth). DNA from the aqueous phase was precipitated using isopropanol.
Enzymatic manipulation of DNA
Site specific restriction endonucleases were used in the appropriate buffers (all NEB). Usually
0.5-5 µg of DNA were digested with 1-10 U of enzyme for 1-3 h in a total volume of 20 µl. In
the case of plasmid DNA 1 U calf intestinal phosphatase (CIP, NEB) was added 1-2 h after
restriction digestion started. PCR products were digested overnight with 5-20 U enzyme in a
total volume of 60 µl. Digested DNA was subjected to agarose gel electrophoresis, bands
were visualized by ethidium bromide staining, cut out and subsequently purified from the gel
slice using standard extraction kits (Qiagen, Macherey&Nagel). To fill in 3! recessed ends to
allow blunt-end cloning of inserts, the large fragment of DNA polymerase I was used (NEB).
DNA was dissolved in any restriction enzyme buffer and supplemented with 33 µM dNTPs.
About 1 U of Klenow was added per µg of DNA and the reaction incubated for 15 min at 25°C.
The reaction was stopped by addition of 10 mM EDTA and heating at 75°C for 10 min.
DNA ligation
Ligation of cohesive or blunt end DNA was carried out using Quick Ligase (NEB).
Approximately 50-100 ng of vector was incubated with a 3- to 10-fold molar excess of insert in
a total volume of 20 µl also comprising 1 µl of Quick Ligase. Samples were incubated for 5-60
min and subsequently transformed into chemically competent bacteria.
Gel electrophoresis of DNA
Agarose gel electrophoresis was performed with Tris-borate buffered solutions (0.5-fold TBE:
45 mM Tris-borate, 1 mM EDTA [pH 8.0]). DNA was mixed with loading buffer (5-fold
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concentrated: 25% glycerol, 0.25% SDS, 25 mM EDTA [pH 8.0], Orange G in H2O) and the
mixtures transferred into the slots of the gel (1-2% agarose in TBE, mixed with 0.005%
ethidium bromide after dissolution of the agarose). Electrophoresis was performed in minigels
for 30-60 min at 5-15 V/cm.
DNA sequencing
DNA sequencing was carried out by a modified Sanger dideoxy terminator cycle sequencing
chemistry using the DYEnamic ET Terminator Cycle Sequencing Kit (Amersham) with 0.1 – 1
µg DNA and 10 pmol primers, the ABI BigDye kit version 3.1, on a ABI 3730 48-capillary
sequencer and 36 cm capillaries which was operated by the MPI of Biochemistry Core
Facility.
Polymerase chain reaction (PCR)
PCR was performed according to standard protocols. Amplification was performed using Pfu
Turbo (Stratagene) or Vent DNA polymerases (NEB) in a total volume of 50 µl. Amplification
was carried out with 30 cycles of melting (95°C for 30 s), annealing (55°C for 30 s) and
amplification (72°C for 60 s per 1 kb of DNA).
DNA mutagenesis
To generate point mutants, primers were designed that flanked the site to be mutated with 10-
15 nt overhangs on either side. The melting temperature of the primer was calculated by Tm =
81.5 + [0.41(GC)] – [675/N] - [% of mismatch]. PCR amplification was performed using Pfu
Turbo (Stratagene) or Vent DNA polymerases (NEB) in a total volume of 50 µl. Amplification
was carried out with 18 cycles of melting (95°C for 30 s), annealing (Tm - 5°C for 60 s) and
amplification (68°C for 60 s per 1 kb of DNA). PCR products were subsequently digested with
10 U DpnI for 1-3 h, heat inactivated and transformed into bacteria.
RT-PCR
To amplify sequences from mRNA an One-Step RT-PCR kit was used (Qiagen) according to
the manufacturer!s recommendations.
Generation of siRNAs from T7 transcribed cDNAs by digestion with Dicer
To generate siRNAs, primers were designed that amplify 300-600 bp of a cDNA of interest.
Both sense and antisense primers contained a 5! T7 phage promoter extension
(TAATACGACTCACTATAGG) that allows amplification of sense and antisense RNA in the
same reaction by T7 RNA polymerase (T7 RiboMAX Express, Promega). dsRNA was then
purified using RNeasy mini kit (Qiagen), quantified (1 OD260 nm = 40 µg RNA) and purified
dsRNA digested with 1 U recombinant Dicer (Stratagene) per µg of RNA for 18-20 h at 37°C.
Dicer products were purified using a modification of the RNeasy kit protocol by Andreina Byrd
and Carsten Watzl (Institut für Immunologie, Universität Heidelberg). Briefly, 1% ß-
mercapoethanol was added to buffer RLT (RLT-!) and an 100 µl of RLT-! added to 100 µl of
the Dicer reaction. Hereafter 100 µl of isopropanol were added, loaded on a RNeasy spin
column and the mixture centrifuged (14000 g, 30 s, RT). In this step small dsRNA does not
bind to the matrix and ends up in the flow through. The flow through was recovered and mixed
with 200 µl of isopropanol and again loaded on a spin column and centrifuged. Here also
small dsRNA binds to the matrix. Subsequent steps are equivalent to the manufacturer!s
protocol.
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6.2  Protein biochemistry
Determination of protein concentrations in aqueous solutions
In most cases the Bradford assay was used to determine protein concentrations. To obtain a
Bradford solution Coomassie Blue G (100 mg) was dissolved in 50 ml of methanol. The
solution was added to 100 ml of 85% H3PO4, and diluted to 200 ml with water. Concentrations
were determined in an OD590 nm reading window of 0.1 to 2 using standard spectrophoto-
meters (Eppendorf).
SDS-polyacrylamide gel electrophoresis
Proteins were resolved using either a Laemmli (Tris/glycine) gel system or a Bis-Tris-buffered
gel system. For both systems gradient gels were prepared using a standard two-chamber
mixer and a peristaltic pump.
Aqueous solutions of proteins or cleared cell lysates were mixed with 5-fold concentrated
SDS sample buffer (312 mM Tris [pH 6.8], 50% glycerol, 10% SDS, 25% ß-mercaptoethanol
and 0.01% bromophenolblue) boiled at 95°C for 5 min and transferred to the slots of the gel.
Precision Plus Protein Standard (Biomol) was used as a marker for relative molecular size of
proteins.
Tris/glycine gels were prepared as 4-20% gradient gels with 50 ml of the 4%-solution
containing 6.7 ml 30% acrylamide/0.8% bisacrylamide, 12.5 ml 1.5 M Tris [pH 8.8], 500 µl
10% SDS and 29.8 ml dH2O; and 50 ml of the 20%-solution containing 7.5 g sucrose, 33.3 ml
30% acrylamid/0.8% bisacrylamid, 12.5 ml 1.5 M Tris [pH 8.8], 500 µl 10% SDS. To start
polymerization 1% v/v of a 10% APS solution and 0.1% v/v TEMED were added. After the
separating gradient gel had solidified, a 3.75% stacking gel was poured on top with 10 ml
containing 1.25 ml 30% acrylamid/0.8% bisacrylamid, 2.5 ml 0.5 M Tris [pH 6.8], 6 ml dH2O,
100µl 10% SDS. To start polymerization 1% v/v of a 10% APS solution and 0.1% v/v TEMED
were added. Gel electrophoresis was carried out in a buffer containing 50 mM Tris, 384 mM
glycine and 0.1% SDS. Electrophoresis was performed with the current not exceeding 3.5
mA/cm.
Bis-Tris gels were prepared as 4-17.5% gradient gels with 50 ml of the 4%-solution containing
36.11 ml dH2O, 7.25 ml 7-fold Bis-Tris/HCl concentrate (2.5 M Bis-Tris, 1.5 M HCl), 6.64 ml
30% acrylamid/0.8% bisacrylamid and 50 ml of the 17.5%-solution containing 9.8 ml dH2O,
3.75 ml 65% sucrose solution, 7.25 ml 7-fold Bis-Tris/HCl concentrate, 29.1 ml 30%
acrylamid/0.8% bisacrylamid. To start polymerization 1% v/v of a 10% APS solution and 0.1%
v/v TEMED were added. Gels were poured without stacking gels and electrophoresis was
carried out with MOPS running buffer prepared from a 20-fold concentrate (1 M MOPS, 1 M
Tris, 69.3 mM SDS, 20.5 mM EDTA). Electrophoresis was performed with the current not
exceeding 3.5 mA/cm.
Gels that were not used for immunoblotting were stained with 0.1% Coomassie Brilliant Blue
R-250 dissolved in 25% methanol, 10% acetic acid. Gels were destained (25% methanol/8%
acetic acid) until sufficient contrast was obtained.
Immunoblot
Proteins resolved by SDS-PAGE were transferred onto PVDF membranes (Millipore) using a
tankblot device (Hoefer). Transfer was carried out in a cold room or using a water-cooling for
4-5 h in transfer buffer (25 mM Tris, 192 mM Glycin, 0.01% SDS and 20% methanol) with a
constant current of 400 mA. Prior to antibody hybridisation the membrane was taken out of
the blotting device, stained with Ponceau S, destained and washed with TBST (25 mM Tris
[pH 7.5], 137 mM NaCl, 2.6 mM KCl, 0.05% Tween-20). Afterwards membranes were blocked
using 5% w/v skim milk powder in TBST (1 h, RT) on a rotating platform (50-100 rpm).
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Primary and secondary antibody were hybridized in 5% w/v skim milk powder in TBST for 1-3
h or overnight followed by extensive washing of the membrane with TBST after each
hybridization step (3-5 times, 5 min, RT). Secondary HRP-conjugated antibodies were used in
combination with chemi-luminiscence detection (ECL-Plus/ECL-Advanced Westernblot
Detection Kit, Amersham) on conventional films (Kodak) or CCD cameras (Fuji). Alternatively
self-prepared solutions for chemiluminescence detection were used. For this purpose, a 90
mM stock solution of coumaric acid and a 250 mM stock solution of luminol (both in DMSO)
were prepared. For detection the blot membrane was coated with a solution prepared from
2.6 µl of 35% H2O2, 25 µl of the coumaric acid stock solution and 50 µl of the luminol stock
solution added to 10 ml of 100 mM Tris [pH 8.5].
To reprobe blots, membranes were stripped by incubation of the membrane in stripping buffer
(63.5 mM Tris [pH 6.8], 2% SDS, 100 mM ß-mercaptoethanol) for 30 min at 65°C.
Preparation of cell lysates
Lysates from cultured mammalian cells were prepared by either scraping cells from plates
using a rubber policeman (for HeLa and U2OS cells) or by pipetting (HEK cells). Cells were
then centrifuged (300 g, 3 min, RT) and washed in PBS. (Occasionally, cell pellets were
stored at –20°C.) Pellets were resuspended in 2-5 pellet volumes of IP buffer (50 mM HEPES
[pH 7.2], 150 mM NaCl, 2 mM EDTA, 0.1% NP-40) supplemented with 1 mM PMSF,
Complete protease inhibitors (Roche) and additionally 1 mM NEM if ubiquitylation should be
preserved. Suspensions were incubated on ice for 30 min. Debris was removed by
centrifugation (10 min, 16000g, 4°C). Hereafter an appropriate amount of the supernatant
representing the cell lysate was mixed with SDS loading buffer.
Alternatively – to prevent BRUCE binding to factors released from ruptured mitochondria – a
lysis buffer was used that allows preservation of mitochondria (20 mM HEPES [pH 7.2], 10
mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 250 mM sucrose, 0.05% digitonin, 1 mM PMSF and
Complete protease inhibitors).
Protein affinity-purifications and co-immunoprecipitations
To 500-1000 µl of cell lysate (5-10 mg total protein) 5-10 µg of antibody or alternatively 25-40
µl of antibody-agarose slurry was added (for HA, myc and FLAG). Coupled antibodies were
incubated for 1-3 h in cell lysates (4°C) on a rotating wheel. In the case of non-coupled
antibodies the mixture was incubated for 1 h (4°C) and subsequently 25-40 µl of protein G- or
protein A-agarose (Amersham) were added and incubation continued for another 2 h.
Afterwards beads were washed five times with IP buffer and bound proteins eluted by either
boiling the beads in SDS loading buffer or by addition of antigenic peptides (0.1 mg/ml FLAG-
peptide).
In vitro ubiquitylation
In vitro ubiquitylation reactions were performed by incubating 10 µM ubiquitin (bovine
ubiquitin, SIGMA), 100 nM recombinant E1, 10-100 µM of the respective substrate protein
and ! 1 µM WT or mutant FLAGBRUCE in a final volume of 30-50 µl ubiquitylation buffer (10
mM HEPES [pH 7.4], 5 mM MgCl2, 5 mM ATP, 0.1 mM DTT) at 30°C for 1 h. Alternatively
32/33P-"-ATP-labeled ubiquitin was prepared and reactions were analyzed by autoradiography.
To label ubiquitin a GST-ubiquitin construct was expressed and purified from E. coli that
contains a thrombin cleavage site downstream of the GST that is followed by a canonical PKA
phosphorylation site. Phosphorylation was performed in phosphorylation buffer (25 mM Tris
[pH 7.5], 50 mM NaCl, 10 mM MgCl2) using 50 µl of glutathione beads (Amersham), 50 µg of
the fusion protein, 1 µl of a PKA solution (catalytic subunit, SIGMA, dissolved at 10 U final
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concentration in 40 mM DTT) and 2 µl 32/33P-!-ATP (at 10 µCi/µl) on ice for 1 h. Afterwards
beads were washed 4 times with phosphorylation buffer and proteins were cleaved off the
matrix using thrombin (30°C, 1 h). The supernatant was removed using a thin needle.
Thrombin was inactivated by incubation at 75°C for 30 min. As a second alternative an ATP-
regenerating system was used instead of 5 mM ATP in the ubiquitylation buffer. This system
comprised 2 mM ATP, 10 mM creatine phosphate, 0.6 U/ml creatine phosphokinase and 0.6
U/ml inorganic pyrophosphatase.
In vitro phosphorylation
Phosphorylations were performed using immunopurified proteins. 2 µg of each protein were
incubated with 10 µCi 32/33P-!-ATP at 30°C for 30 min. Proteins were resolved using SDS-
PAGE, gels were Coomassie-stained (see above) fixed (25% methanol, 10% acetic acid, 2%
glycerol), dried and exposed using BioMax films (Kodak). To preserve phosphorylations 20
mM NaF and 200 µM Na3VO4 were added during lysis and purification.
Expression and purification of recombinant proteins from E. coli
GST- as well as His6-fusion proteins were expressed in E. coli BL21(DE3)/RIL. Cultures were
inoculated and shaken at 37°C in LB with the appropriate antibiotic. When OD600 nm reached
0.4-0.7, cultures were induced by adding 1 mM IPTG and further shaken either 3-5 h at 37°C
or overnight at RT. In the case of expression problems, 2-fold TY medium (16 g tryptone, 10 g
yeast extract, 5 g NaCl, ad 1 l dH2O and adjusted to pH 7.0 with NaOH) was used instead of
LB.
In the case of GST-fusion proteins, cells were pelleted (6000 g, 10 min, 4°C) and
resuspended in 5-10 pellet volumes of lysis buffer (20 mM Tris [pH 7.5], 150 mM NaCl, 2 mM
EDTA, 1 mM PMSF, 1mM DTT, 1 mg/ml lysozyme per g of pellet) and incubated on ice for 30
min. DNA was sheared by sonification (Sonopuls HD2200, Bandelin). Lysates were
centrifuged (30 min, 20000g, 4°C) to remove unbroken cells and debris. The supernatant was
applied to a glutathione-sepharose column (Amersham). The column was washed with 25
column volumes GST washing buffer 1 (20 mM Tris [pH 7.5], 500 mM NaCl, 2 mM EDTA, 1%
Triton-X-100, 1mM DTT), 10 column volumes of GST washing buffer 2 (20 mM Tris [pH 7.5],
150 mM NaCl, 2 mM EDTA, 0.1% Triton-X-100, 1mM DTT) and 10 column volumes of GST
washing buffer 3 (20 mM Tris pH 7.5, 150 mM NaCl, 2 mM EDTA und 1mM DTT). Bound
proteins were eluted with 5 column volumes GST elution buffer (10 mM Tris [pH 8.0], 10 mM
glutathione), dialyzed against appropriate buffers, concentrated and 10% glycerol was added
prior to freezing in liquid nitrogen.
In the case of His6-fusion proteins, pellets were resuspended in Ni-NTA buffer (50 mM
NaH2PO4 [pH 8.0], 300 mM NaCl, 20 mM imidazole, 2 mM PMSF, Complete protease
inhibitors (Roche), 1 mg/ml lysozyme per g of pellet) and incubated on ice for 30 min. Cleared
lysates were applied to Ni-NTA agarose columns (Qiagen), columns washed with 50 column
volumes of Ni-NTA buffer and bound proteins eluted using 5 column volumes of Ni-NTA
elution buffer (50 mM NaH2PO4 [pH 8.0], 150 mM NaCl, 250 mM imidazole).
To further purify fusion proteins, a second purification step of anion exchange
chromatography was occasionally added. Proteins were dialysed against ResourceQ buffer
(50 mM Tris [pH 7.5], 80 mM NaCl, 0.1 mM EDTA) and applied to a ResourceQ column
(Amersham) using a FPLC system (Pharmacia). Proteins were eluted by gradually elevating
NaCl concentration (80 mM to 1 M). Fractions containing the respective protein were pooled,
dialyzed and frozen as described above.
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Covalent coupling of proteins to CNBr sepharose
Pre-activated CNBr sepharose 4 Fast Flow (GE Healthcare) was resuspended in 1 mM HCl
for 30 min. The gel was transferred to a Buchner funnel and washed with 15 gel volumes of
cold 1 mM HCl and afterwards with coupling buffer (0.5 M NaCl, 0.1 M NaHCO3 [pH 8.3]). The
protein to be coupled to the beads was also dialyzed against coupling buffer. The washed gel
and the protein solution were mixed and incubated either overnight at 4°C or for 3-4 h at room
temperature. After coupling the supernatant was removed and any uncoupled sites were
blocked by incubation with 1 M ethanolamine [pH 9.0] for 2 h at room temperature. To remove
ethanolamine, the gel was washed extensively using PBS. Gels were stored at 4°C and 0.1%
azide was added to allow for prolonged storage.
Preparation of ubiquitin activating enzyme E1
A CNBr-sepharose column coupled with ubiquitin was prepared as described above. In
parallel His6-Uba1 was expressed in bacteria and purified via Ni-NTA chromatography. The
ubiquitin column was then equilibrated with 10 column volumes equilibration buffer (50 mM
Tris [pH 7.2], 2 mM ATP, 5 mM MgCl2, 0.2 mM DTT), the prepurified E1 in equilibration buffer
applied and the column washed with 10 column volumes each of equilibration buffer, KCl
buffer (50 mM Tris [pH 7.2], 1 mM KCl), and wash buffer (50 mM Tris [pH 7.2]). E1 was
eluted in five fractions of 2 ml with DTT elution buffer (50 mM Tris [pH 7.2], 10 mM DTT). The
column was cleaned, washed and prepared for storage by applying 10 column volumes each
of pH 9 wash buffer (50 mM Tris [pH 9.0], 2 mM DTT), regeneration buffer (50 mM Tris [pH
9.0], 1 M KCl), and storage buffer (50 mM Tris [pH 7.2], 0.02% NaN3).
TCA precipitation of proteins
Proteins in solution were precipitated by addition of an equal volume of 10% TCA and
incubation on ice for 10 min. Precipitated material was pelleted by centrifugation (16000 g,
4°C, 10 min). Pellets were washed with acetone (-20°C), dried and resuspended in SDS
loading buffer.
Denaturating Ni-NTA precipitation
Transiently transfected HEK 293T cells were harvested and pellets washed once in PBS.
Cells were lysed in 6M guanidine-HCl, 0.1 M NaH2PO4, 0.1% Tween 20, 0.01 M Tris [pH 8.0].
To shear DNA, lysates were briefly sonicated. An aliquot of the lysate was kept for TCA
precipitation. The remaining lysate was incubated with Ni-NTA agarose beads (Qiagen) for 3-
5 h. Beads were washed 5 times with 8 M urea, 0.1 M NaH2PO4, 0.1% Tween 20, 0.01 M Tris
[pH 8.0], and twice with PBS, 0.01% Tween 20. TCA precipitates and beads were boiled in
loading buffer and subjected to SDS-PAGE and immunoblotting.
Antibodies
Antibodies used in this study were mouse monoclonal anti-BRUCE (clone 4), anti-MKLP1
(clone 24), anti-Cdk1 (clone 1), anti-p230 trans Golgi (clone 15), anti-GGA3 (clone 8), anti-
Rab8 (clone 4), anti Rab-11 (clone 47, all BD Biosciences), anti-!-tubulin (clone B-7), anti-"-
tubulin (clone C-11), anti-Plk-1 (clone F-8), anti-HA (clone F-7), anti-GFP (clone B-2), anti-
phosphotyrosine (clone PY99), anti-survivin (clone D8), anti-lamin A/C (clone 636), anti-c-Myc
(clone 9E10), anti-p21 (clone 187), anti-p53 (clone DO-1), anti-MEK1 (clone H-8, all Santa
Cruz), anti-Aurora B (Biozol), anti-rSec6 (clone 9H5), anti-rSec8 (clone 14G1, both abcam),
anti-FLAG (clone M2, SIGMA), goat polyclonal anti-Rab11, rabbit polyclonal anti-MKLP1 (both
Santa Cruz), anti-FLAG (SIGMA), polyclonal sheep anti-TGN46 (AbD Serotec). FITC, TRITC,
AMCA and Cy3-labeled secondary sheep/rat anti-mouse, donkey anti-rabbit antibodies were
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from Jackson ImmunoResearch. Antisera recognizing BRUCE N- and C-termini were
generated by immunizing rabbits with His6-fusion proteins as shown in Figure 7 (see also
Hauser et al., 1998 and Bartke et al., 2004). For standard applications antibodies were diluted
1:750 to 1:2000 for immunoblot analysis and 1:50 to 1:200 for immunofluorescence detection.
6.3  Cell biology
Cell lines
HEK 293 tumorigenic human epithelial kidney cell line, hypotriploid with a modal
chromosome number of 64, contains the left end segment of the
adenovirus 5 genome from nts 1 to 4344 which is integrated into
chromosome 19 (19q13.2)
HEK 293T a highly transfectable derivative of the 293 cell line into which the
temperature sensitive allele for SV40 T-antigen was inserted
HeLa human epithelial cervix adenocarnoma, HeLa cells have been reported to
contain human papilloma virus 18 (HPV-18) sequences
HeLa S3 HeLa S3 is a clonal derivative of the parent HeLa line. S3 was cloned in
1955 by T.T. Puck, P.I. Marcus, and S.J. Cieciura. This line can be
adapted to grow in suspension.
U2OS human osteosarcoma, chromosomally highly altered, with chromosome
counts in the hyper-triploid range
PC12 derived from transplantable rat adrenal gland pheochromo-cytoma, the
cells respond reversibly to NGF by induction of the neuronal phenotype
hTERT-RPE1 human retinal pigment epithelial cell line (Clontech) that stably expresses
telomerase, normal diploid genotype, non-tumorigenic
Plasmids for protein expression in mammalian cells
Plasmids of the pCMV-Tag2/3/4 (Stratagene) and pcDNA3.1/pcDNA3.1-Myc-His (Invitrogen)
series as well as pCI/pCI-Neo (Promega), pEGFP-F, pEGFP/CFP/ YFP, and pDsRed-
monomer vectors (Clontech) were used.
Cloning of BRUCE and engineering of mutants and truncations was described previously
(Bartke et al., 2004). BRUCE cDNAs were expressed from pCI (Promega) or pCMV2
(Stratagene) as were FLAG-tagged cDNAs of luciferase, BRUCE 1-522 and BRUCE 1-648.
GFP-BRUCE-C (amino acids 4711-4845) was cloned into pEGFP-C1 (Clontech) using an
internal XhoI site (bp 14135) in the full length cDNA and an PCR-introduced BamHI site
downstream of the stop codon. Nrdp1 was amplified from HeLa mRNA using primers that
generate an N-terminal FLAG-epitope tag and cloned into pCI (Promega). GFP-Rab8 was a
gift of J. Peranen (Hattula and Peranen, 2000), GFP-Rab11 was obtained from M. Zerial
(Sönnichsen et al., 2000), GFP-ubiquitin was a gift of N. Dantuma (Dantuma et al., 2006), HA-
epitope tagged rat albumin was a gift of D. LeBel (Daull et al., 2004) and FLAG-epitope
tagged UBPY and its mutant were from H. Alwan (Alwan and van Leeuwen, 2007). His6- and
HA-epitope tagged ubiquitin were described previously (Treier et al., 1994).
siRNA sequences and transfection of siRNA
siRNA sequences were designed using rules previously described (Jagla et al., 2005).
siRNAs were 19- or 21-mer duplexes (MWG) with 3! TT-overhangs. siRNA duplexes targeting
BRUCE in human cells were oligo_1 CUCAGGAGAGUACUGCUCA, oligo_2 GAACCAGAA
GGACUUACUC,   oligo_3 (as in Ren et al. 2005) GUUUCAAAGCAGGAUGAUG, siRNA tar-
geting lamin A/C CUGGACUUCCAGAAGAACA, p53 (Warburton et al., 2005) GGACAUACC
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AGCUUAGAUU, p21 GUCAGAACCGGCTGGGGAU, survivin (Lens et al., 2003) GAGGCUG
GCUUCAUCCACU and MKLP1 (Liu et al., 2004) GGGCUUUCCUGAUCAAGAGUG.
Propagation of mammalian tissue culture cells
MEF, hTERT-RPE1, U2OS, HeLa and HEK 293/T cells were maintained at 37°C, 7.5% CO2
in DMEM (SIGMA) supplemented with 10% FCS (referred to as normal culture medium). To a
15 cm dish 20 ml of culture medium were added, to a 10 cm dish 10 ml, and to a 6-well cavity
3 ml.
Preparation of large scale suspension cultures for cell cycle arrests
HeLa S3 cells were grown on standard cell culture plastic dishes until 75% confluence was
reached. Cells were then dislodged by trypsin treatment and transferred into spinner flasks
(Bellco). Cells were arrested by incubation with either 100 ng/ml nocodazole (arresting cells in
prometaphase), 1 mM taxol (arresting cells at G2/M) or 5 mM hydroxyurea (arresting cells at
G1) for 16 h.
Transfections
Transient transfections were performed in 10 cm dishes (HEK 293T) or 6-well plates (HeLa,
U2OS, hTERT-RPE1) using calcium phosphate or lipofection protocols. Furthermore U2OS
cells were also transfected by electroporation using the Nucleofector kit (Amaxa).
For standard calcium phosphate transfections (HEK 293T) 2 x 106 cells were seeded in a 10
cm dish one day before transfection. Transfection mixes were prepared in 2 ml Eppendorf
tubes comprising 12-15 µg plasmid DNA adjusted to 450 µl with dH2O. To this solution 50 µl
of a 2.5 M CaCl2-solution were added drop wise and the mix was agitated vigorously.
Hereafter 500 µl of 2-fold HBS solution (16.012 g NaCl, 0.744 g KCl, 9.532 g HEPES, 0.248 g
Na2HPO4 ad 1 l dH2O and adjusted to pH 7.05 with NaOH) were added dropwise and the mix
again agitated vigorously. The transfection mixture was incubated for 3 min at RT and added
to the cells. Cells were then incubated for 5 h with the transfection mix under normal culture
conditions and the medium was hereafter replaced with fresh medium. After an additional 30-
50 h of incubation, cells were harvested.
To transfect HeLa cells, a modification of the standard calcium phosphate protocol was used.
After seeding 1.5 x 105 cells per 6-well cavity the day prior to transfection, the normal culture
medium was exchanged for transfection medium (DMEM supplemented with 10% heat
inactivated horse serum, 2.5 µg/ml 25-hydroxy-cholesterol) right before the transfection. The
transfection solution was prepared as described above apart from using a BES buffered
solution instead of the HBS buffered one (2-fold BES solution: 50 mM BES [pH 6.95], 280 mM
NaCl und 1.5 mM Na2HPO4). Only 300 µl of the total 1000 µl of transfection mix were added
to one cavity of a 6-well plate. Cells were then incubated for not more than 4 h with the
transfection mix under normal culture conditions and the medium was hereafter replaced with
fresh normal culture medium. After an additional 12-30 h of incubation, cells were harvested.
Nota bene that the pH of HBS/BES solutions has to be experimentally adjusted to allow high
transfection rates.
U2OS and hTERT-RPE1 cells used for siRNA experiments were transfected by
electroporation. A confluent plate of cells was split 1:2 the day before transfection. On the day
of transfection cells were dislodged by trypsination and 1 x 106 cells per transfection were
pelleted by centrifugation. The supernatant was removed and the pellet resuspended in 100 µl
Amaxa nucleofector solution V per transfection. siRNA duplexes obtained from MWG were
transfected at a final concentration of 100 nM. The cell suspension and the siRNAs were
mixed in the electroporation cuvette and the nucleofector device with a preset program
(U2OS, ATCC) used for applying the electroporation pulse. After transfection 1 x 106 U2OS
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cells were seeded in either 10 cm dishes or 1 x 105 cells in 35 mm dishes. Cells used in
immunofluorescence microscopy were seeded on glass coverslips (Roth).
Additionally HeLa and U2OS cells were frequently also transfected by lipofection. 1 x 105 cells
were seeded in a cavity of a 6-well plate the day before transfection. To transfect plasmid
DNA, 3 µg of the respective DNA were added to 200 µl of OptiMEM medium (Invitrogen) and
at the same time 3 µl of lipofectamine 2000 (Invitrogen) were added to a separate vial also
containing 200 µl of OptiMEM medium. Both solutions were incubated for not more than 5 min
and then united, mixed and incubated for another 15 min. This mix was added to cells and
cells were incubated for up to 4 h with the transfection mixture. Subsequently cell culture
medium was replaced with normal culture medium and cells were harvested 12-30 h after
transfection.
To transfect siRNAs, 3 µg of the respective dsRNAs were added to 200 µl of OptiMEM
medium (Invitrogen) and at the same time 3 µl of oligofectamine (Invitrogen) were added to a
separate vial also containing 200 µl of OptiMEM medium. Both solutions were incubated for
not more than 5 min and then united, mixed and incubated for another 15 min. During this
incubation the cell culture medium was replaced with OptiMEM. The transfection mix was
then added to cells and cells were incubated for up to 4 h with the transfection mixture.
Subsequently, cell culture medium was replaced with normal culture medium and cells were
harvested 30-50 h after transfection.
Generation of stable cell lines
HeLa cells stably expressing HA-rAlb and U2OS cells stably expressing GFP-Rab8, GFP-
Rab11 and GFP-ubiquitin were generated by transfecting cells in a 6-well format using
lipofection. One day after transfection cells were replated in 15 cm dishes and 750-1000 µg/ml
G418 (SIGMA) were added to the normal culture medium. Afterwards medium was
exchanged every 2-4 d and cells were cultivated until visible colonies appeared (which took
approximately 3-4 weeks). Then either a polyclonal cell line was generated by simply
trypsinizing all clones and replating. Alternatively colonies were screened for expression of
the protein of interest and single colonies were picked from the plate using trypsin-soaked
cloning discs and these were then transferred to the cavities of a 12-well plate and expanded.
Flow cytometry
To obtain DNA histograms by propidium iodide staining cells were harvested by either
scraping or trypsination, centrifuged and the pellets washed with PBS. Cell pellets were then
resuspended in 300 µl PBS and while mildly agitating the suspension 700 µl of –20°C ethanol
were added drop wise. Cell suspensions were then incubated for at least 4 h at 4°C.
Thereafter, cells were pelleted, washed with PBS, resuspended in staining solution (100 µg/ml
propidium iodide, 200 µg/ml RNase A in PBS) and incubated for 30-60 min in the dark. Cell
cycle profiles were obtained using a FACSCalibur system and CELLQuest analysis software
(Becton Dickinson). Transfection status of cells was checked by assessing the GFP signal
either through co-transfection of a membrane anchored GFP-variant (EGFP-F, which contains
the Ras prenylation signal) or by the signal of the GFP-fusion protein of interest.
Immunofluorescence and live cell video microscopy
Immunofluorescence was performed according to standard protocols after fixation in
methanol. Cells were carefully washed with PBS and PBS was removed via vacuum
aspiration. Cells were then placed in a -20°C freezer and precooled methanol was added (-
20°C, 3 min). After incubation methanol was removed by aspiration and the cells were dried
for 3-5 min. Rewetting was performed using TBST followed by blocking with TBST
supplemented with 2% BSA (1 h, RT, mild shaking). Coverslips (24 x 24 mm, Roth) were then
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placed on Parafilm (Pechiney) in a humidified chamber. On each coverslip a 1:50 to 1:200
dilution of primary antibody in TBST + 2% BSA was pipetted. Coverslips were incubated for 1-
2 h and then washed three times in TBST (3 min each, RT). After incubation with secondary
antibody in a procedure corresponding to that with the primary, cover slips were mounted
using glycerol-based mounting medium (0.5% p-phenylenediamine, 20 mM Tris [pH 8.8], 90%
glycerol – the p-phenylenediamine is dissolved by bubbling nitrogen into the mixture for 3-4
h).
Mouse testis was obtained as frozen tissue slices on glass support (BioChain). Slices were
rehydrated in TBST and processed for immunofluorescence as described above.
Images were acquired on a Leica DM RXA microscope equipped with a Hamatsu ORCA-ER
camera. Image acquisition and deconvolution of images was carried out using Openlab
software. Confocal laser scanning microscopy was performed with a Leica TCS SP2 confocal
scanning microscope. For fluorescence live cell video microscopy and photobleaching
experiments, U2OS cells were cultured in 35 mm µ-dishes with No. 1.5 bottom (ibidi). Live cell
video microscopy and FRAP were carried out on an AppliedPrecision DeltaVision RT system
equipped with a quantifiable laser module. After photobleaching of the GFP fluorescence with
25-50% laser intensity images were obtained every second during a time frame of 3 min.
Fluorescence intensities were measured and quantified and images processed using
SoftWorx software (AppliedPrecision). For live cell video microscopy DIC or phase and
fluorescence images were taken every 1-5 min over a time frame of 10 to 48 h.
Neuronal differentiation of PC-12 cells
PC-12 cells were maintained in RPMI 1640 (Invitrogen) supplemented with 10% fetal bovine
serum and 5% horse serum at 37°C, 7.5% CO2. Cells were resuspended using a glass pipette
with narrow opening that was prepared by melting the opening with the flame of a Bunsen
burner. For differentiation cells were grown in RPMI 1640 supplemented with 1% horse serum
and 100 ng/ml NGF (NGF-7S, SIGMA) for three days and processed for immunofluorescence
microscopy.
Mouse embryonic fibroblasts
MEFs were generated from E11.5 to E14.5 embryos by shearing the embryo in a 18/19G
needle in 5 ml DMEM + 10% FCS + 100 U/ml penicillin/streptomycin. Embryo fragments were
plated, incubated for 1 day and adhering cells and embryonic bodies trypsinized. After
sedimentation of embryonic bodies the fibroblast-rich supernatent was plated. Immortalization
was carried out using a so-called 3T3 protocol. Every three days 3 x 105 cells were replated
on a 6 cm dish. During growth crisis cells were not replated, instead only the medium was
exchanged.
6.4  Software
Resources of the National Center for Biotechnology Information (NCBI) were used for data
base searching and retrieval of sequences. Analysis of DNA and proteins was carried out
using DNA Star package (DNA Star). Texts, graphs and tables were prepared using Excel
and Word (Microsoft), images were prepared using Photoshop and Illustrator (Adobe). Gels
and films were scanned on a Duoscan T1200 (AGFA) and on a Scan Maker i900 (Mikrotek).
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Cytokinesis involves the formation of a cleavage fur-
row, followed by abscission, the cutting of the mid-
body channel, the final bridge between dividing cells.
Recently, the midbody ring became known as central
for abscission, but its regulation remains enigmatic.
Here, we identify BRUCE, a 528 kDa multifunctional
protein, which processes ubiquitin-conjugating ac-
tivity, as a major regulator of abscission. During cyto-
kinesis, BRUCE moves from the vesicular system to
the midbody ring and serves as a platform for the
membrane delivery machinery and mitotic regula-
tors. Depletion of BRUCE in cell cultures causes
defective abscission and cytokinesis-associated
apoptosis, accompanied by a block of vesicular tar-
geting and defective formation of the midbody and
the midbody ring. Notably, ubiquitin relocalizes
from midbody microtubules to the midbody ring dur-
ing cytokinesis, and depletion of BRUCE disrupts
this process. We propose that BRUCE coordinates
multiple steps required for abscission and that ubiq-
uitylation may be a crucial trigger.
INTRODUCTION
Cytokinesis is the concluding step of cell division by which the
prospective daughter cells separate their cytoplasmic volumes.
This process starts by contraction of a plasma-membrane-an-
chored actomyosin ring, leading to the formation of a cleavage
furrow (Eggert et al., 2006). By the end of furrowing, the dividing
cells are connected by a narrow, tubular intercellular bridge,
which contains the midbody consisting of tightly bundled anti-
parallel microtubules, which embrace a phase-dense circular
structure called midbody ring (or occasionally Flemming body).
At the final stage of cytokinesis, in a process termed abscission,
this bridge is cleaved, and two daughter cells are formed.
At the midbody, several cytokinesis-coupled events converge,
including degradation of cell cycle regulators, cytoskeleton rear-
rangements, membrane traffic, and plasma membrane remodel-
ing. Recent reports demonstrate a direct involvement of the
traffic-regulating GTPases Arf1, Arf6 and Rab11 in cytokinesis832 Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc.(Albertson et al., 2005). Arf6 and Rab11 are coupled to the exo-
cyst complex, which seems crucial for the proper targeting of
vesicles to the site of abscission. Interestingly, some types of
vesicles seem to arrive at the midbody ring chiefly from only
one of the prospective daughter cells (Gromley et al., 2005), sug-
gesting an intrinsic asymmetric element in cytokinesis. The fac-
tors that control targeting to the midbody and guide midbody
ring assembly are largely unknown, but one protein required
for exocyst targeting to the midbody ring was recently identified
as centriolin, which also binds to the maternal centriole (Gromley
et al., 2003, 2005).
Previous studies revealed an emerging role of ubiquitylation
and proteasomal activity in regulating cytokinesis (Pines and
Lindon, 2005). Notably, ubiquitin-activating enzyme E1 and the
proteasome are concentrated on midbodies (Grenfell et al.,
1994; Wojcik et al., 1995), and both proteolytic and non-proteo-
lytic functions of ubiquitin seem to play a role. Chromosomal
passenger proteins, the kinase Aurora B and the baculovirus in-
hibitor of apoptosis repeat (BIR)-containing protein survivin, as
well as the Polo-like kinase Plk1 (Lindon and Pines, 2004) are
degraded just before or during cytokinesis (Lindon and Pines,
2004; Sumara et al., 2007). Proteasome inhibition after ana-
phase onset results in incomplete cytokinesis (Straight et al.,
2003), and, interestingly, combined inhibition of Cdk1 and pro-
teasomes can revert late cytokinesis to an apparent preana-
phase state (Potapova et al., 2006). A non-proteolytic role of
ubiquitin in cytokinesis is suggested by the fact that the ubiqui-
tin-controlled endosomal sorting complex required for transport
(ESCRT) is necessary for abscission (Carlton and Martin-Ser-
rano, 2007).
Proteins harboring a BIR domain (BIRPs) are primarily known
for their function to protect cells against apoptosis by their activ-
ity to inhibit caspases and proapoptotic factors through binding
and ubiquitin-dependent degradation (Verhagen et al., 2001).
However, BIRPs like survivin and cIAP1 are also crucial for cell
cycle events and cytokinesis (Li et al., 1999; Samuel et al.,
2005). Here, we report that another conserved BIRP, the 528
kDa protein BRUCE (also known as Apollon or BIRC6), is a crucial
regulator for the final stages of cytokinesis. BRUCE is a multi-
functional protein owing to the presence of different functional
domains and multiple binding partners (Bartke et al., 2004;
Hauser et al., 1998). Close to its amino (N)-terminus, BRUCE har-
bors a single BIR domain, which most closely resembles the BIR
of survivin. BRUCE can inhibit caspases through this domain,
Figure 1. BRUCE Shows a Cell Cycle-Dependent Localization
(A) BRUCE localizes to mitotic structures. Immunofluorescence (IF) of HeLa cells stained with anti-Plk-1 (red) and anti-BRUCE (green) and DAPI to visualize DNA.
The box outlined in yellow shows the enlarged midbody region of the cytokinesis merge. The scale bar represents 10 mm.
(B) BRUCE localizes to the midbody ring of U2OS cells. The midbody region is shown with anti-Aurora B (red) and anti-BRUCE (green) staining. The scale bar
represents 1 mm.
(C) Localization of BRUCE to the midbody ring depends on MKLP1. Top: lysates from siRNA-transfected HeLa cells were analyzed by BRUCE, MKLP1,
and a-tubulin immunoblotting. Bottom: midbodies of siRNA-treated cells are shown stained with anti-a-tubulin (red) and anti-BRUCE (green). The scale bar
represents 1 mm.
(D) BRUCE is found on midbody ring remnants. U2OS cells were stained with anti-BRUCE (green) and anti-golgin p230 (red), and DAPI (blue). The scale bar
represents 10 mm. The top z-stack on the left shows a midbody ring remnant in the plane of the plasma membrane (shown enlarged on the left).
(E) Relationship between BRUCE and constitutive secretory cargo. HeLa cells stably expressing HA-albumin are shown in different cell cycle stages with anti-HA
(green) and anti-BRUCE (red) staining. The scale bar represents 10 mm. The arrow shows the position of the midbody ring.and has antiapoptotic potential (Bartke et al., 2004). However, its
antiapoptotic function may be particularly relevant for the trans-
Golgi network (TGN) and vesicular structures where it mainly lo-
calizes (Hauser et al., 1998). Near its carboxy (C)-terminal end,
BRUCE carries a ubiquitin-conjugating (UBC) domain, which en-
dows the protein with a hybrid E2/E3 ubiquitin ligase activity
(Bartke et al., 2004; Hauser et al., 1998). In vitro, BRUCE primar-
ily mono- or oligo-ubiquitylates proteins, suggesting that its main
role is non-proteolytic (Bartke et al., 2004). BRUCE-knockout
mice usually die perinatally due to impaired placental develop-
ment that can be attributed to insufficient differentiation (Lotz
et al., 2004), and depletion of BRUCE in cultured cells sensitizes
against apoptotic stimuli and finally leads to cell death (Hao et al.,
2004; Ren et al., 2005).In this report we show that BRUCE is an important novel player
of cytokinesis and important for abscission. We demonstrate
that BRUCE localizes to the midbody ring during cytokinesis,
where it binds mitotic regulators and components of the vesicle
targeting machinery. Microscopic studies and live-cell imaging
with wild-type and BRUCE-depleted cells, and of cells that
express a dominant-negative version, revealed that BRUCE is
involved in the correct delivery of membrane vesicles to the site
of abscission and for the integrity of the midbody, in particular
the midbody ring. We further discovered a remarkable dynamic
relocalization of ubiquitin from the midbody to the midbody
ring, show that both BRUCE and MKLP1 are ubiquitylated and
that UBPY serves as their deubiquitylating enzyme. Our work
suggests that this giant protein, through its multiple activities,Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc. 833
Figure 2. BRUCE Is a Component of Tubular Endosomes, Interacts with Membrane Targeting Factors, and Contains a Midbody Ring-Target-
ing Domain
(A) BRUCE localizes to Rab8 tubular endosomes in interphase cells. U2OS cells stably expressing GFP-Rab8 (green) were fixed and stained with anti-BRUCE
(red) and DAPI (blue). The scale bar represents 10 mm.
(B) BRUCE colocalizes with the exocyst component Sec8 in a perinuclear compartment. Fixed U2OS cells; anti-BRUCE (red), anti-Sec8 (green). The scale bar
represents 15 mm.
(C) BRUCE copurifies with exocyst components Sec6, Sec8, and endosomal GTPases Rab8, Rab11. HEK293T cells were transfected with either FLAG-epitope
tagged luciferase or BRUCE. Cells were lysed and FLAG-fusion proteins purified. Bound material was eluted with FLAG peptide and analyzed by western
blots (WB).
(D) Colocalization of BRUCE with Rab11 recycling endosomes in cytokinesis. Fixed HeLa cells; anti-Rab11 (red), anti-BRUCE (green), and DAPI (blue). The scale
bar represents 15 mm.
(E) Rab8 tubular endosomes are found in the midbody region. Fixed U2OS cells; anti-tubulin (blue), and propidium iodide DNA staining (red). The scale bar
represents 10 mm.834 Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc.
crucially coordinates several events that conclude cytokinesis,
and additionally uncovers a previously unrecognized role of ubiq-
uitin in this process.
RESULTS
BRUCE Localizes to the Midbody Ring and Associates
with Mitotic Regulators
BRUCE is a cytosolic protein, which is peripherally associated
with endomembranes (Hauser et al., 1998). By using three differ-
ent polyclonal antibodies directed against N- or C-terminal re-
gions of BRUCE (Bartke et al., 2004; Hauser et al., 1998)
(Figure S1 available online) we found in both HeLa and U2OS
cells that BRUCE relocalizes considerably during the cell cycle.
It concentrates in a pericentriolar compartment in interphase,
moves partially to spindle poles in metaphase, and finally local-
izes to the spindle midzone and the midbody in telophase and
during cytokinesis (Figure 1A and Figure S2). On the midbody,
BRUCE localizes in a characteristic ring-like arrangement that
is embraced by Aurora B and microtubules (Figures 1B and
1C), indicating that BRUCE is associated with the midbody
ring (Gromley et al., 2005). By using siRNAs targeting MKLP1,
a mitotic kinesin essential for the formation of the midbody ma-
trix (Matuliene and Kuriyama, 2002), we observed in midbody
forming cells a complete loss of BRUCE at the midbody (Fig-
ure 1C). In untreated cells, BRUCE localized to the midbody ring
as soon as this structure first appeared in telophase, and BRUCE
persisted on the ring even after its uptake by one of the daughter
cells after completion of abscission (Figures 1D and 1E). To
investigate membrane traffic and to trace vesicles containing
constitutively secreted cargo, we constructed a HeLa cell line
expressing HA-epitope tagged albumin. Localization of secre-
tory vesicles on the midbody ring was visible only in late cytoki-
nesis when the intercellular bridge had constricted to about
1mm in diameter, whereas BRUCE, as an apparent firm resident
of the midbody ring, localized to the midbody ring much earlier,
concurrently when it had been formed (Figure 1E).
Given its highly dynamic localization pattern during cell divi-
sion, we searched for binding partners and asked whether
BRUCE might be a target for mitotic phosphorylation. Indeed,
we found that BRUCE was particularly phosphorylated in
S-phase extracts (data not shown) and that immunopurified
BRUCE was also phosphorylated by copurified factors
(Figure S3A). By immunopurification (IP) of FLAG-tagged
BRUCE, or immunoprecipitation of endogenous BRUCE, we
found BRUCE associated with the mitotic kinases Cdk1,
MEK1, and Plk-1 (Figures S3B–S3G) and also a-tubulin (datanot shown). Moreover, overexpressed BRUCE could immuno-
precipitate endogenous survivin, and vice versa, indicating that
these two BIRPs may cooperate at the midzone or the midbody,
where both proteins were found (Figures S3H and S3I).
BRUCE Is a Component of Tubular and Recycling
Endosomes and Associates with the Exocyst
To characterize BRUCE localization further, we assayed for co-
localization with markers of the vesicular system. We found
only partial colocalization with the TGN markers golgin p230
and TGN38 (Figure S2B and Hauser et al., 1998). However, we
observed substantial colocalization with GFP-tagged versions
of the endosomal GTPases Rab8 and Rab11, even with Rab8-
positive, peripheral tubular endosomes (Figure 2A and
Figure S4A) and with the exocyst subunit Sec8 (Figure 2B). Im-
portantly, Rab8 and Rab11, as well as the exocyst subunits
Sec6 and Sec8, physically associate with BRUCE, as demon-
strated by immunoprecipitations (Figure 2C and Figures S4B
and S4C). Similar to the mitotic kinases (Figure S3B), the binding
site for the exocyst seems to lie within the N-terminal region of
BRUCE (Figure S4D) and thus involves a different region in
BRUCE than for midbody ring interaction (see below). Notably,
similar to exocyst subunit Exo70 (Vega and Hsu, 2001), BRUCE
also relocalizes to growth cones in neuronally differentiated cells
(Figure S4E), strongly indicating that BRUCE is firmly connected
to the exocyst and plays a more general role in targeted mem-
brane delivery.
Rab11 and Rab8-Endosomes Are Sources of Membrane
Material in Cytokinesis and the Midbody Ring Acts
as a Barrier
Next, we asked whether vesicles containing BRUCE participate
in cytokinesis. We could confirm previous observations (Fielding
et al., 2005) that suggested a role for recycling Rab11-endo-
somes in cytokinesis. Two pools of Rab11-endosomes were
found on both sides of the intercellular bridge during cytokine-
sis, and a small fraction also seemed to reach the midbody
ring (Figure 2D). However, in contrast to a recent report on
HeLa cells (Yu et al., 2007), we found in engineered U2OS cells
also GFP-Rab8 staining at the midbody (Figures 2E and 2F) and
also at the newly formed plasma membrane at the contact site
of dividing cells (Figure 2G). Indeed, live-cell imaging suggests
that Rab8-endosomes are delivered to the midbody ring and
that this supplied material then diffuses at the plasma mem-
brane laterally (data not shown). Remarkably, by using photo-
bleaching experiments, we found that Rab8-endosomes are un-
able to move freely from one perspective daughter cell to the(F and G) Rab8 is found at the midbody ring and at the newly formed plasma membrane between dividing cells. Fixed U2OS cells; arrowheads indicate the site of
the newly formed plasma membrane. The scale bars represent, respectively, (F) 10 mm and (G) 2 mm. The smaller figures are enlargements of the framed areas.
The position of the midbody ring is indicated by an arrow.
(H) The C terminus of BRUCE represents a midbody ring-targeting domain. GFP fused to the C terminus of BRUCE (amino acids 4711–4845, GFP-BRUCE-C) is
localized to the midbody ring. The movie stills (of Movie S5) show GFP-BRUCE-C on the midbody ring of HeLa cells. The scale bar represents 15 mm.
(I) Localization of BRUCE-C relative to centrosomes. HeLa cells transfected with GFP-BRUCE-C (green) were stained with anti-g-tubulin (red). The image shows
a merge with the bright-field channel. The scale bar represents 15 mm.
(J) The midbody ring-targeting domain of BRUCE interacts with MKLP1. Top: lysates of HEK293T cells were immunoprecipitated (IP) with either rabbit IgGs or
anti-MKLP1 antibodies and analyzed by anti-BRUCE WB. Middle: HEK293T cells transfected with GFP-FLAG-BRUCE-C were lysed and proteins immunopre-
cipitated with rabbit IgG (control) or anti-MKLP1 IgGs. Input and precipitates (IP) were analyzed by anti-FLAG blots (WB) detecting BRUCE-C. Bottom: HEK293T
cells were either transfected with empty vector or GFP-FLAG-BRUCE-C. Lysates were subjected to anti-FLAG IP and analyzed by anti-MKLP1 WB.Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc. 835
Figure 3. BRUCE Depletion Causes Cytokinesis Defects and Cytokinesis-Associated Apoptosis
(A) BRUCE depletion in U2OS cells has only minor consequences for p53 levels. Lysates of cells transfected with the indicated siRNAs were analyzed by western
blots with the indicated antibodies.
(B) BRUCE depletion in U2OS cells induces syncytia-like structures. Cells were treated with siRNAs for 3 days as shown in Figure 1C targeting lamin A/C, survivin,
or BRUCE. After 3 days of incubation, a representative area of cells was photographed (scale bar represents 20 mm), cells were harvested and prepared for
propidium iodide staining, and the DNA content of cells was analyzed by flow cytometry. The 4N peak is marked by an arrow.
(C) Cell cycle distribution after treatment with increasing concentrations of siRNA. Cells were treated with siRNA as in (A). The graph represents the cell cycle
distribution as obtained by flow cytometry of the DNA content.
(D) Defective cytokinesis after BRUCE depletion. siRNA-treated U2OS cells were observed by differential interference contrast (DIC) microscopy. The images
represent stills of movies at representative time points. The scale bar represents 20 mm.
(E) HeLa cells depleted of BRUCE undergo cytokinesis-associated apoptosis. HeLa cells were treated with siRNAs for 2 days as in (A), fixed, and stained with
anti-MKLP1 (green) and anti-a-tubulin (red). The scale bar represents 15 mm.
(F) Quantification of (E) with apoptotic cells relative to total cells and apoptotic cytokinesis versus total cells in cytokinesis (error bars represent ± SD of two
independent experiments).836 Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc.
other once the midbody ring has been assembled in telophase
(Movies S1 and S2), which differs from the otherwise mobile be-
havior of these vesicles during interphase. This finding consider-
ably substantiates the idea that midbody rings, in addition to
acting as the site for membrane delivery, may play a role as a dif-
fusion barrier in-between the two prospective daughter cells
(Schmidt and Nichols, 2004). Apparently, this barrier does not
only prevent intercellular exchange of plasma membrane-asso-
ciated material as shown before (Schmidt and Nichols, 2004),
but also of endosomal vesicles.
BRUCE Harbors a Midbody Ring-Targeting Domain
The distinctive and dynamic localization of BRUCE suggested
the presence of dedicated targeting domains. By using trunca-
tion constructs we in fact noticed that the typical localization of
BRUCE at sorting compartments requires its C-terminal region
(Figure S4F). Surprisingly, when we constructed a GFP-fusion
of the C-terminal 145 amino acids of BRUCE (termed BRUCE-
C), this construct localized exclusively to the midbody ring (Fig-
ures 2H and 2I and Movie S3 and S4). Time-lapse video micros-
copy revealed that the BRUCE-C-labeled ring-like structure
showed a degree of mobility and tilting characteristic for the mid-
body ring, and that it was taken up by one of the daughter cells
after abscission (Figure 2H and Movie S5). As the localization of
endogenous BRUCE to the midbody ring depends on MKLP1
(Figure 1C), we speculated that BRUCE-C might contain a spe-
cific interaction domain with midbody ring components. Indeed,
we found MKLP1 coprecipitating with full-length, endogenous
BRUCE (Figure 2J, top panel) and also with BRUCE-C
(Figure 2J, middle panel). Interestingly, BRUCE-C selectively
bound the faster migrating variant, MKLP1, but not CHO1,
a larger variant caused by alternative splicing that additionally
possesses an actin-interacting tail (Figure 2J, lower panel). As
both isoforms are present at the midbody (Kuriyama et al.,
2002), this finding argues for different functions of these two var-
iants during late stages of cytokinesis. Notably, the C-terminal
tail of BRUCE (BRUCE-C) is highly conserved from flies to verte-
brates, suggesting that the identified midbody ring-targeting do-
main (MTD) and the interaction with MKLP1 are features of all
BRUCE family members.
BRUCE Depletion Causes Defective Abscission
and Cytokinesis-Associated Apoptosis
Depleting BRUCE from cultured cells was previously shown to
reduce cell viability (Ren et al., 2005). To identify the basis of
this phenotype, we designed different siRNAs targeting BRUCE
(see Supplemental Experimental Procedures and Figure S5).
Delivery of BRUCE-targeted siRNA by electroporation in U2OS
cells depleted BRUCE to undetectable levels 3 days after trans-
fection (Figure 3A). These cells acquired a striking elongated
appearance and built up interconnected cells, but in contrast
to survivin depletion, no cells with giant nuclei developed
(Figure 3B and Figure S1C). Moreover, reminiscent of centriolin
depletion (Gromley et al., 2003), some apparently not com-
pletely detached cells fused again together or underwent mito-sis (data not shown and see below). Higher siRNA concentra-
tions and longer incubation times resulted in a decrease in the
amount of normal G1 phase (2N) cells (Figure 3C and data not
shown) but a strong rise of a sub-G1 population, indicative of
syncytia-like cells, which finally undergo apoptosis. However,
different from the results by Ren and coworkers (Ren et al.,
2005), no rise in the levels of p53 or of p53 targets like p21
were observed (Figure 3A), suggesting that apoptosis in these
cells is not an immediate response to BRUCE depletion but
a later corollary. Live-cell video microscopy showed that
BRUCE-depleted cells form a normal cleavage furrow, but do
not complete cytokinesis even after hours, and that some
cells even did not regain their normal flattened appearance
(Figure 3D). When we depleted BRUCE in HeLa cells, cells
underwent apoptosis, but, intriguingly, only during attempted
cytokinesis (Figures 3E–3G). After the formation of the midbody
ring, almost 60% of the cells were apoptotic (Figure 3F), and
membrane blebbing occurred already 30 min after furrowing
(Figure 3G). This suggests a mechanism by which apoptosis is
triggered by cues that originate at the midbody in the absence
of BRUCE.
BRUCE Is Involved in Membrane Delivery
to the Midbody Ring
Because BRUCE-C binds to the midbody ring so well, we won-
dered whether we could utilize it as a dominant-negative tool
specifically to monitor the function of BRUCE at this location. In-
deed, overexpression of BRUCE-C could displace endogenous
BRUCE from MKLP1 and the midbody ring (Figure 4A) and led to
aberrant cytokinesis and binucleation (Figures 4B and 4C). Nota-
bly, after prolonged expression of BRUCE-C for 3 days, apopto-
sis occurred (Figure S6), indicating that the apoptotic signal is in
fact triggered by the absence of BRUCE from the midbody ring.
When we analyzed HeLa cells that stably express tagged albu-
min, we found secretory vesicles within the intercellular bridge.
Intriguingly, however, cells overexpressing BRUCE-C showed
single balloon-like accumulations of cargo-containing vesicles
in close proximity to the intercellular bridge, but only on one of
its sides (Figure 4B). From these findings we conclude that the
presence of BRUCE at the midbody is needed for normal delivery
of vesicles to the site of abscission and that prolonged absence
of BRUCE interferes with cytokinesis.
To corroborate BRUCE’s role in vesicle traffic, we next ad-
dressed in U2OS cells that stably express GFP-Rab11 whether
also siRNA-directed BRUCE depletion interferes with normal
membrane targeting. When we examined control cells (trans-
fected with a control siRNA) that had just completed cytokinesis
(Figure 4D, upper panel), Rab11 had already adopted typical in-
terphase localization and phosphotyrosine was found on the
midbody as reported (Kasahara et al., 2007). In striking contrast,
BRUCE-depleted cells accumulated Rab11-endosomes, as well
as phosphotyrosine-positive material, in close proximity to one
side of the midbody (Figure 4D, lower panel). This finding con-
firms our conclusion that BRUCE is needed for the targeting of
vesicles to the midbody, and further suggests that BRUCE is(G) Stills with DIC live-cell microscopy of HeLa cells treated with lamin siRNA (top) or BRUCE siRNA (bottom) for 2 days. Note that cells depleted for BRUCE
undergo apoptosis after attempted cytokinesis. The scale bar represents 15 mm.Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc. 837
Figure 4. BRUCE Functions in Membrane Delivery to the Midbody Ring
(A) Exogenously expressed BRUCE fragment containing the midbody ring-targeting domain competes with endogenous BRUCE for midbody ring binding via
MKLP1. HEK293T cells were transfected with increasing amounts of GFP-BRUCE-C and decreasing amounts of GFP. Lysates (inputs are shown in the left panel)
were subjected to immunoprecipitation (IP) with rabbit IgGs (control) or anti-MKLP-1 antibodies, and precipitated proteins were analyzed by western blots. Com-
petition on the single-cell level is shown for HeLa cells by immunofluorescence (endogenous, full-length BRUCE, red; GFP-BRUCE-C, green; DNA stained with
DAPI). The arrowhead marks the midbody ring. The scale bar represents 10 mm.
(B) Expression of BRUCE-C leads to secretory vesicle accumulation in close vicinity to the midbody ring. Top: enlarged midbody region of a HeLa cell stably
expressing albumin (green; cells as in Figure 1E) and stained for endogenous BRUCE (red). Bottom: similar to above, but cells were transfected with GFP-
BRUCE-C (green), fixed, and stained. A representative cell in cytokinesis is shown with the enlarged midbody region on the right. The scale bar represents
10 mm; scale bar of clippings represents 2 mm.838 Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc.
crucial for the presence of tyrosine kinases at the midbody as
well. Both functions might be linked, however, as sorting of Src
and ERK to the midbody seems to depend on Rab11 (Kasahara
et al., 2007).
Midbodies and Midbody Rings Are Platforms
for Ubiquitylation
Since BRUCE possesses ubiquitin ligase activity (Bartke et al.,
2004; Hauser et al., 1998), we next asked whether the midbody
ring might be a site of ubiquitylation. Contrary to the current be-
lief (Pines and Lindon, 2005), we could observe a dramatic reloc-
alization of ubiquitin during cytokinesis (Figure 5A and Movie S6)
using a cell line that stably expresses a GFP-ubiquitin fusion pro-
tein that can form conjugates in vivo (Dantuma et al., 2006). Par-
allel to the formation of the midbody ring in late telophase, ubiq-
uitin is first concentrated on midzone microtubules but not on the
midbody ring. However, once the microtubules start to constrict
to form the midbody, the bulk of ubiquitin vanishes rapidly from
this area, but after a brief period of absence, reappears concen-
trated on the midbody ring.
Motivated by this so far unrecognized behavior of ubiquitin, we
performed fluorescent recovery after photobleaching (FRAP)
experiments with U2OS cells to address the dynamics of this
unusual process. In contrast to normal ubiquitin pools in the
same cell in the cytosol or on midbody microtubules, ubiquitin
on the midbody ring during cytokinesis showed a vastly reduced
recovery (Figure 5B, left panels). Moreover, also midbody rings
that had already been taken up by one daughter after completed
cytokinesis showed virtually no recovery (Figure 5B, right
panels). This suggests that ubiquitin has a high turnover at the
midbody through active ubiquitylation and deubiquitylation of
proteins near the midbody microtubules. In striking contrast,
ubiquitin on midbody ring components, once this modification
had occurred, can barely be replaced, suggesting that the local
ubiquitylation activity is turned off at this stage. Notably, BRUCE
and ubiquitin are closely associated during cell division and co-
localize at the midbody ring during late cytokinesis (Figure 5C),
suggesting that at least some of the detected ubiquitylation
may be mediated by BRUCE (see Discussion).
Relocalization of ubiquitin during cytokinesis was similar in
HeLa cells (Figure 5D, top panel), and cells of both cell lines often
harbored besides the midbody ring engaged in cytokinesis one
or rarely two additional rings, which most likely represent rem-
nants from previous divisions. Intriguingly, only the putative ac-
tive midbody ring in the intercellular bridge was decorated with
ubiquitin whereas the midbody ring remnants had apparently
gradually lost the modification (Figure 5D, lower panel). This
finding is in agreement with our FRAP data (Figure 5B), showing
that ubiquitylation of the midbody ring occurs only once during
cytokinesis, before the onset of abscission.
BRUCE is known to homooligomerize (Bartke et al., 2004) and
seems to associate in part with the deubiquitylating enzymeUBPY (alias USP8) and the RING-finger ubiquitin ligase Nrdp1
(alias FLRF) (Wu et al., 2004). We therefore asked whether deubi-
quitylating activity might influence midbody localized ubiquitin as
well. By using a catalytically inactive form of UBPY (UBPYC > A)
that serves as a substrate trap (Alwan and van Leeuwen, 2007),
we observed that it bound both BRUCE and MKLP1 (Figure 5E).
Intriguingly, also UBPYC > A localizes to the midbody ring
(Figure S7), suggesting that ubiquitylation and deubiquitylation
activities may perhaps work as a switchboard at this site. BRUCE
itself is ubiquitylated at its C-terminal domain (data not shown)
and this modification is enhanced upon Nrdp1 overexpression,
and conversely lost when UBPY is overexpressed (Figure 5F).
Using a denaturing purification protocol that preserves ubiquitin
modifications we also found that MKLP1 is modified by mono-/
oligo- but not poly-ubiquitylation, and that this modification is
strongly reduced if UBPY was overexpressed (Figure 5G). While
BRUCE overexpression triggered no increase in MKLP1 ubiqui-
tylation (data not shown), overexpression of the dominant-nega-
tive UBPYC > A version induced this modification (Figure 5G),
suggesting that another ubiquitin ligase acts on MKLP1, or that
deubiquitylation rather than ubiquitylation activity might be
limiting and important for regulation. In fact, more than 30% of
HeLa cells transfected with UBPYC > A exhibited cytokinesis
defects linked with binucleation and mislocalized MKLP1 from
its normal interphase localization in the nucleus to the cytoplasm
(Figure 5H). This phenotype is reminiscent of an MKLP1 knock-
down, suggesting that perhaps UBPY-mediated deubiquitylation
of MKLP1 may trigger nuclear import, which appears to be
needed for normal cytokinesis (Liu and Erikson, 2007).
BRUCE Is Crucial for Midbody Integrity,
Midbody Ring Formation, and Midbody-Localized
Ubiquitin
Prompted by the striking physical and functional connection of
BRUCE with the midbody and the midbody ring, we next asked
whether BRUCE itself is crucial for the organization of these
structures. Indeed, we observed significantly reduced MKLP1-
positive midbody material in BRUCE-depleted cells (Figure 6A
and see also Figure 4D). Additionally, we detected a gradual
effect on the midbody structure upon continued BRUCE deple-
tion. Depletion for no more than three days led to moderately
misorganized midbodies with unfocused Aurora B staining
(Figure 6B, top panel) and unconstricted microtubules
(Figure 6C, top panel). However, BRUCE depletion for five
days resulted in syncytia-like cells, which contained severely
malformed midbodies, as visualized by Aurora B or MKLP1
staining (Figures 6B and 6C lower panels). In the end, most cells
failed to form their midbody rings altogether and no remnants
persisted, and those few cells that retained their midbody rings
(less than 10%), had hitherto not adopted a syncytia-like appear-
ance (Figures 6D and 6E). We also explored whether BRUCE
depletion affects the distribution of ubiquitin at the midbody.(C) Prolonged expression of BRUCE-C leads to binucleation and apoptosis. HeLa cells were transfected either with GFP or GFP-BRUCE-C, stained with propi-
dium iodide 1 and 3 days after transfection and DNA content was analyzed by flow cytometry gating for transfected cells.
(D) Recycling endosomes accumulate close to the midbody ring in BRUCE-depleted cells. U2OS cells stably expressing GFP-Rab11 (green) were treated with
siRNAs as in Figure 1C fixed and stained for MKLP1 (blue) and phosphotyrosine (pY, red) with enlarged views of the midbody ring on the right. The scale bar
represents 15 mm; scale bar of clippings represents 1 mm.Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc. 839
Figure 5. Ubiquitylation on the Midbody Ring
(A) Ubiquitin (Ub) is concentrated on midbody microtubules and reappears on the midbody ring after midbody constriction. U2OS cells stably expressing GFP-
tagged ubiquitin (GFP-Ub) were analyzed by time-lapse video microscopy. A representative cell is shown with the movie stills (of Movie S6) starting in prome-
taphase and ending shortly before abscission. The scale bar represents 20 mm.
(B) Ubiquitin at the midbody ring shows almost no exchange with the cellular ubiquitin pool. U2OS cells as in (A) were used for FRAP experiments. Left: a cell with
ubiquitin on the midbody ring was bleached in the cytoplasm or at the midbody ring. The recovery of the fluorescence signal is shown on the right. Right: a cell with
a midbody ring remnant in the plane of the plasma membrane was either bleached in the cytoplasm or at the midbody ring remnant. Only fluorescence recovery
curves are shown. The scale bar represents 20 mm.
(C) Association of BRUCE with ubiquitin at the midbody ring. U2OS cells were transiently transfected with HA-epitope tagged ubiquitin (HA-Ub, red). Cells were
fixed and stained with anti-BRUCE (green) and DAPI (blue). The scale bar represents 10 mm. The framed areas are shown enlarged.840 Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc.
Indeed, in contrast to cells treated with a control siRNA
(Figure 6F, upper panel, and Movie S7), cells depleted for
BRUCE neither showed a distinct ubiquitin staining at midbody
microtubules nor at the surviving midbody rings (Figure 6F, lower
panel and Movie S8). These results suggest that BRUCE is not
only crucial for normal vesicle targeting to the site of abscission,
but also for the integrity of the midbody and the midbody ring,
and its striking ubiquitin modification.
DISCUSSION
The two most perceptible processes of cytokinesis of animal
cells, the contraction of the cleavage furrow and the physical
separation of the daughter cells by abscission, are now recog-
nized as two functionally and mechanistically different steps.
Central to abscission is the midbody, which is the target site
for membrane delivery and membrane fusion, the driving forces
of abscission. In particular the unique midbody ring, located at
the midpoint of the intercellular bridge, has drawn attention re-
cently as it seems to be the key structural element that guides
the events that lead to abscission. This rigid and unvaryingly
sized structure, originally described by Flemming as ‘‘Zentral-
körper’’ (Flemming, 1891), thus sometimes called ‘‘Flemming
body,’’ materializes in telophase and survives in one daughter
cell often until the next division.
In this report, we identified BRUCE as a constant companion
of the midbody ring and found that its normal assembly requires
BRUCE. Moreover, we found that BRUCE is crucial for mem-
brane delivery to the cleavage site and for normal abscission.
Membrane Dynamics
Recent studies have emphasized the decisive role of plasma
membrane reorganization during abscission (Albertson et al.,
2005). This process requires vesicle-mediated transport and
the incorporation of additional membrane to the site of abscis-
sion by hetero- and homotypic membrane fusion events. As
shown previously for (Rab11-positive) recycling endosomes,
our data suggest that also (Rab8-positive) tubular endosomes
significantly contribute to membrane dynamics during cytokine-
sis (Figure 2G). Previous studies suggested that membrane de-
livery to the midbody occurs largely asymmetric, i.e., only from
one of the prospective daughter cells. However, when we mon-
itored cargo delivery or endosomal sorting in unperturbed U2OS
cells (which may require more membrane reshaping than HeLacells) we failed to detect any marked asymmetry of membrane
delivery to the intercellular bridge. However, upon interfering
with BRUCE function by either BRUCE depletion or overexpres-
sion of the dominant-negative BRUCE-C variant (that does not
bind the exocyst or Rab8/11 GTPases) cells strikingly accumu-
lated large vesicular structures close to only one side of the mid-
body ring. Thus abscission has indeed an intrinsic asymmetric
contribution, and BRUCE appears to be crucial for normal vesi-
cle targeting. In fact, BRUCE seems well equipped to function as
a midbody targeting factor for vesicles as it binds via its N-termi-
nal region to the exocyst and endosomal components and via its
C-terminal targeting domain to the midbody ring.
BRUCE and the Midbody Ring
Our studies suggest an intimate relationship between BRUCE
and the midbody ring. In interphase cells, BRUCE localizes to
the TGN and endosomes, but during cytokinesis, a fraction
moves to the midzone where it specifically arrives at the midbody
ring. Notably, BRUCE associates with the midbody ring concom-
itantly with its appearance in telophase, travels after completed
abscission with the midbody ring into one daughter cell, and re-
mains bound to the discarded midbody ring all along until a new
ring is formed during the next cell division (Figure 1A and 5D).
Most importantly, BRUCE depletion prevents normal midbody
ring formation, suggesting that its activity may indeed be re-
quired for proper ring assembly.
The midbody ring appears to mediate at least two functions.
First, it seems to play a role as the docking site for vesicles,
which supply the plasma membrane with new material at the
site of abscission. As detailed above, BRUCE is crucial for this
process. Second, perhaps similar to the septin ring of yeast
(Faty et al., 2002), the midbody ring seems to function as a diffu-
sion barrier. Previous studies indicated that the midbody ring
prevents plasma membrane diffusion across the intercellular
bridge (Schmidt and Nichols, 2004). Our FRAP experiments ex-
tend these findings as they indicate that also Rab8-endosomes
are unable to transverse the ring from one prospective daughter
cell to the other. Therefore, the midbody ring may represent the
first physical barrier that disunites the daughter cells. As ob-
served before (Gromley et al., 2005), perhaps fueled by asym-
metric membrane delivery, the midbody ring is pushed to one
daughter cell where it is eventually dissolved. As BRUCE follows
the same path, even the final fate of the midbody ring appears to
be allied with BRUCE.(D) Ubiquitin is lost from midbody ring remnants when cells acquired an active midbody ring. HeLa cells were transfected with GFP-Ub (green). Top panels show
fixed cells in telophase with anti-MKLP1 staining (red). Lower panels show a cell in late cytokinesis with a putative active midbody ring and a remnant, both lying in
the intercellular bridge. Note that the midbody ring remnant (open arrowhead) is not labeled with ubiquitin. The scale bar represents 10 mm and 2 mm (for enlarged
areas).
(E) Both BRUCE and MKLP1 interact with UBPY. HEK293T cells were transfected with empty vector or FLAG-epitope tagged UBPY and its catalytically inactive
mutant (C > A). Cells were lysed and proteins were immunoprecipitated (IP) with anti-FLAG and analyzed by western blots (WB).
(F) BRUCE is deubiquitylated by UBPY. HEK293T cells were transfected with empty vector and HA-tagged ubiquitin (HAUb) in combination with FLAG-tagged
UBPY wild-type and mutant proteins (FLAGUBPY, FLAGUBPY(C > A)) and FLAG-tagged Nrdp1 (FLAGNrdp1). Lysates were prepared and subjected to anti-HA
immunoprecipitation, and both lysates (Input) and immunoprecipitated material (IP) were analyzed by western blots (WB).
(G) MKLP1 is ubiquitylated in cells and is deubiquitylated by UBPY. HEK293T cells were transfected with HAUb or His6-epitope tagged ubiquitin (His6-Ub) in
combination with FLAGUBPY and FLAGUBPY(C > A). Lysates were subjected to denaturing Ni-NTA pull down and analyzed by western blots (WB).
(H) Overexpression of catalytically inactive UBPY leads to MKLP1 mislocalization and binucleation of cells. HeLa cells were transfected with empty vector (mock)
or FLAGUBPY(C > A). Left: cells were fixed and stained with anti-MKLP1 (green) and anti-FLAG (red) antibodies. The open arrowhead marks a transfected cell. The
scale bar represents 15 mm. Right: quantification of binucleate versus total cells (two independent experiments labeled #1 and #2, respectively).Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc. 841
Figure 6. BRUCE Depletion Causes Structural Aberrations of the Midbody and Ubiquitin Mislocalization
(A) Reduced midbody material after BRUCE depletion as revealed by MKLP1 staining. U2OS cells were treated with siRNAs targeting lamin A/C or BRUCE as in
Figure 1B. After 3 days, cells were fixed and stained with anti-a-tubulin (green) or anti-MKLP1 (red) antibodies. The scale bar represents 15 mm.
(B) Misorganization and rupture of the midbody after BRUCE depletion. U2OS cells were treated with siRNAs as in (A). Cells were fixed after 3 days and stained
with anti-Aurora B (green) antibodies and DAPI. Top: BRUCE-depleted cells that have hitherto not acquired an elongated appearance exhibit aberrant midbodies
(shown enlarged in insets) (scale bar y 15 mm). Bottom: BRUCE-depleted cells that resemble syncytia contain fragmented Aurora B-positive material. The scale
bar represents 20 mm.
(C) Midbody ring rupture in BRUCE-depleted cells as indicated by MKLP1 localization. The experiment was performed as in (B), and cells were fixed either after
3 or 5 days, stained for MKLP1 (green), a-tubulin (red), or DNA with DAPI (blue). After 5 days of siRNA treatment, syncytial cells arose with aberrant midbody rings
(arrowheads). The scale bar represents 10 mm.
(D) Growth retardation and loss of midbody rings after BRUCE depletion. Experiment was performed as in (B); cells were fixed after 5 days and stained with anti-
MKLP1 (green) and DAPI. Arrowheads point to MKLP1-stained midbody rings.
(E) Quantification of (D). The scale bar represents 30 mm.
(F) Concentration of ubiquitin at the midbody is lost in BRUCE-depleted cells. U2OS cells stably expressing GFP-Ub (see Figure 5A) were analyzed by time-lapse
video microscopy. Stills are from Movie S8. The scale bar represents 15 mm.BRUCE Is Crucial for Faithful Cell Division
A further consequence of BRUCE depletion is the appearance of
syncytial cells and sometimes a reunion followed by mitosis of
apparently incompletely separated cells (Movie S8). Syncytial
cells also form upon centriolin depletion (Gromley et al., 2005),
suggesting that perhaps BRUCE and centriolin, a protein of un-842 Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc.known biochemical activity, fulfill related or coupled functions in
cytokinesis. Although BRUCE/ embryos survive embryogene-
sis and usually die only shortly before birth, we also noticed a
delay in cell cycle progression of mouse embryonic fibroblasts
(MEFs) isolated from BRUCE/ embryos (Lotz et al., 2004)
and aberrant divisions characterized by multipolar spindles
and tripolar cytokinesis in spontaneously immortalized BRUCE/
MEFs (unpublished data). This suggests that cells may adapt to
a loss of BRUCE activity, however, with the predisposition (per-
haps depending on the cell type) of erroneous cell divisions. In-
triguingly, BRUCE depletion in HeLa cells induces apoptosis
precisely at the time of attempted abscission (Figure 3G). Since
we also observed apoptosis upon prolonged expression of
BRUCE-C, which displaces endogenous BRUCE from the mid-
body ring (Figure S6D), the apoptotic cue seems to materialize
specifically when BRUCE is absent from this structure. As
BRUCE possesses antiapoptotic activity and binds caspases
(Bartke et al., 2004), it seems reasonable to assume that the ob-
served cell death may be a direct consequence of the lack of
BRUCE activity at the midbody ring. Notably, BRUCE also phys-
ically associates with survivin, which also localizes to the mid-
body, and BRUCE is able to ubiquitylate this BIRP in vitro
(Figure S3 and data not shown). It thus seems attractive to spec-
ulate that perhaps BRUCE and survivin normally collaborate, and
that BRUCE depletion alters the local antiapoptotic activity with
possible consequences for caspase activation (O’Connor et al.,
2000).
Ubiquitin Dynamics During Cytokinesis
In this study we discovered a unique and highly dynamic localiza-
tion pattern of ubiquitin conjugates at the midbody during cytoki-
nesis. At the time when the actomyosin ring has maximally con-
stricted, ubiquitin is unusually concentrated in two large foci
symmetrically localized near both plus-end tips of midbody mi-
crotubules (Figure 5A). This almost compartmentalized compac-
tion may be indicative of a concentration of ubiquitylation/deubi-
quitylation activities and extensive protein turnover at these sites.
It seems attractive to speculate that substrates may include mi-
totic regulators or components of the vesicular sorting machin-
ery. Strikingly, in the succeeding 15–30 min interval, ubiquitin dis-
appeared from the midbody to undetectable levels, but
reappears firmly associated with the midbody ring. Ubiquitylation
of the midbody ring seems to occur only once during cytokinesis
and appears to be stable until abscission is completed, as indi-
cated by our photobleaching experiments. Furthermore, this
modification appears to be largely mono-ubiquitin as indicated
by the fact that conjugates of GFP-ubiquitin, in which the ubiqui-
tin domain lacks lysine residues (GFP-ubiquitin-K0), enriched
normally at the midbody ring but not at the midbody flanks
(Figure S8). Together these data suggest that midbody ring
(mono) ubiquitylation may serve structural or regulatory functions
rather than promoting proteasomal proteolysis.
As BRUCE is tightly connected to the midbody ring and re-
quired for its integrity, it seems reasonable to speculate that its
ubiquitin ligase activity may contribute to these ubiquitylation
events. However, ubiquitylation is also required for protein sort-
ing via the ESCRT pathway, which plays a role in cytokinesis
(Carlton and Martin-Serrano, 2007; Morita et al., 2007). In fact,
the BRUCE-associated deubiquitylating enzyme UBPY harbors
a so-called MIT-domain that mediates association with proteins
of the ESCRTIII complex (Row et al., 2007). Moreover, disassem-
bly of the ESCRTIII complex is thought to be catalyzed by Vps4,
an AAA-ATPase that seems to play a crucial role at late stages of
cytokinesis (Morita et al., 2007). Whatever the crucial ubiquityla-tion targets are, the unique combination of multiple activities in
a single large protein suggests that BRUCE may coordinate cy-
tokinesis events perhaps in a stepwise fashion. Strikingly, after
completed cytokinesis, midbody ring-localized BRUCE is dis-
carded into only one of the two daughter cells as well, possibly
representing the final manifestation of the apparent built-in
asymmetry of cytokinesis.
EXPERIMENTAL PROCEDURES
Plasmids and siRNA
Cloning of BRUCE and engineering of mutants and truncations was described
previously (Bartke et al., 2004; Hauser et al., 1998). BRUCE cDNAs were ex-
pressed from pCI (Promega) or pCMV2 vectors (Stratagene) as was FLAG-
tagged cDNA of luciferase. GFP-BRUCE-C (amino acids 4711–4845) was
cloned into pEGFP-CI (Clontech) using an internal XhoI site (bp 14135).
Nrdp1 was amplified from HeLa mRNA using primers that generate an N-ter-
minal FLAG-epitope tag and cloned into pCI. GFP-Rab8 was a gift of J. Perä-
nen, GFP-Rab11 was obtained from M. Zerial, GFP-ubiquitin and GFP-ubiqui-
tin-K0 were gifts of N. Dantuma, HA-epitope-tagged rat albumin was a gift of
D. LeBel and FLAG-epitope-tagged UBPY and its mutant were from H. Alwan.
Antibodies
A detailed list of antibodies can be found in the Supplemental Experimental
Procedures.
Cell Culture and Transfections
U2OS, HeLa, and HEK293T cells were maintained at 37C, 7.5% CO2 in
DMEM (SIGMA) supplemented with 10% FCS. Transient transfections were
performed in 10 cm dishes (293T) or 6-well plates (HeLa) using calcium phos-
phate or lipofection protocols, as described previously (Bartke et al., 2004).
U2OS cells were transfected by electroporation using AMAXA Nucleofector
kit according to the manufacturer’s recommendations. siRNA duplexes
were obtained from MWG and were transfected at a final concentration of
100 nM. siRNA sequences are listed in supplemental material and methods.
HeLa cells stably expressing HA-rAlb and U2OS cells stably expressing
GFP-Rab8, GFP-Rab11 and GFP-ubiquitin were generated by selecting cells
with 750 mg/ml G418 (SIGMA) after lipofection for 3–4 weeks.
Flow Cytometry
DNA histograms were obtained by flow cytometry of PI-stained ethanol-fixed
cells using standard protocols, a FACSCalibur system and CELLQuest analy-
sis software (Becton Dickinson).
Coimmunoprecipitations and Immunoblot Analysis
Immunoprecipitations, purification of FLAG-fusion proteins, and immunoblot
analysis were carried out as described previously (Bartke et al., 2004).
Denaturating Ni-NTA Pull-Down
Transiently transfected HEK293T cells were harvested and pellets were
washed once in PBS. Cells were lysed in 6 M guanidine-HCl, 0.1M NaH2PO4,
0.1% Tween-20, 0.01M Tris (pH 8.0). Lysates were briefly sonicated to shear
DNA. An aliquot of the lysate was kept for TCA precipitation. The remaining ly-
sate was incubated with Ni-NTA agarose beads (QIAGEN) for 3–5 hr. Beads
were washed 5 times with 8 M urea, 0.1 M NaH2PO4, 0,1% Tween-20,
0.01M Tris (pH 8.0), and twice with PBS, 0.01% Tween-20. TCA precipitates
and beads were boiled in loading buffer and subjected to SDS-PAGE and
immunoblotting.
Immunofluorescence and Live-Cell Microscopy
Immunofluorescence was performed according to standard protocols after
fixation in methanol (20C, 3 min). Images were acquired on a Leica DM
RXA microscope equipped with a Hamatsu ORCA-ER camera. Image acquisi-
tion and deconvolution of images was carried out using Openlab software. For
fluorescence live-cell video microscopy and photobleaching experiments,Cell 132, 832–845, March 7, 2008 ª2008 Elsevier Inc. 843
U2OS cells were cultured in 35 mm m-dishes with No. 1.5 bottom (Integrated
BioDiagnostics). Confocal laser scanning microscopy was performed with
a Leica TCS SP2 confocal scanning microscope. Live-cell video microscopy
and FRAP were carried out on an AppliedPrecision DeltaVision RT system
equipped with a quantifiable laser module. After photobleaching of the GFP
fluorescence with 25%–50% laser intensity, images were obtained every sec-
ond during a time frame of 3 min. Fluorescence intensities were measured and
quantified and images processed using SoftWorx software (AppliedPrecision).
For live-cell video microscopy, DIC or phase and fluorescence images were
taken every 1–5 min over a time frame of 10–48 hr.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, Supple-
mental References, eight figures, and eight movies and can be found with
this article online at http://www.cell.com/cgi/content/full/132/5/832/DC1/.
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